ID,Study,Reference,Grouping,Analyte,t0,tend,t Unit,AUC Avg,AUC AvgUnit,AUC AvgType,AUC Var,AUC VarUnit,AUC VarType,AUC Type,Cmax Avg,Cmax AvgUnit,Cmax AvgType,Cmax Var,Cmax VarUnit,Cmax VarType,Cmax Type,CL Avg,CL AvgUnit,CL AvgType,CL Var,CL VarUnit,CL VarType,CL Type,Comment
61,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Normal,Buspirone,0,inf,h,2.89,ng*h/mL,arith. mean,3.4,ng*h/mL,arith. SD,AUC_inf,1.01,ng/mL,arith. mean,0.87,ng/mL,arith. SD,Cmax,,,,,,,,
62,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Renal mild,Buspirone,0,inf,h,6.63,ng*h/mL,arith. mean,4.59,ng*h/mL,arith. SD,AUC_inf,2.48,ng/mL,arith. mean,2.12,ng/mL,arith. SD,Cmax,,,,,,,,
63,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Renal moderate,Buspirone,0,inf,h,4.64,ng*h/mL,arith. mean,3.7,ng*h/mL,arith. SD,AUC_inf,1.81,ng/mL,arith. mean,1.17,ng/mL,arith. SD,Cmax,,,,,,,,
64,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Renal severe,Buspirone,0,inf,h,4.09,ng*h/mL,arith. mean,3.35,ng*h/mL,arith. SD,AUC_inf,1.83,ng/mL,arith. mean,1.26,ng/mL,arith. SD,Cmax,,,,,,,,
65,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Hepatic compensated,Buspirone,0,inf,h,15.4,ng*h/mL,arith. mean,12.5,ng*h/mL,arith. SD,AUC_inf,4.61,ng/mL,arith. mean,3.64,ng/mL,arith. SD,Cmax,,,,,,,,
66,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Hepatic decompensated,Buspirone,0,inf,h,70.2,ng*h/mL,arith. mean,65.3,ng*h/mL,arith. SD,AUC_inf,11.7,ng/mL,arith. mean,8.66,ng/mL,arith. SD,Cmax,,,,,,,,
67,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Normal,Buspirone,96,108,h,1.9,ng*h/mL,arith. mean,2.63,ng*h/mL,arith. SD,AUC_tau,0.96,ng/mL,arith. mean,1.13,ng/mL,arith. SD,Cmax,,,,,,,,
68,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Renal mild,Buspirone,96,108,h,9.18,ng*h/mL,arith. mean,6.22,ng*h/mL,arith. SD,AUC_tau,3.42,ng/mL,arith. mean,2.09,ng/mL,arith. SD,Cmax,,,,,,,,
69,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Renal moderate,Buspirone,96,108,h,6.58,ng*h/mL,arith. mean,6.53,ng*h/mL,arith. SD,AUC_tau,4.26,ng/mL,arith. mean,4.64,ng/mL,arith. SD,Cmax,,,,,,,,
70,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Renal severe,Buspirone,96,108,h,10,ng*h/mL,arith. mean,10.8,ng*h/mL,arith. SD,AUC_tau,4.74,ng/mL,arith. mean,5.72,ng/mL,arith. SD,Cmax,,,,,,,,
71,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Hepatic compensated,Buspirone,96,108,h,27.6,ng*h/mL,arith. mean,44.7,ng*h/mL,arith. SD,AUC_tau,13.46,ng/mL,arith. mean,23.89,ng/mL,arith. SD,Cmax,,,,,,,,
72,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Hepatic decompensated,Buspirone,96,108,h,54,ng*h/mL,arith. mean,33.5,ng*h/mL,arith. SD,AUC_tau,13.1,ng/mL,arith. mean,9.8,ng/mL,arith. SD,Cmax,,,,,,,,
73,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Normal,Buspirone,96,108,h,2.91,ng*h/mL,arith. mean,3.37,ng*h/mL,arith. SD,AUC_tau,1.08,ng/mL,arith. mean,0.8,ng/mL,arith. SD,Cmax,,,,,,,,
74,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Renal mild,Buspirone,216,228,h,13.6,ng*h/mL,arith. mean,15.1,ng*h/mL,arith. SD,AUC_tau,5.38,ng/mL,arith. mean,5.4,ng/mL,arith. SD,Cmax,,,,,,,,
75,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Renal moderate,Buspirone,216,228,h,9.58,ng*h/mL,arith. mean,11.6,ng*h/mL,arith. SD,AUC_tau,4.03,ng/mL,arith. mean,3.97,ng/mL,arith. SD,Cmax,,,,,,,,
76,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Renal severe,Buspirone,216,228,h,11.1,ng*h/mL,arith. mean,10.1,ng*h/mL,arith. SD,AUC_tau,4.61,ng/mL,arith. mean,3.52,ng/mL,arith. SD,Cmax,,,,,,,,
77,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Hepatic compensated,Buspirone,216,228,h,24.8,ng*h/mL,arith. mean,33.5,ng*h/mL,arith. SD,AUC_tau,9.78,ng/mL,arith. mean,15.7,ng/mL,arith. SD,Cmax,,,,,,,,
78,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Hepatic decompensated,Buspirone,216,228,h,54.5,ng*h/mL,arith. mean,36.2,ng*h/mL,arith. SD,AUC_tau,13,ng/mL,arith. mean,8.51,ng/mL,arith. SD,Cmax,,,,,,,,
123,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 5,Buspirone,144,156,h,0.69,ng*h/mL,geo. mean,80,%,geo. CV,AUC_tau,0.25,ng/mL,geo. mean,93,%,geo. CV,Cmax,,,,,,,,
124,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 10,Buspirone,264,276,h,1,ng*h/mL,geo. mean,73,%,geo. CV,AUC_tau,0.44,ng/mL,geo. mean,83,%,geo. CV,Cmax,,,,,,,,
125,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 15,Buspirone,384,396,h,2.3,ng*h/mL,geo. mean,73,%,geo. CV,AUC_tau,1.1,ng/mL,geo. mean,79,%,geo. CV,Cmax,,,,,,,,
126,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 20,Buspirone,504,516,h,3.4,ng*h/mL,geo. mean,64,%,geo. CV,AUC_tau,1.3,ng/mL,geo. mean,63,%,geo. CV,Cmax,,,,,,,,
127,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 25,Buspirone,624,636,h,4.7,ng*h/mL,geo. mean,82,%,geo. CV,AUC_tau,2,ng/mL,geo. mean,101,%,geo. CV,Cmax,,,,,,,,
134,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Autistic children,Buspirone,0,inf,h,,,,,,,,1141.3,pg/mL,arith. mean,748,pg/mL,arith. SD,Cmax,87.8,L/h/kg,arith. mean,44.8,L/h/kg,arith. SD,CL/F,
168,Gammans 1986,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Intravenous 1mg (n=8),Buspirone,0,inf,h,9.25,ng*h/mL,arith. mean,5.42,ng*h/mL,arith. SEM,AUC_inf,,,,,,,,,,,,,,,
169,Gammans 1986,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Oral 20 mg (n=8),Buspirone,0,inf,h,6.31,ng*h/mL,arith. mean,6.31,ng*h/mL,arith. SEM,AUC_inf,2.47,ng/mL,arith. mean,2.11,ng/mL,arith. SEM,Cmax,,,,,,,,
165,Gammans 1985,https://www.ncbi.nlm.nih.gov/pubmed/2860931,10 mg,Buspirone,0,inf,h,2.7,ng*h/mL,arith. mean,1.4,ng*h/mL,arith. SD,AUC_inf,0.88,ng/mL,arith. mean,0.4,ng/mL,arith. SEM,Cmax,,,,,,,,means taken from Gammans 1986 Table III
166,Gammans 1985,https://www.ncbi.nlm.nih.gov/pubmed/2860931,20 mg,Buspirone,0,inf,h,4.69,ng*h/mL,arith. mean,2.4,ng*h/mL,arith. SD,AUC_inf,1.66,ng/mL,arith. mean,1,ng/mL,arith. SEM,Cmax,,,,,,,,means taken from Gammans 1986 Table III
167,Gammans 1985,https://www.ncbi.nlm.nih.gov/pubmed/2860931,40 mg,Buspirone,0,inf,h,9.43,ng*h/mL,arith. mean,4.9,ng*h/mL,arith. SD,AUC_inf,3.22,ng/mL,arith. mean,2,ng/mL,arith. SEM,Cmax,,,,,,,,means taken from Gammans 1986 Table III
230,Hanley 2013,https://www.ncbi.nlm.nih.gov/pubmed/22943633,Control (Perpetrator Placebo),Buspirone,0,inf,h,3.11,ng*h/mL,arith. mean,0.52,ng*h/mL,arith. SEM,AUC_inf,1.14,ng/mL,arith. mean,0.24,ng/mL,arith. SEM,Cmax,78,L/min,arith. mean,20,L/min,arith. SEM,CL/F,
231,Hanley 2013,https://www.ncbi.nlm.nih.gov/pubmed/22943633,with Perpetrator (GFJ),Buspirone,15,inf,h,6.15,ng*h/mL,arith. mean,0.92,ng*h/mL,arith. SEM,AUC_inf,1.53,ng/mL,arith. mean,0.2,ng/mL,arith. SEM,Cmax,33,L/min,arith. mean,7,L/min,arith. SEM,CL/F,
317,Kivistö 1997,https://www.ncbi.nlm.nih.gov/pubmed/9333111,Control (Perpetrator Placebo),Buspirone,0,inf,h,3.3,ng*h/mL,arith. mean,3.9,ng*h/mL,arith. SD,AUC_inf,1,ng/mL,arith. mean,0.99,ng/mL,arith. SD,Cmax,,,,,,,,
318,Kivistö 1997,https://www.ncbi.nlm.nih.gov/pubmed/9333111,with Perpetrator (Erythromycin),Buspirone,79,inf,h,19.5,ng*h/mL,arith. mean,13.6,ng*h/mL,arith. SD,AUC_inf,5,ng/mL,arith. mean,2.3,ng/mL,arith. SD,Cmax,,,,,,,,
320,Kivistö 1997,https://www.ncbi.nlm.nih.gov/pubmed/9333111,with Perpetrator (Itraconazole),Buspirone,79,inf,h,63.2,ng*h/mL,arith. mean,29.5,ng*h/mL,arith. SD,AUC_inf,13.4,ng/mL,arith. mean,3.9,ng/mL,arith. SD,Cmax,,,,,,,,
326,Lamberg 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9923581,Control (Perpetrator Placebo),Buspirone,0,inf,h,4.81,ng*h/mL,arith. mean,2.75,ng*h/mL,arith. SD,AUC_inf,1.87,ng/mL,arith. mean,1.17,ng/mL,arith. SD,Cmax,,,,,,,,
327,Lamberg 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9923581,with Perpetrator (Fluvoxamine),Buspirone,114,inf,h,11.3,ng*h/mL,arith. mean,8.54,ng*h/mL,arith. SD,AUC_inf,3.76,ng/mL,arith. mean,2.51,ng/mL,arith. SD,Cmax,,,,,,,,
328,Lamberg 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9578186,Control (Perpetrator Placebo),Buspirone,0,inf,h,22,ng*h/mL,arith. mean,15.1,ng*h/mL,arith. SD,AUC_inf,6.6,ng/mL,arith. mean,3.7,ng/mL,arith. SD,Cmax,,,,,,,,
329,Lamberg 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9578186,with Perpetrator (Rifampicin),Buspirone,113,inf,h,1.64,ng*h/mL,arith. mean,1.64,ng*h/mL,arith. SD,AUC_inf,0.84,ng/mL,arith. mean,0.23,ng/mL,arith. SD,Cmax,,,,,,,,
330,Lamberg 1998c,https://www.ncbi.nlm.nih.gov/pubmed/9663178,Control (Perpetrator Placebo),Buspirone,0,inf,h,6.9,ng*h/mL,arith. mean,2.5,ng*h/mL,arith. SD,AUC_inf,2.6,ng/mL,arith. mean,1,ng/mL,arith. SD,Cmax,,,,,,,,
331,Lamberg 1998c,https://www.ncbi.nlm.nih.gov/pubmed/9663178,with Perpetrator (Verapamil),Buspirone,30,inf,h,24.3,ng*h/mL,arith. mean,19.2,ng*h/mL,arith. SD,AUC_inf,8.8,ng/mL,arith. mean,7.9,ng/mL,arith. SD,Cmax,,,,,,,,
333,Lamberg 1998c,https://www.ncbi.nlm.nih.gov/pubmed/9663178,with Perpetrator (Diltiazem),Buspirone,30,inf,h,36.8,ng*h/mL,arith. mean,15.2,ng*h/mL,arith. SD,AUC_inf,10.3,ng/mL,arith. mean,3.5,ng/mL,arith. SD,Cmax,,,,,,,,
335,Lamberg 1999,https://www.ncbi.nlm.nih.gov/pubmed/10227067,Control (Perpetrator Placebo),Buspirone,0,inf,h,6.7,ng*h/mL,arith. mean,3.2,ng*h/mL,arith. SD,AUC_inf,2.4,ng/mL,arith. mean,1.1,ng/mL,arith. SD,Cmax,,,,,,,,
339,Lilja 1998,https://www.ncbi.nlm.nih.gov/pubmed/9871430,Control (Perpetrator Placebo),Buspirone,0,inf,h,4.32,ng*h/mL,arith. mean,1.4,ng*h/mL,arith. SEM,AUC_inf,1.96,ng/mL,arith. mean,0.74,ng/mL,arith. SEM,Cmax,,,,,,,,
340,Lilja 1998,https://www.ncbi.nlm.nih.gov/pubmed/9871430,with Perpetrator (GFJ),Buspirone,50,inf,h,39.8,ng*h/mL,arith. mean,9.6,ng*h/mL,arith. SEM,AUC_inf,8.4,ng/mL,arith. mean,0.74,ng/mL,arith. SEM,Cmax,,,,,,,,
135,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 1,Buspirone,0,inf,h,,,,,,,,414,pg/mL,individual,,,,Cmax,190.1,L/h/kg,individual,,,,CL/F,
136,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 2,Buspirone,0,inf,h,,,,,,,,840.7,pg/mL,individual,,,,Cmax,49.4,L/h/kg,individual,,,,CL/F,
137,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 3,Buspirone,0,inf,h,,,,,,,,1149.9,pg/mL,individual,,,,Cmax,63.7,L/h/kg,individual,,,,CL/F,
138,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 5,Buspirone,0,inf,h,,,,,,,,926.3,pg/mL,individual,,,,Cmax,72.9,L/h/kg,individual,,,,CL/F,
139,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 7,Buspirone,0,inf,h,,,,,,,,423,pg/mL,individual,,,,Cmax,155.4,L/h/kg,individual,,,,CL/F,
140,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 8,Buspirone,0,inf,h,,,,,,,,1281.2,pg/mL,individual,,,,Cmax,77.6,L/h/kg,individual,,,,CL/F,
141,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 9,Buspirone,0,inf,h,,,,,,,,773.9,pg/mL,individual,,,,Cmax,75,L/h/kg,individual,,,,CL/F,
142,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 10,Buspirone,0,inf,h,,,,,,,,3001.3,pg/mL,individual,,,,Cmax,48.1,L/h/kg,individual,,,,CL/F,
143,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 12,Buspirone,0,inf,h,,,,,,,,1461.7,pg/mL,individual,,,,Cmax,122.8,L/h/kg,individual,,,,CL/F,
144,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 13,Buspirone,0,inf,h,,,,,,,,901.1,pg/mL,individual,,,,Cmax,81.7,L/h/kg,individual,,,,CL/F,
145,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 14,Buspirone,0,inf,h,,,,,,,,530,pg/mL,individual,,,,Cmax,132.3,L/h/kg,individual,,,,CL/F,
146,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 15,Buspirone,0,inf,h,,,,,,,,786.2,pg/mL,individual,,,,Cmax,72.1,L/h/kg,individual,,,,CL/F,
147,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 16,Buspirone,0,inf,h,,,,,,,,877.2,pg/mL,individual,,,,Cmax,144.5,L/h/kg,individual,,,,CL/F,
148,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 17,Buspirone,0,inf,h,,,,,,,,764.2,pg/mL,individual,,,,Cmax,57.6,L/h/kg,individual,,,,CL/F,
149,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 18,Buspirone,0,inf,h,,,,,,,,1829.2,pg/mL,individual,,,,Cmax,28.9,L/h/kg,individual,,,,CL/F,
150,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 19,Buspirone,0,inf,h,,,,,,,,2603.1,pg/mL,individual,,,,Cmax,60.4,L/h/kg,individual,,,,CL/F,
151,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 20,Buspirone,0,inf,h,,,,,,,,1260.3,pg/mL,individual,,,,Cmax,71.6,L/h/kg,individual,,,,CL/F,
152,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 21,Buspirone,0,inf,h,,,,,,,,494.9,pg/mL,individual,,,,Cmax,88,L/h/kg,individual,,,,CL/F,
153,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 23,Buspirone,0,inf,h,,,,,,,,2227.2,pg/mL,individual,,,,Cmax,23.6,L/h/kg,individual,,,,CL/F,
154,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 24,Buspirone,0,inf,h,,,,,,,,280.5,pg/mL,individual,,,,Cmax,140.6,L/h/kg,individual,,,,CL/F,
79,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fasted,Itraconazole,0,inf,h,2094,ng*h/mL,arith. mean,905,ng*h/mL,arith. SD,AUC_inf,140,ng/mL,arith. mean,65,ng/mL,arith. SD,Cmax,,,,,,,CL/F,
80,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fasted,Hydroxy-Itraconazole,0,inf,h,5194,ng*h/mL,arith. mean,2489,ng*h/mL,arith. SD,AUC_inf,287,ng/mL,arith. mean,101,ng/mL,arith. SD,Cmax,,,,,,,,
81,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fed,Itraconazole,0,inf,h,3415,ng*h/mL,arith. mean,1153,ng*h/mL,arith. SD,AUC_inf,239,ng/mL,arith. mean,85,ng/mL,arith. SD,Cmax,,,,,,,,
82,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fed,Hydroxy-Itraconazole,0,inf,h,7952,ng*h/mL,arith. mean,2648,ng*h/mL,arith. SD,AUC_inf,397,ng/mL,arith. mean,103,ng/mL,arith. SD,Cmax,,,,,,,,
83,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 15 fed,Itraconazole,432,444,h,22.6,µg*h/mL,arith. mean,5.4,µg*h/mL,arith. SD,AUC_tau,2282,ng/mL,arith. mean,514,ng/mL,arith. SD,Cmax,,,,,,,,
84,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 15 fed,Hydroxy-Itraconazole,432,444,h,38.6,µg*h/mL,arith. mean,8.5,µg*h/mL,arith. SD,AUC_tau,3488,ng/mL,arith. mean,742,ng/mL,arith. SD,Cmax,,,,,,,,
85,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fasted,Itraconazole,0,24,h,4519.9,ng*h/mL,arith. mean,160.2,µg*h/mL,arith. SD,AUC_tend,545.7,ng/mL,arith. mean,22,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
86,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fasted,Hydroxy-Itraconazole,0,24,h,9554.5,ng*h/mL,arith. mean,199.8,µg*h/mL,arith. SD,AUC_tend,622.1,ng/mL,arith. mean,15.2,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
87,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fasted,Itraconazole,336,360,h,29287.7,ng*h/mL,arith. mean,841.2,µg*h/mL,arith. SD,AUC_tau,1965.3,ng/mL,arith. mean,54.5,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
88,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fasted,Hydroxy-Itraconazole,336,360,h,45143.9,ng*h/mL,arith. mean,1061.6,µg*h/mL,arith. SD,AUC_tau,2053.2,ng/mL,arith. mean,48.6,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
89,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fed,Itraconazole,0,24,h,3161.7,ng*h/mL,arith. mean,160.2,µg*h/mL,arith. SD,AUC_tend,306.9,ng/mL,arith. mean,22,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
90,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fed,Hydroxy-Itraconazole,0,24,h,6904.3,ng*h/mL,arith. mean,199.8,µg*h/mL,arith. SD,AUC_tend,424.3,ng/mL,arith. mean,15.2,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
91,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fed,Itraconazole,336,360,h,22738.4,ng*h/mL,arith. mean,841.2,µg*h/mL,arith. SD,AUC_tau,1429.8,ng/mL,arith. mean,54.5,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
92,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fed,Hydroxy-Itraconazole,336,360,h,38717.6,ng*h/mL,arith. mean,1061.6,µg*h/mL,arith. SD,AUC_tau,1776.2,ng/mL,arith. mean,48.6,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
1,Acocella 1972a,https://doi.org/10.1007/BF00561755,day 1,Rifampicin,0,12,h,,,,,,,,13.4,µg/mL,arith. mean,1.5,µg/mL,arith. SEM,Cmax,,,,,,,,
2,Acocella 1972a,https://doi.org/10.1007/BF00561755,day 7,Rifampicin,144,156,h,,,,,,,,8.9,µg/mL,arith. mean,2.8,µg/mL,arith. SEM,Cmax,,,,,,,,
355,Nitti 1977,https://www.ncbi.nlm.nih.gov/pubmed/832508,300 mg,Rifampicin,0,12,h,17.642,µg*h/mL,arith. mean,6.76,µg*h/mL,arith. SEM,AUC_tend,,,,,,,,,,,,,,,
356,Nitti 1977,https://www.ncbi.nlm.nih.gov/pubmed/832508,450 mg,Rifampicin,0,12,h,50.48,µg*h/mL,arith. mean,12.47,µg*h/mL,arith. SEM,AUC_tend,,,,,,,,,,,,,,,
357,Nitti 1977,https://www.ncbi.nlm.nih.gov/pubmed/832508,600 mg,Rifampicin,0,12,h,64.12,µg*h/mL,arith. mean,5.8,µg*h/mL,arith. SEM,AUC_tend,,,,,,,,,,,,,,,
100,Blume 1989,https://doi.org/10.1002/pauz.19900190516,450 mg REFERENZ,Rifampicin,0,inf,h,34,mg*h/L,arith. mean,36,%,arith. CV,AUC_inf,5.8,mg/L,arith. mean,40,%,arith. CV,Cmax,,,,,,,,
101,Blume 1989,https://doi.org/10.1002/pauz.19900190516,600 mg REFERENZ,Rifampicin,0,inf,h,48.9,mg*h/L,arith. mean,39,%,arith. CV,AUC_inf,10,mg/L,arith. mean,40,%,arith. CV,Cmax,,,,,,,,
93,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,Solution,Itraconazole,0,inf,h,5838,ng*h/mL,arith. mean,,,,AUC_inf,306.4,ng/mL,arith. mean,,,,Cmax,,,,,,,,
94,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,Solution,Hydroxy-Itraconazole,0,inf,h,15025.5,ng*h/mL,arith. mean,,,,AUC_inf,527,ng/mL,arith. mean,,,,Cmax,,,,,,,,
95,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F05 Capsule,Itraconazole,0,inf,h,4475.8,ng*h/mL,arith. mean,,,,AUC_inf,314.7,ng/mL,arith. mean,,,,Cmax,,,,,,,,
96,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F05 Capsule,Hydroxy-Itraconazole,0,inf,h,10937.8,ng*h/mL,arith. mean,,,,AUC_inf,501,ng/mL,arith. mean,,,,Cmax,,,,,,,,
97,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F12 Capsule,Itraconazole,0,inf,h,4441.3,ng*h/mL,arith. mean,,,,AUC_inf,301.9,ng/mL,arith. mean,,,,Cmax,,,,,,,,
98,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F12 Capsule,Hydroxy-Itraconazole,0,inf,h,11148.1,ng*h/mL,arith. mean,,,,AUC_inf,504.3,ng/mL,arith. mean,,,,Cmax,,,,,,,,
232,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,A 100 mg OD (day 1),Itraconazole,0,inf,h,1320,ng*h/mL,arith. mean,651,ng*h/mL,arith. SD,AUC_inf,110,ng/mL,arith. mean,57.5,ng/mL,arith. SD,Cmax,1.511,L/h/kg,arith. mean,0.863,L/h/kg,arith. SD,CL/F,
234,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,A 100 mg OD (day 15),Itraconazole,360,384,h,5330,ng*h/mL,arith. mean,1470,ng*h/mL,arith. SD,AUC_tau,412,ng/mL,arith. mean,79.5,ng/mL,arith. SD,Cmax,0.308,L/h/kg,arith. mean,0.073,L/h/kg,arith. SD,CL/F,
235,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,B 200 mg OD (day 1),Itraconazole,0,inf,h,4160,ng*h/mL,arith. mean,1949,ng*h/mL,arith. SD,AUC_inf,272,ng/mL,arith. mean,81.2,ng/mL,arith. SD,Cmax,0.937,L/h/kg,arith. mean,0.587,L/h/kg,arith. SD,CL/F,
237,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,B 200 mg OD (day 15),Itraconazole,360,384,h,15400,ng*h/mL,arith. mean,6880,ng*h/mL,arith. SD,AUC_tau,1070,ng/mL,arith. mean,499,ng/mL,arith. SD,Cmax,0.233,L/h/kg,arith. mean,0.087,L/h/kg,arith. SD,CL/F,
472,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ITZ day 1,Itraconazole,0,inf,h,2862,nmol*h/L,arith. mean,2158,nmol*h/L,arith. SD,AUC_inf,362,nmol/L,arith. mean,148,nmol/L,arith. SD,Cmax,,,,,,,,
473,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ITZ day 7,Itraconazole,144,168,h,7240,nmol*h/L,arith. mean,3177,nmol*h/L,arith. SD,AUC_tau,1152,nmol/L,arith. mean,203,nmol/L,arith. SD,Cmax,,,,,,,,
474,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,OH-ITZ day 1,Hydroxy-Itraconazole,0,inf,h,4237,nmol*h/L,arith. mean,2175,nmol*h/L,arith. SD,AUC_inf,358,nmol/L,arith. mean,118,nmol/L,arith. SD,Cmax,,,,,,,,
475,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,OH-ITZ day 7,Hydroxy-Itraconazole,144,168,h,9811,nmol*h/L,arith. mean,5263,nmol*h/L,arith. SD,AUC_tau,608,nmol/L,arith. mean,206,nmol/L,arith. SD,Cmax,,,,,,,,
476,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,keto-ITZ day 1,Keto-Itraconazole,0,inf,h,322,nmol*h/L,arith. mean,96,nmol*h/L,arith. SD,AUC_inf,39,nmol/L,arith. mean,11,nmol/L,arith. SD,Cmax,,,,,,,,
477,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,keto-ITZ day 7,Keto-Itraconazole,144,168,h,308,nmol*h/L,arith. mean,81,nmol*h/L,arith. SD,AUC_tau,23,nmol/L,arith. mean,9,nmol/L,arith. SD,Cmax,,,,,,,,
478,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ND-OH-ITZ day 1,N-desalkyl-Itraconazole,0,inf,h,389,nmol*h/L,arith. mean,150,nmol*h/L,arith. SD,AUC_inf,15,nmol/L,arith. mean,7,nmol/L,arith. SD,Cmax,,,,,,,,
479,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ND-OH-ITZ day 7,N-desalkyl-Itraconazole,144,168,h,394,nmol*h/L,arith. mean,133,nmol*h/L,arith. SD,AUC_tau,22,nmol/L,arith. mean,3,nmol/L,arith. SD,Cmax,,,,,,,,
480,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fasting ITZ,Itraconazole,0,inf,h,3716,ng*h/mL,arith. mean,2711,ng*h/mL,arith. SD,AUC_inf,349,ng/mL,arith. mean,239,ng/mL,arith. SD,Cmax,,,,,,,,
481,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fasting OH-ITZ,Hydroxy-Itraconazole,0,inf,h,8007,ng*h/mL,arith. mean,5185,ng*h/mL,arith. SD,AUC_inf,424,ng/mL,arith. mean,147,ng/mL,arith. SD,Cmax,,,,,,,,
482,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fed ITZ,Itraconazole,0,inf,h,2861,ng*h/mL,arith. mean,1914,ng*h/mL,arith. SD,AUC_inf,147,ng/mL,arith. mean,74,ng/mL,arith. SD,Cmax,,,,,,,,
483,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fed OH-ITZ,Hydroxy-Itraconazole,0,inf,h,6132,ng*h/mL,arith. mean,4448,ng*h/mL,arith. SD,AUC_inf,250,ng/mL,arith. mean,76,ng/mL,arith. SD,Cmax,,,,,,,,
484,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"100 mg Solution, fasting",Itraconazole,0,inf,h,1920,ng*h/mL,arith. mean,679,ng*h/mL,arith. SD,AUC_inf,223,ng/mL,arith. mean,84,ng/mL,arith. SD,Cmax,,,,,,,,
485,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"100 mg Capsules, fasting",Itraconazole,0,inf,h,722,ng*h/mL,arith. mean,289,ng*h/mL,arith. SD,AUC_inf,38.4,ng/mL,arith. mean,19.9,ng/mL,arith. SD,Cmax,,,,,,,,
486,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"100 mg Capsules, with food",Itraconazole,0,inf,h,1900,ng*h/mL,arith. mean,838,ng*h/mL,arith. SD,AUC_inf,132,ng/mL,arith. mean,67,ng/mL,arith. SD,Cmax,,,,,,,,
488,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"50 mg Capsules, with food",Itraconazole,0,inf,h,567,ng*h/mL,arith. mean,264,ng*h/mL,arith. SD,AUC_inf,44.5,ng/mL,arith. mean,16.4,ng/mL,arith. SD,Cmax,,,,,,,,
489,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"200 mg Capsules, with food",Itraconazole,0,inf,h,5210,ng*h/mL,arith. mean,2120,ng*h/mL,arith. SD,AUC_inf,289,ng/mL,arith. mean,100,ng/mL,arith. SD,Cmax,,,,,,,,
490,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,iv 100 mg SD,Itraconazole,0,inf,h,4.6,µg*h/mL,arith. mean,1.09,µg*h/mL,arith. SD,AUC_inf,664,ng/mL,arith. mean,234,ng/mL,arith. SD,Cmax,,,,,,,,
491,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg SD fed,Itraconazole,0,inf,h,2.48,µg*h/mL,arith. mean,0.74,µg*h/mL,arith. SD,AUC_inf,127,ng/mL,arith. mean,37,ng/mL,arith. SD,Cmax,,,,,,,,
492,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg SD (metabolite screening),Itraconazole,0,inf,h,2.01,µg*h/mL,arith. mean,1.08,µg*h/mL,arith. SD,AUC_inf,149,ng/mL,arith. mean,112,ng/mL,arith. SD,Cmax,,,,,,,,
493,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg SD (metabolite screening),Hydroxy-Itraconazole,0,inf,h,4.67,µg*h/mL,arith. mean,1.97,µg*h/mL,arith. SD,AUC_inf,255,ng/mL,arith. mean,74,ng/mL,arith. SD,Cmax,,,,,,,,
494,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg MD OD,Itraconazole,672,696,h,8.17,µg*h/mL,arith. mean,5.23,µg*h/mL,arith. SD,AUC_tau,621,ng/mL,arith. mean,337,ng/mL,arith. SD,Cmax,,,,,,,,
496,Miura 2010,https://www.ncbi.nlm.nih.gov/pubmed/20595406,po 100 mg MD Japanese,Itraconazole,216,240,h,7908,ng*h/mL,arith. mean,2542,ng*h/mL,arith. SD,AUC_tau,653,ng/mL,arith. mean,269,ng/mL,arith. SD,Cmax,,,,,,,,
497,Miura 2010,https://www.ncbi.nlm.nih.gov/pubmed/20595406,po 100 mg MD Japanese,Hydroxy-Itraconazole,216,240,h,15795,ng*h/mL,arith. mean,5286,ng*h/mL,arith. SD,AUC_tau,1059,ng/mL,arith. mean,598,ng/mL,arith. SD,Cmax,,,,,,,,
498,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with water,Itraconazole,0,inf,h,7.07,mg*h/L,arith. mean,1.77,mg*h/mL,arith. SD,AUC_inf,589.9,ng/mL,arith. mean,244.2,ng/mL,arith. SD,Cmax,0.43,L/h/kg,arith. mean,0.17,L/h/kg,arith. SD,CL/F,
499,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with water,Hydroxy-Itraconazole,0,inf,h,16.5,mg*h/L,arith. mean,5,mg*h/mL,arith. SD,AUC_inf,766.1,ng/mL,arith. mean,218.4,ng/mL,arith. SD,Cmax,,,,,,,,
500,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with GFJ,Itraconazole,0,inf,h,8.45,mg*h/L,arith. mean,2.91,mg*h/mL,arith. SD,AUC_inf,580.6,ng/mL,arith. mean,252.8,ng/mL,arith. SD,Cmax,0.37,L/h/kg,arith. mean,0.16,L/h/kg,arith. SD,CL/F,
501,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with GFJ,Hydroxy-Itraconazole,0,inf,h,17.9,mg*h/L,arith. mean,6.7,mg*h/mL,arith. SD,AUC_inf,690.7,ng/mL,arith. mean,248.3,ng/mL,arith. SD,Cmax,,,,,,,,
502,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with water,Itraconazole,0,inf,h,6.7,mg*h/L,arith. mean,1.8,mg*h/mL,arith. SD,AUC_inf,545.5,ng/mL,arith. mean,212.5,ng/mL,arith. SD,Cmax,0.53,L/h/kg,arith. mean,0.19,L/h/kg,arith. SD,CL/F,
503,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with water,Hydroxy-Itraconazole,0,inf,h,16.7,mg*h/L,arith. mean,6.3,mg*h/mL,arith. SD,AUC_inf,799.3,ng/mL,arith. mean,281.9,ng/mL,arith. SD,Cmax,,,,,,,,
504,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with water,Itraconazole,0,inf,h,7.4,mg*h/L,arith. mean,1.8,mg*h/mL,arith. SD,AUC_inf,634.2,ng/mL,arith. mean,276.3,ng/mL,arith. SD,Cmax,0.43,L/h/kg,arith. mean,0.19,L/h/kg,arith. SD,CL/F,
505,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with water,Hydroxy-Itraconazole,0,inf,h,16.4,mg*h/L,arith. mean,3.6,mg*h/mL,arith. SD,AUC_inf,732.8,ng/mL,arith. mean,137.1,ng/mL,arith. SD,Cmax,,,,,,,,
506,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with GFJ,Itraconazole,0,inf,h,8.7,mg*h/L,arith. mean,3.6,mg*h/mL,arith. SD,AUC_inf,577.2,ng/mL,arith. mean,256.6,ng/mL,arith. SD,Cmax,0.34,L/h/kg,arith. mean,0.08,L/h/kg,arith. SD,CL/F,
507,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with GFJ,Hydroxy-Itraconazole,0,inf,h,19.3,mg*h/L,arith. mean,8.8,mg*h/mL,arith. SD,AUC_inf,748.3,ng/mL,arith. mean,317.2,ng/mL,arith. SD,Cmax,,,,,,,,
508,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with GFJ,Itraconazole,0,inf,h,8.2,mg*h/L,arith. mean,2.3,mg*h/mL,arith. SD,AUC_inf,584,ng/mL,arith. mean,262.8,ng/mL,arith. SD,Cmax,0.31,L/h/kg,arith. mean,0.09,L/h/kg,arith. SD,CL/F,
509,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with GFJ,Hydroxy-Itraconazole,0,inf,h,16.4,mg*h/L,arith. mean,3.7,mg*h/mL,arith. SD,AUC_inf,633.2,ng/mL,arith. mean,148.9,ng/mL,arith. SD,Cmax,,,,,,,,
510,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 1 (Japanese),Itraconazole,0,24,h,932.5,ng*h/mL,arith. mean,378.9,ng*h/mL,arith. SD,AUC_tend,107.1,ng/mL,arith. mean,44.1,ng/mL,arith. SD,Cmax,3.4,L/h,arith. mean,2.1,L/h,arith. SD,CL/F,
511,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 1 (Japanese),Hydroxy-Itraconazole,0,24,h,2610.7,ng*h/mL,arith. mean,1129,ng*h/mL,arith. SD,AUC_tend,230.2,ng/mL,arith. mean,87.3,ng/mL,arith. SD,Cmax,,,,,,,,
512,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 6 (Japanese),Itraconazole,120,144,h,3485.5,ng*h/mL,arith. mean,1159.6,ng*h/mL,arith. SD,AUC_tau,287.7,ng/mL,arith. mean,82.9,ng/mL,arith. SD,Cmax,0.7,L/h,arith. mean,0.3,L/h,arith. SD,CL/F,
513,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 6 (Japanese),Hydroxy-Itraconazole,120,144,h,7664.7,ng*h/mL,arith. mean,1961.5,ng*h/mL,arith. SD,AUC_tau,523.7,ng/mL,arith. mean,158.1,ng/mL,arith. SD,Cmax,,,,,,,,
514,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with water (Korean),Itraconazole,0,inf,h,2290,ng*h/mL,arith. mean,1430,ng*h/mL,arith. SD,AUC_inf,248,ng/mL,arith. mean,137,ng/mL,arith. SD,Cmax,,,,,,,,
515,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with water (Korean),Hydroxy-Itraconazole,0,inf,h,7580,ng*h/mL,arith. mean,5000,ng*h/mL,arith. SD,AUC_inf,519,ng/mL,arith. mean,272,ng/mL,arith. SD,Cmax,,,,,,,,
516,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with cola (Korean),Itraconazole,0,inf,h,4050,ng*h/mL,arith. mean,2060,ng*h/mL,arith. SD,AUC_inf,478,ng/mL,arith. mean,265,ng/mL,arith. SD,Cmax,,,,,,,,
517,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with cola (Korean),Hydroxy-Itraconazole,0,inf,h,11900,ng*h/mL,arith. mean,5670,ng*h/mL,arith. SD,AUC_inf,734,ng/mL,arith. mean,354,ng/mL,arith. SD,Cmax,,,,,,,,
518,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with vit. C (Korean),Itraconazole,0,inf,h,3420,ng*h/mL,arith. mean,1750,ng*h/mL,arith. SD,AUC_inf,387,ng/mL,arith. mean,212,ng/mL,arith. SD,Cmax,,,,,,,,
519,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with vit. C (Korean),Hydroxy-Itraconazole,0,inf,h,10600,ng*h/mL,arith. mean,5900,ng*h/mL,arith. SD,AUC_inf,748,ng/mL,arith. mean,371,ng/mL,arith. SD,Cmax,,,,,,,,
524,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_A 100 mg,Itraconazole,144,168,h,12713,µg*h/L,arith. mean,2153,µg*h/L,arith. SD,AUC_tau,2902,µg/L,arith. mean,1470,µg/L,arith. SD,Cmax,8.06,L/h,arith. mean,1.52,L/h,arith. SD,CLiv,
525,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_B 200 mg,Itraconazole,144,168,h,39858,µg*h/L,arith. mean,8240,µg*h/L,arith. SD,AUC_tau,4111,µg/L,arith. mean,864,µg/L,arith. SD,Cmax,5.18,L/h,arith. mean,1.04,L/h,arith. SD,CLiv,
526,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_C 300 mg,Itraconazole,144,168,h,44184,µg*h/L,arith. mean,1825,µg*h/L,arith. SD,AUC_tau,4554,µg/L,arith. mean,343,µg/L,arith. SD,Cmax,6.8,L/h,arith. mean,0.27,L/h,arith. SD,CLiv,
527,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_D 200 mg (HPBCD),Itraconazole,144,168,h,31783,µg*h/L,arith. mean,2675,µg*h/L,arith. SD,AUC_tau,3349,µg/L,arith. mean,334,µg/L,arith. SD,Cmax,6.32,L/h,arith. mean,0.5,L/h,arith. SD,CLiv,
532,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_A 100 mg,Hydroxy-Itraconazole,144,168,h,18177,µg*h/L,arith. mean,2236,µg*h/L,arith. SD,AUC_tau,1028,µg/L,arith. mean,310,µg/L,arith. SD,Cmax,5.56,L/h,arith. mean,0.64,L/h,arith. SD,CLiv,
533,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_B 200 mg,Hydroxy-Itraconazole,144,168,h,50407,µg*h/L,arith. mean,7355,µg*h/L,arith. SD,AUC_tau,2339,µg/L,arith. mean,374,µg/L,arith. SD,Cmax,4.03,L/h,arith. mean,0.55,L/h,arith. SD,CLiv,
534,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_C 300 mg,Hydroxy-Itraconazole,144,168,h,67923,µg*h/L,arith. mean,8643,µg*h/L,arith. SD,AUC_tau,3424,µg/L,arith. mean,367,µg/L,arith. SD,Cmax,4.47,L/h,arith. mean,0.17,L/h,arith. SD,CLiv,
535,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_D 200 mg (HPBCD),Hydroxy-Itraconazole,144,168,h,48317,µg*h/L,arith. mean,2275,µg*h/L,arith. SD,AUC_tau,2272,µg/L,arith. mean,93,µg/L,arith. SD,Cmax,4.15,L/h,arith. mean,0.19,L/h,arith. SD,CLiv,
520,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_A 50 mg,Itraconazole,0,inf,h,2506,µg*h/L,arith. mean,296,µg*h/L,arith. SD,AUC_inf,,,,,,,,20.2,L/h,arith. mean,2.3,L/h,arith. SD,CLiv,
522,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_A 200 mg,Itraconazole,0,inf,h,7498,µg*h/L,arith. mean,2697,µg*h/L,arith. SD,AUC_inf,,,,,,,,14.8,L/h,arith. mean,5,L/h,arith. SD,CLiv,
521,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_B 100 mg,Itraconazole,0,inf,h,15292,µg*h/L,arith. mean,2869,µg*h/L,arith. SD,AUC_inf,,,,,,,,13.5,L/h,arith. mean,2.7,L/h,arith. SD,CLiv,
523,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_B 300 mg,Itraconazole,0,inf,h,28146,µg*h/L,arith. mean,1488,µg*h/L,arith. SD,AUC_inf,,,,,,,,10.7,L/h,arith. mean,0.6,L/h,arith. SD,CLiv,
542,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_s_A 100 mg,Itraconazole,0,inf,h,4531,µg*h/L,arith. mean,891,µg*h/L,arith. SD,AUC_inf,,,,,,,,22.8,L/h,arith. mean,4.8,L/h,arith. SD,CLiv,
543,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_s_B 200 mg,Itraconazole,0,inf,h,14815,µg*h/L,arith. mean,4128,µg*h/L,arith. SD,AUC_inf,,,,,,,,14.2,L/h,arith. mean,3.3,L/h,arith. SD,CLiv,
544,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_s_C 300 mg,Itraconazole,0,inf,h,24920,µg*h/L,arith. mean,1562,µg*h/L,arith. SD,AUC_inf,,,,,,,,12.1,L/h,arith. mean,0.8,L/h,arith. SD,CLiv,
545,Zhou 1998,https://www.ncbi.nlm.nih.gov/pubmed/9702843,IV 200 mg OD,Itraconazole,0,12,h,6511,ng*h/mL,arith. mean,1864,ng*h/mL,arith. SD,AUC_tend,9141,ng/mL,arith. mean,546,ng/mL,arith. SD,Cmax,,,,,,,,
546,Zhou 1998,https://www.ncbi.nlm.nih.gov/pubmed/9702843,IV 200 mg OD,Hydroxy-Itraconazole,0,12,h,4578,ng*h/mL,arith. mean,1588,ng*h/mL,arith. SD,AUC_tend,464,ng/mL,arith. mean,150,ng/mL,arith. SD,Cmax,,,,,,,,
548,Mahadik 2012,https://www.ncbi.nlm.nih.gov/pubmed/22275128,Reference,Mefenamic acid,0,inf,h,12458.728,ng*h/mL,arith. mean,3004.021,ng*h/mL,arith. SD,AUC_inf,2168.6,ng/mL,arith. mean,208.4,ng/mL,arith. SD,Cmax,,,,,,,,
51,Allonen 1981,https://www.ncbi.nlm.nih.gov/pubmed/6117393,oral,Midazolam,0,inf,h,,,,,,,,154,ng/mL,arith. mean,51,ng/mL,arith. SD,Cmax,,,,,,,,
52,Allonen 1981,https://www.ncbi.nlm.nih.gov/pubmed/6117393,iv,Midazolam,0,inf,h,,,,,,,,,,,,,,,283,mL/min,arith. mean,43,mL/min,arith. SD,CLiv,
112,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,Control (Perpetrator Placebo),Midazolam,0,inf,h,49,ng*h/mL,geom. mean,22-103,ng*h/mL,range,AUC_inf,23,ng/mL,geom. mean,9-41,ng/mL,Range,Cmax,25,mL/min,geom. mean,12-57,mL/min/kg,Range,CL/F,
113,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Rifampicin),Midazolam,166,inf,h,6.1,ng*h/mL,geom. mean,3.4-10,ng*h/mL,range,AUC_inf,3.9,ng/mL,geom. mean,1.7-6.2,ng/mL,Range,Cmax,203,mL/min,geom. mean,125-371,mL/min/kg,Range,CL/F,
114,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Ketoconazole),Midazolam,118,inf,h,466,ng*h/mL,geom. mean,146-1010,ng*h/mL,range,AUC_inf,55,ng/mL,geom. mean,31-100,ng/mL,Range,Cmax,2.7,mL/min,geom. mean,1.2-8.5,mL/min/kg,Range,CL/F,
115,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,Control (Perpetrator Placebo),Simvastatin,0,inf,h,29,ng*h/mL,geom. mean,8-56,ng*h/mL,range,AUC_inf,7.4,ng/mL,geom. mean,3.1-19,ng/mL,Range,Cmax,312,mL/min,geom. mean,151-1478,mL/min/kg,Range,CL/F,
116,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Rifampicin),Simvastatin,190,inf,h,2.6,ng*h/mL,geom. mean,0.8-26,ng*h/mL,range,AUC_inf,1.1,ng/mL,geom. mean,0.3-7.2,ng/mL,Range,Cmax,3536,mL/min,geom. mean,413-10329,mL/min/kg,Range,CL/F,
117,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Ketoconazole),Simvastatin,190,inf,h,364,ng*h/mL,geom. mean,84-1351,ng*h/mL,range,AUC_inf,55,ng/mL,geom. mean,17-218,ng/mL,Range,Cmax,25,mL/min,geom. mean,8.0-147,mL/min/kg,Range,CL/F,
392,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 0 after Perpetrator (Rifampicin),Midazolam,648,816,h,2.64,ng*h/mL,geom. mean,45.3,%,geom. CV,AUC_inf,1.33,ng/mL,geom. mean,45.3,%,geom. CV,Cmax,,,,,,,,
393,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 1 after Perpetrator (Rifampicin),Midazolam,816,984,h,8.2,ng*h/mL,geom. mean,30.9,%,geom. CV,AUC_inf,3.31,ng/mL,geom. mean,44.9,%,geom. CV,Cmax,,,,,,,,
394,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 2 after Perpetrator (Rifampicin),Midazolam,984,1320,h,17.44,ng*h/mL,geom. mean,37.2,%,geom. CV,AUC_inf,6,ng/mL,geom. mean,31.1,%,geom. CV,Cmax,,,,,,,,
395,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 4 after Perpetrator (Rifampicin),Midazolam,1320,inf,h,21.41,ng*h/mL,geom. mean,33.6,%,geom. CV,AUC_inf,8.21,ng/mL,geom. mean,27.5,%,geom. CV,Cmax,,,,,,,,
396,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 0 after Perpetrator (Rifampicin),Digoxin,649,652,h,3.83,ng*h/mL,geom. mean,26.2,%,geom. CV,AUC_tend,2.04,ng/mL,geom. mean,38.2,%,geom. CV,Cmax,,,,,,,,
397,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 1 after Perpetrator (Rifampicin),Digoxin,817,820,h,1.79,ng*h/mL,geom. mean,114.3,%,geom. CV,AUC_tend,0.95,ng/mL,geom. mean,60.7,%,geom. CV,Cmax,,,,,,,,
398,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 2 after Perpetrator (Rifampicin),Digoxin,985,988,h,2.56,ng*h/mL,geom. mean,24.1,%,geom. CV,AUC_tend,1.2,ng/mL,geom. mean,31.8,%,geom. CV,Cmax,,,,,,,,
399,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 4 after Perpetrator (Rifampicin),Digoxin,1321,1324,h,2.62,ng*h/mL,geom. mean,19.1,%,geom. CV,AUC_tend,1.37,ng/mL,geom. mean,24.1,%,geom. CV,Cmax,,,,,,,,
415,Smith 1981,https://www.ncbi.nlm.nih.gov/pubmed/6116606,iv 5 mg,Midazolam,0,inf,h,190.3,µg*h/L,arith. mean,49.2,µg*h/L,arith. SD,AUC_inf,112.6,µg/L,arith. mean,16.1,µg/L,arith. SD,Cmax,0.383,L/h/kg,arith. mean,0.094,L/h/kg,arith. SD,CLiv,
416,Smith 1981,https://www.ncbi.nlm.nih.gov/pubmed/6116606,oral solution 10 mg,Midazolam,0,inf,h,135.6,µg*h/L,arith. mean,55,µg*h/L,arith. SD,AUC_inf,60,µg/L,arith. mean,13.8,µg/L,arith. SD,Cmax,,,,,,,,
417,Smith 1981,https://www.ncbi.nlm.nih.gov/pubmed/6116606,oral tablet 10 mg,Midazolam,0,inf,h,147,µg*h/L,arith. mean,78.9,µg*h/L,arith. SD,AUC_inf,77.5,µg/L,arith. mean,27.8,µg/L,arith. SD,Cmax,,,,,,,,
418,Stone 2004,https://www.ncbi.nlm.nih.gov/pubmed/4037525,Day 14 of Rifampin alone,Rifampicin,312,336,h,35.25,µg*h/mL,geom. mean,,,,AUC_tau,8.86,µg/mL,geom. mean,,,,Cmax,,,,,,,,
468,Yeates 1996,http://www.ncbi.nlm.nih.gov/pubmed/8880291,Control (Perpetrator Placebo),Midazolam,0,inf,h,248.84,ng*h/mL,arith. mean,24.41,ng*h/mL,arith. SEM,AUC_inf,76.89,ng/mL,arith. mean,9.25,ng/mL,arith. SEM,Cmax,,,,,,,,
469,Yeates 1996,http://www.ncbi.nlm.nih.gov/pubmed/8880291,with Perpetrator (Clarithromycin),Midazolam,97.5,inf,h,888.75,ng*h/mL,arith. mean,94.13,ng*h/mL,arith. SEM,AUC_inf,187.61,ng/mL,arith. mean,29.15,ng/mL,arith. SEM,Cmax,,,,,,,,
470,Zimmermann 1996,https://www.ncbi.nlm.nih.gov/pubmed/8720318,Control (Perpetrator Placebo),Midazolam,0,inf,h,173.77,ng*h/mL,arith. mean,24.66,ng*h/mL,arith. SEM,AUC_inf,67.23,ng/mL,arith. mean,11.39,ng/mL,arith. SEM,Cmax,,,,,,,,
471,Zimmermann 1996,https://www.ncbi.nlm.nih.gov/pubmed/8720318,with Perpetrator (Erythromycin),Midazolam,97.5,inf,h,662.71,ng*h/mL,arith. mean,76.52,ng*h/mL,arith. SEM,AUC_inf,182.29,ng/mL,arith. mean,182.29,ng/mL,arith. SEM,Cmax,,,,,,,,
279,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,28.4,ng*h/mL,arith. mean,4,ng*h/mL,arith. SD,AUC_inf,50.2,ng/mL,arith. mean,11.9,ng/mL,arith. SD,Cmax,8.3,mL/min/kg,arith. Mean,1.6,mL/min/kg,arith. SD,Cliv,
280,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (Rifampicin),Midazolam,0,128,h,14.8,ng*h/mL,arith. mean,2.7,ng*h/mL,arith. SD,AUC_inf,50.7,ng/mL,arith. mean,17.7,ng/mL,arith. SD,Cmax,16,mL/min/kg,arith. Mean,2.3,mL/min/kg,arith. SD,Cliv,
281,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (GFJ),Midazolam,0,inf,h,35.5,ng*h/mL,arith. mean,17.4,ng*h/mL,arith. SD,AUC_inf,51.2,ng/mL,arith. mean,35.4,ng/mL,arith. SD,Cmax,7.6,mL/min/kg,arith. Mean,7.6,mL/min/kg,arith. SD,Cliv,
282,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv Control (Perpetrator Placebo),Alfentanil,0,inf,h,64.8,ng*h/mL,arith. mean,26.6,ng*h/mL,arith. SD,AUC_inf,90.2,ng/mL,arith. mean,22.2,ng/mL,arith. SD,Cmax,4.39,mL/min/kg,arith. Mean,1.48,mL/min/kg,arith. SD,Cliv,
283,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (Rifampicin),Alfentanil,0,129,h,24.3,ng*h/mL,arith. mean,6.5,ng*h/mL,arith. SD,AUC_inf,90.5,ng/mL,arith. mean,25.5,ng/mL,arith. SD,Cmax,10.8,mL/min/kg,arith. Mean,2.1,mL/min/kg,arith. SD,Cliv,
284,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (GFJ),Alfentanil,0,inf,h,68.3,ng*h/mL,arith. mean,19.9,ng*h/mL,arith. SD,AUC_inf,93.7,ng/mL,arith. mean,19.7,ng/mL,arith. SD,Cmax,4.02,mL/min/kg,arith. Mean,1.34,mL/min/kg,arith. SD,Cliv,
285,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 Control (Perpetrator Placebo),Midazolam,0,inf,h,20.9,ng*h/mL,arith. mean,4.2,ng*h/mL,arith. SD,AUC_inf,9.1,ng/mL,arith. mean,2.4,ng/mL,arith. SD,Cmax,35.4,mL/min/kg,arith. Mean,13.7,mL/min/kg,arith. SD,CL/F,
286,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 with Perpetrator (Rifampicin),Midazolam,0,inf,h,1.1,ng*h/mL,arith. mean,0.5,ng*h/mL,arith. SD,AUC_inf,1,ng/mL,arith. mean,0.6,ng/mL,arith. SD,Cmax,735,mL/min/kg,arith. Mean,424,mL/min/kg,arith. SD,CL/F,
287,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 (60 µg/kg) Control (Perpetrator Placebo),Alfentanil,0,inf,h,103,ng*h/mL,arith. mean,30,ng*h/mL,arith. SD,AUC_inf,45,ng/mL,arith. mean,14.5,ng/mL,arith. SD,Cmax,10.6,mL/min/kg,arith. Mean,30,mL/min/kg,arith. SD,CL/F,
288,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 (60 µg/kg) with Perpetrator (Rifampicin),Alfentanil,0,inf,h,4.7,ng*h/mL,arith. mean,4.6,ng*h/mL,arith. SD,AUC_inf,5,ng/mL,arith. mean,3.6,ng/mL,arith. SD,Cmax,339,mL/min/kg,arith. Mean,4.6,mL/min/kg,arith. SD,CL/F,
289,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 Control (Perpetrator Placebo),Midazolam,0,inf,h,22.8,ng*h/mL,arith. mean,9.2,ng*h/mL,arith. SD,AUC_inf,10.3,ng/mL,arith. mean,4.4,ng/mL,arith. SD,Cmax,34,mL/min/kg,arith. Mean,12.5,mL/min/kg,arith. SD,CL/F,
290,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 with Perpetrator (GFJ),Midazolam,0,inf,h,39.5,ng*h/mL,arith. mean,6.4,ng*h/mL,arith. SD,AUC_inf,15.6,ng/mL,arith. mean,4.2,ng/mL,arith. SD,Cmax,17.9,mL/min/kg,arith. Mean,3.3,mL/min/kg,arith. SD,CL/F,
291,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 (23 µg/kg) Control (Perpetrator Placebo),Alfentanil,0,inf,h,38,ng*h/mL,arith. mean,13.3,ng*h/mL,arith. SD,AUC_inf,61.3,ng/mL,arith. mean,9.8,ng/mL,arith. SD,Cmax,11.2,mL/min/kg,arith. Mean,3.8,mL/min/kg,arith. SD,CL/F,
292,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 (23 µg/kg) with Perpetrator (GFJ),Alfentanil,0,inf,h,62.5,ng*h/mL,arith. mean,19.3,ng*h/mL,arith. SD,AUC_inf,30.4,ng/mL,arith. mean,6.9,ng/mL,arith. SD,Cmax,6.7,mL/min/kg,arith. Mean,2.5,mL/min/kg,arith. SD,CL/F,
53,Backman 1996,https://www.ncbi.nlm.nih.gov/pubmed/8549036,Control (Perpetrator Placebo),Midazolam,0,inf,h,10.2,µg*min/ml,arith. mean,0.8,µg*min/ml,arith. SEM,AUC_inf,55,ng/mL,arith. mean,4,ng/ml,arith. SEM,Cmax,,,,,,,,
54,Backman 1996,https://www.ncbi.nlm.nih.gov/pubmed/8549036,with Perpetrator (Rifampicin),Midazolam,113,inf,h,0.42,µg*min/ml,arith. mean,0.05,µg*min/ml,arith. SEM,AUC_inf,3.5,ng/mL,arith. mean,0.7,ng/ml,arith. SEM,Cmax,,,,,,,,
109,Burger 2006,https://www.ncbi.nlm.nih.gov/pubmed/17005814,Rifampin alone,Rifampicin,216,240,h,31267.7,ng*h/mL,geom. Mean,46,%,geom. CV,AUC_tau,8057.6,ng/mL,geom. Mean,45,%,geom. CV,Cmax,,,,,,,,
190,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,po Control (Perpetrator Placebo),Digoxin,0,inf,h,54.8,ng*h/ml,arith. mean,11.6,ng*h/mL,arith. SD,AUC_tend,5.4,ng/ml,arith. mean,1.9,ng/mL,arith. SD,Cmax,159,mL/min,arith. Mean,30,mL/min,arith. SD,,"CL Type: renal Clearance, AUC(0-144h)=38,2+/-12,4"
191,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,po with Perpetrator (Rifampicin),Digoxin,240,inf,h,38.2,ng*h/ml,arith. mean,12.4,ng*h/mL,arith. SD,AUC_tend,2.6,ng/ml,arith. mean,0.7,ng/mL,arith. SD,Cmax,159,mL/min,arith. Mean,38,mL/min,arith. SD,,"CL Type: renal Clearance, AUC(240-384h)=54,8+/-11,6"
192,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,iv Control (Perpetrator Placebo),Digoxin,0,inf,h,87.3,ng*h/ml,arith. mean,8.3,ng*h/mL,arith. SD,AUC_tend,24.7,ng/ml,arith. mean,5.2,ng/mL,arith. SD,Cmax,151,mL/min,arith. Mean,25,mL/min,arith. SD,,"CL Type: renal Clearance; AUC(0-144,5h)=87,3+/-8,3; nonrenal clearance = 17+/-17 ml/min; systemic clearance = renal + nonrenal clearance"
193,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,iv with Perpetrator (Rifampicin),Digoxin,240,inf,h,74.5,ng*h/ml,arith. mean,10.5,ng*h/mL,arith. SD,AUC_tend,20.9,ng/ml,arith. mean,1.8,ng/mL,arith. SD,Cmax,147,mL/min,arith. Mean,18,mL/min,arith. SD,,"CL Type: renal Clearance; AUC(240-384,5h)=74,5+/-10,5; nonrenal clearance = 54+/-29 ml/min; systemic clearance = renal + nonrenal clearance"
423,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,Control (Perpetrator Placebo),Midazolam,0,inf,h,63,nmol*h/L,arith. mean,39,nmol*h/L,arith. SD,AUC_inf,,,,,,,,122,L/h,arith. Mean,49,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
424,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,with Perpetrator (Itraconazole @ 50 mg),Midazolam,4,inf,h,114,nmol*h/L,arith. mean,41,nmol*h/L,arith. SD,AUC_inf,,,,,,,,61,L/h,arith. Mean,28,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
425,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,with Perpetrator (Itraconazole @ 200 mg),Midazolam,4,inf,h,256,nmol*h/L,arith. mean,75,nmol*h/L,arith. SD,AUC_inf,,,,,,,,26,L/h,arith. Mean,9,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
426,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,with Perpetrator (Itraconazole @ 400 mg),Midazolam,4,inf,h,289,nmol*h/L,arith. mean,57,nmol*h/L,arith. SD,AUC_inf,,,,,,,,22,L/h,arith. Mean,4,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
214,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Rifampicin (Perpetrator Placebo),Midazolam,0,inf,h,79.6,ng*h/mL,arith. mean,23.2,ng*h/mL,arith. SD,AUC_inf,30.6,ng/mL,arith. mean,14.6,ng/mL,arith. SD,Cmax,110.8,L/h,arith. Mean,33.2,L/h,arith. SD,CL/F,
215,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,with Perpetrator (Rifampicin),Midazolam,146,inf,h,4.55,ng*h/mL,arith. mean,2.24,ng*h/mL,arith. SD,AUC_inf,3.7,ng/mL,arith. mean,2.6,ng/mL,arith. SD,Cmax,2256,L/h,arith. Mean,1168,L/h,arith. SD,CL/F,
216,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Clarithromycin (Perpetrator Placebo),Midazolam,0,inf,h,89.6,ng*h/mL,arith. mean,30.6,ng*h/mL,arith. SD,AUC_inf,31.8,ng/mL,arith. mean,11.6,ng/mL,arith. SD,Cmax,99.3,L/h,arith. Mean,25.2,L/h,arith. SD,CL/F,
217,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,with Perpetrator (Clarithomycin),Midazolam,146,inf,h,752,ng*h/mL,arith. mean,398,ng*h/mL,arith. SD,AUC_inf,120.7,ng/mL,arith. mean,29.3,ng/mL,arith. SD,Cmax,12.8,L/h,arith. Mean,6.5,L/h,arith. SD,CL/F,
218,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Black cohosh (Perpetrator Placebo),Midazolam,0,inf,h,94.8,ng*h/mL,arith. mean,29.2,ng*h/mL,arith. SD,AUC_inf,34.6,ng/mL,arith. mean,15.5,ng/mL,arith. SD,Cmax,93.3,L/h,arith. Mean,32.6,L/h,arith. SD,CL/F,
219,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Milk thistle (Perpetrator Placebo),Midazolam,0,inf,h,96.2,ng*h/mL,arith. mean,42.2,ng*h/mL,arith. SD,AUC_inf,37.2,ng/mL,arith. mean,18.1,ng/mL,arith. SD,Cmax,95.3,L/h,arith. Mean,33,L/h,arith. SD,CL/F,
220,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Rifampicin (Perpetrator Placebo),Midazolam,0,inf,h,107.1,ng*h/mL,arith. mean,40.7,ng*h/mL,arith. SD,AUC_inf,44.6,ng/mL,arith. mean,15.8,ng/mL,arith. SD,Cmax,92.7,L/h,arith. Mean,33.2,L/h,arith. SD,CL/F,
221,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,with Perpetrator (Rifampicin),Midazolam,146,inf,h,6.46,ng*h/mL,arith. mean,3.51,ng*h/mL,arith. SD,AUC_inf,4.8,ng/mL,arith. mean,3.8,ng/mL,arith. SD,Cmax,1649,L/h,arith. Mean,927,L/h,arith. SD,CL/F,
222,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Clarithromycin (Perpetrator Placebo),Midazolam,0,inf,h,102.4,ng*h/mL,arith. mean,43.9,ng*h/mL,arith. SD,AUC_inf,52.2,ng/mL,arith. mean,26.7,ng/mL,arith. SD,Cmax,95.7,L/h,arith. Mean,46.1,L/h,arith. SD,CL/F,
223,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,with Perpetrator (Clarithomycin),Midazolam,146,inf,h,561.5,ng*h/mL,arith. mean,188.6,ng*h/mL,arith. SD,AUC_inf,113.5,ng/mL,arith. mean,36.2,ng/mL,arith. SD,Cmax,16.3,L/h,arith. Mean,6.2,L/h,arith. SD,CL/F,
224,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Goldenseal (Perpetrator Placebo),Midazolam,0,inf,h,107.9,ng*h/mL,arith. mean,43.3,ng*h/mL,arith. SD,AUC_inf,50.6,ng/mL,arith. mean,26.9,ng/mL,arith. SD,Cmax,88.8,L/h,arith. Mean,39.1,L/h,arith. SD,CL/F,
225,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Kava kava (Perpetrator Placebo),Midazolam,0,inf,h,107.1,ng*h/mL,arith. mean,41.9,ng*h/mL,arith. SD,AUC_inf,38.6,ng/mL,arith. mean,15.1,ng/mL,arith. SD,Cmax,86.9,L/h,arith. Mean,35.7,L/h,arith. SD,CL/F,
226,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,Control to Perpetrator Rifampicin,Digoxin,0,inf,h,8.1,ng*h/mL,arith. mean,1.9,ng*h/mL,arith. SD,AUC_inf,1.3,ng/mL,arith. mean,0.4,ng/mL,arith. SD,Cmax,,,,,,,,
227,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,with Perpetrator (Rifampicin),Digoxin,146,inf,h,6.1,ng*h/mL,arith. mean,1.9,ng*h/mL,arith. SD,AUC_inf,0.8,ng/mL,arith. mean,0.3,ng/mL,arith. SD,Cmax,,,,,,,,
228,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,Control to Perpetrator Clarithromycin,Digoxin,0,inf,h,7.3,ng*h/mL,arith. mean,2,ng*h/mL,arith. SD,AUC_inf,1.2,ng/mL,arith. mean,0.3,ng/mL,arith. SD,Cmax,,,,,,,,
229,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,with Perpetrator (Clarithomycin),Digoxin,146,inf,h,10.7,ng*h/mL,arith. mean,3.4,ng*h/mL,arith. SD,AUC_inf,2.1,ng/mL,arith. mean,0.9,ng/mL,arith. SD,Cmax,,,,,,,,
261,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,iv 0.001 mg,Midazolam,0,inf,h,37.9,pg*h/mL,geo. mean,13.2,%,geo. CV,AUC_inf,39.1,pg/mL,geo. mean,43.7,%,geo. CV,Cmax,439,mL/min,geo. Mean,11.9,%,geo. CV,CLiv,
262,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,iv 1 mg,Midazolam,0,inf,h,39000,pg*h/mL,geo. mean,14,%,geo. CV,AUC_inf,37100,pg/mL,geo. mean,61.3,%,geo. CV,Cmax,428,mL/min,geo. Mean,14.9,%,geo. CV,CLiv,
263,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,po 0.003 mg,Midazolam,0,inf,h,26.6,pg*h/mL,geo. mean,30.9,%,geo. CV,AUC_inf,11.9,pg/mL,geo. mean,38.2,%,geo. CV,Cmax,1880,mL/min,geo. Mean,32.3,%,geo. CV,CL/F,
264,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,po 3 mg,Midazolam,0,inf,h,24400,pg*h/mL,geo. mean,31.3,%,geo. CV,AUC_inf,9990,pg/mL,geo. mean,51,%,geo. CV,Cmax,2050,mL/min,geo. Mean,35.8,%,geo. CV,CL/F,
293,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,40.9,ng*h/mL,arith. mean,7.6,ng*h/mL,arith. SD,AUC_inf,62,ng/mL,arith. Mean,29,ng/mL,arith. SD,Cmax,5.9,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
294,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 5 mg),Midazolam,108,132,h,34,ng*h/mL,arith. mean,6.5,ng*h/mL,arith. SD,AUC_inf,64,ng/mL,arith. Mean,26,ng/mL,arith. SD,Cmax,7.1,mL/min/kg,arith. mean,2.1,mL/min/kg,arith. SD,CLiv,
295,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 10 mg),Midazolam,108,132,h,30.7,ng*h/mL,arith. mean,4.5,ng*h/mL,arith. SD,AUC_inf,66,ng/mL,arith. Mean,19,ng/mL,arith. SD,Cmax,7.6,mL/min/kg,arith. mean,2,mL/min/kg,arith. SD,CLiv,
296,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 25 mg),Midazolam,108,132,h,25.2,ng*h/mL,arith. mean,3.6,ng*h/mL,arith. SD,AUC_inf,52,ng/mL,arith. Mean,23,ng/mL,arith. SD,Cmax,9.3,mL/min/kg,arith. mean,1.8,mL/min/kg,arith. SD,CLiv,
297,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 75 mg),Midazolam,108,132,h,24.1,ng*h/mL,arith. mean,4.5,ng*h/mL,arith. SD,AUC_inf,82,ng/mL,arith. Mean,34,ng/mL,arith. SD,Cmax,9.8,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
298,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv Control (Perpetrator Placebo),Alfentanil,0,inf,h,78,ng*h/mL,arith. mean,30.7,ng*h/mL,arith. SD,AUC_inf,102,ng/mL,arith. Mean,37,ng/mL,arith. SD,Cmax,3.7,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
299,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 5 mg),Alfentanil,109,133,h,61.7,ng*h/mL,arith. mean,19.4,ng*h/mL,arith. SD,AUC_inf,106,ng/mL,arith. Mean,35,ng/mL,arith. SD,Cmax,4.4,mL/min/kg,arith. mean,1.2,mL/min/kg,arith. SD,CLiv,
300,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 10 mg),Alfentanil,109,133,h,55.5,ng*h/mL,arith. mean,16.7,ng*h/mL,arith. SD,AUC_inf,107,ng/mL,arith. Mean,23,ng/mL,arith. SD,Cmax,4.9,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
301,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 25 mg),Alfentanil,109,133,h,44,ng*h/mL,arith. mean,15.9,ng*h/mL,arith. SD,AUC_inf,102,ng/mL,arith. Mean,27,ng/mL,arith. SD,Cmax,6.3,mL/min/kg,arith. mean,1.8,mL/min/kg,arith. SD,CLiv,
302,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 75 mg),Alfentanil,109,133,h,37,ng*h/mL,arith. mean,37,ng*h/mL,arith. SD,AUC_inf,105,ng/mL,arith. Mean,26,ng/mL,arith. SD,Cmax,7.1,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
303,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po Control (Perpetrator Placebo),Midazolam,0,inf,h,35,ng*h/mL,arith. mean,12.8,ng*h/mL,arith. SD,AUC_inf,15,ng/mL,arith. Mean,5,ng/mL,arith. SD,Cmax,23,mL/min/kg,arith. mean,10,mL/min/kg,arith. SD,CL/F,
304,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 5 mg),Midazolam,132,inf,h,26.8,ng*h/mL,arith. mean,8.4,ng*h/mL,arith. SD,AUC_inf,12,ng/mL,arith. Mean,4,ng/mL,arith. SD,Cmax,28.4,mL/min/kg,arith. mean,10,mL/min/kg,arith. SD,CL/F,
305,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 10 mg),Midazolam,132,inf,h,22.7,ng*h/mL,arith. mean,6.9,ng*h/mL,arith. SD,AUC_inf,14,ng/mL,arith. Mean,6,ng/mL,arith. SD,Cmax,33.4,mL/min/kg,arith. mean,12.8,mL/min/kg,arith. SD,CL/F,
306,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 25 mg),Midazolam,132,inf,h,13.3,ng*h/mL,arith. mean,3.3,ng*h/mL,arith. SD,AUC_inf,7.6,ng/mL,arith. Mean,3,ng/mL,arith. SD,Cmax,56.5,mL/min/kg,arith. mean,19.4,mL/min/kg,arith. SD,CL/F,
307,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 75 mg),Midazolam,132,inf,h,8.1,ng*h/mL,arith. mean,1.9,ng*h/mL,arith. SD,AUC_inf,5.1,ng/mL,arith. Mean,1.9,ng/mL,arith. SD,Cmax,95.5,mL/min/kg,arith. mean,35.8,mL/min/kg,arith. SD,CL/F,
308,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po Control (Perpetrator Placebo),Alfentanil,0,inf,h,146,ng*h/mL,arith. mean,84,ng*h/mL,arith. SD,AUC_inf,51,ng/mL,arith. Mean,21,ng/mL,arith. SD,Cmax,11.1,mL/min/kg,arith. mean,5.7,mL/min/kg,arith. SD,CL/F,
309,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 5 mg),Alfentanil,133,inf,h,101,ng*h/mL,arith. mean,42,ng*h/mL,arith. SD,AUC_inf,44,ng/mL,arith. Mean,15,ng/mL,arith. SD,Cmax,14.8,mL/min/kg,arith. mean,7.2,mL/min/kg,arith. SD,CL/F,
310,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 10 mg),Alfentanil,133,inf,h,81,ng*h/mL,arith. mean,41,ng*h/mL,arith. SD,AUC_inf,44,ng/mL,arith. Mean,17,ng/mL,arith. SD,Cmax,19.7,mL/min/kg,arith. mean,11.6,mL/min/kg,arith. SD,CL/F,
311,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 25 mg),Alfentanil,133,inf,h,43,ng*h/mL,arith. mean,27,ng*h/mL,arith. SD,AUC_inf,25,ng/mL,arith. Mean,12,ng/mL,arith. SD,Cmax,41.9,mL/min/kg,arith. mean,28.7,mL/min/kg,arith. SD,CL/F,
312,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 75 mg),Alfentanil,133,inf,h,18,ng*h/mL,arith. mean,13,ng*h/mL,arith. SD,AUC_inf,13,ng/mL,arith. Mean,10,ng/mL,arith. SD,Cmax,91.7,mL/min/kg,arith. mean,44.6,mL/min/kg,arith. SD,CL/F,
421,Szalat 2007,https://www.ncbi.nlm.nih.gov/pubmed/17553741,Control (Perpetrator Placebo),Midazolam,0,inf,h,5367,ng*min/mL,arith. Mean,981,ng*min/mL,arith. SD,AUC_inf,,,,,,,,10.1,mL/min/kg,arith. Mean,2.2,mL/min/kg,arith. SD,CLiv,
422,Szalat 2007,https://www.ncbi.nlm.nih.gov/pubmed/17553741,with Perpetrator (Rifampicin),Midazolam,132,inf,h,3110,ng*min/mL,arith. Mean,420,ng*min/mL,arith. SD,AUC_inf,,,,,,,,16.2,mL/min/kg,arith. Mean,22.9,mL/min/kg,arith. SD,CLiv,
341,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,125.8,ng*h/mL,median,,,,AUC_inf,151,ng/mL,median,,,,Cmax,15.9,L/h,median,,,,CLiv,
342,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,iv with Perpetrator (Rifampicin),Midazolam,144,inf,h,82.4,ng*h/mL,median,,,,AUC_inf,167,ng/mL,median,,,,Cmax,24.4,L/h,median,,,,CLiv,
343,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,po Control (Perpetrator Placebo),Midazolam,0,inf,h,102.9,ng*h/mL,median,,,,AUC_inf,63.1,ng/mL,median,,,,Cmax,,,,,,,,
344,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,po with Perpetrator (Rifampicin),Midazolam,144,inf,h,1.6,ng*h/mL,median,,,,AUC_inf,2.2,ng/mL,median,,,,Cmax,,,,,,,,
383,Peloquin 1997,https://www.ncbi.nlm.nih.gov/pubmed/9420037,600 mg,Rifampicin,0,inf,h,79.79,µg*h/mL,arith. mean,27.35,µg*h/mL,arith. SD,AUC_inf,13.61,µg/mL,arith. mean,3.96,µg/mL,arith. SD,Cmax,8.3,L/h,arith. mean,2.5,L/h,arith. SD,CL/F,
384,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,fast1,Rifampicin,0,inf,h,57.15,µg*h/mL,arith. Mean,23,%,arith. CV,AUC_inf,10.54,µg/mL,arith. mean,30,%,arith. CV,Cmax,,,,,,,,
385,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,fast2,Rifampicin,0,inf,h,58.98,µg*h/mL,arith. Mean,27,%,arith. CV,AUC_inf,11.32,µg/mL,arith. mean,27,%,arith. CV,Cmax,,,,,,,,
386,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,antacid,Rifampicin,0,inf,h,58.37,µg*h/mL,arith. Mean,32,%,arith. CV,AUC_inf,10.89,µg/mL,arith. mean,48,%,arith. CV,Cmax,,,,,,,,
387,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,fed,Rifampicin,0,inf,h,55.2,µg*h/mL,arith. Mean,26,%,arith. CV,AUC_inf,7.27,µg/mL,arith. mean,31,%,arith. CV,Cmax,,,,,,,,
414,Schwagmeier 1998,https://www.ncbi.nlm.nih.gov/pubmed/9764959,iv administration,Midazolam,0,inf,min,15016,ng*min/mL,arith. Mean,3778,ng*min/mL,arith. SD,AUC_inf,118.8,ng/mL,arith. mean,75.7-155.7,ng/mL,Range,Cmax,362.6,mL/min,arith. mean,85.2,mL/min,arith. SD,CLiv,
427,Tham 2006,https://www.ncbi.nlm.nih.gov/pubmed/16628140,Control (Perpetrator Placebo),Midazolam,0,inf,h,0.17,mg*h/L,arith. Mean,0.28,mg*h/L,arith. SD,AUC_inf,0.26,mg/L,arith. mean,0.72,mg/L,arith. SD,Cmax,26.4,L/h,arith. mean,12.27,L/h,arith. SD,CLiv,
428,Tham 2006,https://www.ncbi.nlm.nih.gov/pubmed/16628140,with Perpetrator (Ketoconazole 50 mg),Midazolam,47,inf,h,0.27,mg*h/L,arith. Mean,0.15,mg*h/L,arith. SD,AUC_inf,0.06,mg/L,arith. mean,0.03,mg/L,arith. SD,Cmax,4.49,L/h,arith. mean,1.82,L/h,arith. SD,CLiv,
388,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,Control (Perpetrator Placebo),Midazolam,0,inf,h,3180,ng*min/mL,arith. Mean,840,ng*min/mL,arith. SD,AUC_inf,,,,,,,,4.37,mL/min/kg,arith. Mean,1.29,mL/min/kg,arith. SD,CLiv,
389,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,with Perpetrator (Rifampicin),Midazolam,106,inf,h,1530,ng*min/mL,arith. Mean,290,ng*min/mL,arith. SD,AUC_inf,,,,,,,,8.78,mL/min/kg,arith. Mean,1.6,mL/min/kg,arith. SD,CLiv,
390,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,Control (Perpetrator Placebo),Alfentanil,0,inf,h,6680,ng*min/mL,arith. Mean,3480,ng*min/mL,arith. SD,AUC_inf,,,,,,,,2.84,mL/min/kg,arith. Mean,1.44,mL/min/kg,arith. SD,CLiv,
391,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,with Perpetrator (Rifampicin),Alfentanil,107,inf,h,2890,ng*min/mL,arith. Mean,568,ng*min/mL,arith. SD,AUC_inf,,,,,,,,5.33,mL/min/kg,arith. Mean,0.95,mL/min/kg,arith. SD,CLiv,
400,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,po Control (Perpetrator Placebo),Midazolam,0,inf,h,91,ng*h/mL,arith. Mean,30,ng*h/mL,arith. SD,AUC_inf,24.1,ng/mL,arith. mean,7.2,ng/mL,arith. SD,Cmax,20.1,mL/min/kg,arith. Mean,8.1,mL/min/kg,arith. SD,CL/F,
401,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,po with Perpetrator (Voriconazole),Midazolam,37,inf,h,855,ng*h/mL,arith. Mean,104,ng*h/mL,arith. SD,AUC_tau,86.6,ng/mL,arith. mean,26.2,ng/mL,arith. SD,Cmax,1.9,mL/min/kg,arith. Mean,0.3,mL/min/kg,arith. SD,CL/F,
402,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,po with Perpetrator (Voriconazole),Voriconazole,36,60,h,12201,ng*h/mL,arith. Mean,6044,ng*h/mL,arith. SD,AUC_tend,1441,ng/mL,arith. mean,329,ng/mL,arith. SD,Cmax,,,,,,,,
403,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,151,ng*h/mL,arith. Mean,40,ng*h/mL,arith. SD,AUC_inf,,,,,,,,5.9,mL/min/kg,arith. Mean,1.5,mL/min/kg,arith. SD,CLiv,
404,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,iv with Perpetrator (Voriconazole),Midazolam,37,inf,h,534,ng*h/mL,arith. Mean,88,ng*h/mL,arith. SD,AUC_inf,,,,,,,,1.6,mL/min/kg,arith. Mean,0.3,mL/min/kg,arith. SD,CLiv,
405,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,iv with Perpetrator (Voriconazole),Voriconazole,36,60,h,13776,ng*h/mL,arith. Mean,10758,ng*h/mL,arith. SD,AUC_tend,1495,ng/mL,arith. mean,609,ng/mL,arith. SD,Cmax,,,,,,,,
55,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase I (Control (Perpetrator Placebo)),Midazolam,0,inf,h,277,ng*h/ml,arith. Mean,72,ng*h/ml,arith. SEM,AUC_inf,69.5,ng/mL,arith. mean,10.4,ng/ml,arith. SEM,Cmax,,,,,,,,
56,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase IV (during Perpetrator (Rifampicin)),Midazolam,113,185,h,4.4,ng*h/ml,arith. Mean,1,ng*h/ml,arith. SEM,AUC_inf,3.4,ng/mL,arith. mean,0.8,ng/ml,arith. SEM,Cmax,,,,,,,,
57,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase V (4 days after Perpetrator (Rifampicin)),Midazolam,185,inf,h,27.1,ng*h/ml,arith. Mean,5.1,ng*h/ml,arith. SEM,AUC_inf,13.4,ng/mL,arith. mean,3.7,ng/ml,arith. SEM,Cmax,,,,,,,,
58,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase II (during Perpetrator (Itraconazole)),Midazolam,74,170,h,1707,ng*h/ml,arith. Mean,204,ng*h/ml,arith. SEM,AUC_inf,202,ng/mL,arith. mean,30,ng/ml,arith. SEM,Cmax,,,,,,,,
59,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase III (4 days after Perpetrator (Itraconazole)),Midazolam,170,inf,h,695,ng*h/ml,arith. Mean,208,ng*h/ml,arith. SEM,AUC_inf,120,ng/mL,arith. mean,7,ng/ml,arith. SEM,Cmax,,,,,,,,
110,Chouchane 1995,https://www.ncbi.nlm.nih.gov/pubmed/8983939,Rimactan,Rifampicin,0,inf,h,25.57,µg*h/mL,arith. Mean,12.16,µg*h/mL,arith. SD,AUC_inf,6.06,µg/mL,arith. mean,2.95,µg/mL,arith. SD,Cmax,,,,,,,,
111,Chouchane 1995,https://www.ncbi.nlm.nih.gov/pubmed/8983939,Rifampicin Generic,Rifampicin,0,inf,h,26.11,µg*h/mL,arith. Mean,9.1,µg*h/mL,arith. SD,AUC_inf,6.55,µg/mL,arith. mean,2.47,µg/mL,arith. SD,Cmax,,,,,,,,
118,Darwish 2008,https://www.ncbi.nlm.nih.gov/pubmed/18076219,oral,Midazolam,0,inf,h,53.8,ng*h/mL,arith. Mean,19.5,ng*h/mL,arith. SD,AUC_inf,18.7,ng/mL,arith. mean,6.3,ng/mL,arith. SD,Cmax,1717.6,mL/min,arith. mean,529.2,mL/min,arith. SD,CL/F,
119,Darwish 2008,https://www.ncbi.nlm.nih.gov/pubmed/18076219 ,iv,Midazolam,0,inf,h,76.9,ng*h/mL,arith. Mean,16.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,451.9,mL/min,arith. mean,92.1,mL/min,arith. SD,CLiv,
120,Darwish 2008,https://www.ncbi.nlm.nih.gov/pubmed/18076219 ,oral,Caffeine,0,inf,h,47.3,µg*h/mL,arith. Mean,20.4,µg*h/mL,arith. SD,AUC_inf,5.01,µg/mL,arith. mean,1.16,µg/mL,arith. SD,Cmax,84.3,mL/min,arith. mean,37.2,mL/min,arith. SD,CL/F,CL: n = 23
172,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,po Control (Perpetrator Placebo),Midazolam,0,inf,h,48,µg*h/L,arith. Mean,21,µg/L/hr,arith. SD,AUC_inf,,,,,,,,103,L/h,arith. mean,53,L/h,arith. SD,CL/F,
173,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,po with Perpetrator (Clarithromycin),Midazolam,146,inf,h,336,µg*h/L,arith. Mean,140,µg/L/hr,arith. SD,AUC_inf,,,,,,,,15,L/h,arith. mean,8.7,L/h,arith. SD,CL/F,
174,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,127,µg*h/L,arith. Mean,61,µg/L/hr,arith. SD,AUC_inf,,,,,,,,27.8,L/h,arith. mean,9.3,L/h,arith. SD,CLiv,
175,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,iv with Perpetrator (Clarithromycin),Midazolam,146,inf,h,349,µg*h/L,arith. Mean,119,µg/L/hr,arith. SD,AUC_inf,,,,,,,,10.1,L/h,arith. mean,3.2,L/h,arith. SD,CLiv,
176,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,po Control (Perpetrator Placebo),Midazolam,0,inf,h,35.8,µg*h/L,arith. Mean,20.8,µg*h/L,arith. SD,AUC_inf,17.9,ng/mL,arith. mean,7.6,ng/mL,arith. SD,Cmax,115.9,L/h,arith. mean,58.6,L/h,arith. SD,CL/F,
177,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,po with Perpetrator (Rifampicin),Midazolam,132,inf,h,3.7,µg*h/L,arith. Mean,2.8,µg*h/L,arith. SD,AUC_inf,1.8,ng/mL,arith. mean,1.1,ng/mL,arith. SD,Cmax,2691.4,L/h,arith. mean,1996.1,L/h,arith. SD,CL/F,
178,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,117.6,µg*h/L,arith. Mean,41.6,µg*h/L,arith. SD,AUC_inf,,,,,,,,32.8,L/h,arith. mean,12.2,L/h,arith. SD,CLiv,
179,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,iv with Perpetrator (Rifampicin),Midazolam,132,inf,h,52.8,µg*h/L,arith. Mean,15.7,µg*h/L,arith. SD,AUC_inf,,,,,,,,70.8,L/h,arith. mean,20.1,L/h,arith. SD,CLiv,
180,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - f, 136kg, 36y (obese female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
181,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - f, 61kg, 37y (normal female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
182,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - m, 70kg, 32y (young male)",Midazolam,0,inf,h,,,,,,,,,,,,,,,534,ml/min,arith. mean,32,ml/min,arith. SD,CLiv,
183,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - m, 80kg, 70y (elderly male)",Midazolam,0,inf,h,,,,,,,,,,,,,,,339,ml/min,arith. mean,43,ml/min,arith. SD,CLiv,
184,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - f, 136kg, 36y (obese female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
185,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - f, 61kg, 37y (normal female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
186,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - m, 70kg, 32y (young male)",Midazolam,0,inf,h,,,,,,,,69,ng/ml,arith. mean,12,ng/ml,arith. SD,Cmax,,,,,,,,
187,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - m, 80kg, 70y (elderly male)",Midazolam,0,inf,h,,,,,,,,85,ng/ml,arith. mean,11,ng/ml,arith. SD,Cmax,,,,,,,,
188,Greenblat 2003,https://www.ncbi.nlm.nih.gov/pubmed/12891222,Control (Perpetrator Placebo),Midazolam,0,inf,h,64.9,ng*h/mL,arith. Mean,7.2,ng*h/mL,arith. SE,AUC_inf,18.8,ng/mL,arith. mean,1.9,ng/mL,arith. SE,Cmax,27.5,mL/min/kg,arith. mean,3.5,mL/min/kg,arith. SEM,CL/F,
189,Greenblat 2003,https://www.ncbi.nlm.nih.gov/pubmed/12891223,with Perpetrator (GFJ),Midazolam,0,inf,h,106.8,ng*h/mL,arith. Mean,12.1,ng*h/mL,arith. SE,AUC_inf,29.1,ng/mL,arith. mean,2.7,ng/mL,arith. SE,Cmax,18.8,mL/min/kg,arith. mean,2.1,mL/min/kg,arith. SEM,CL/F,
275,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,3.3,mL/min/kg,arith. mean,1,mL/min/kg,arith. SD,CLiv,
276,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,with Perpetrator (Rifampicin),Midazolam,120,inf,h,,,,,,,,,,,,,,,8.7,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
277,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,Control (Perpetrator Placebo),Alfentanil,0,inf,h,,,,,,,,,,,,,,,5.3,mL/min/kg,arith. mean,2.3,mL/min/kg,arith. SD,CLiv,
278,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,with Perpetrator (Rifampicin),Alfentanil,120.5,inf,h,,,,,,,,,,,,,,,14.6,mL/min/kg,arith. mean,3.8,mL/min/kg,arith. SD,CLiv,Significantly different from control (P<0.05). Microconstants were not statistically compared.
374,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 1 (po) Control (Perpetrator Placebo),Midazolam,0,inf,h,78,ng*h/mL,arith. mean,24,ng*h/mL,arith. SD,AUC_inf,28,ng/mL,arith. mean,9,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
375,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 4 (iv) Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,8.7,mL/min/kg,arith. mean,2.7,mL/min/kg,arith. SD,CLiv,
376,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 6 (po) Control (Perpetrator Placebo),Midazolam,0,inf,h,87,ng*h/mL,arith. mean,39,ng*h/mL,arith. SD,AUC_inf,35,ng/mL,arith. mean,14,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
377,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 1 (po) with Perpetrator (Itraconazole),Midazolam,2,74,h,267,ng*h/mL,arith. mean,107,ng*h/mL,arith. SD,AUC_inf,49,ng/mL,arith. mean,20,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
378,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 4 (iv) with Perpetrator (Itraconazole),Midazolam,74,122,h,,,,,,,,,,,,,,,2.7,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
379,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 6 (po) with Perpetrator (Itraconazole),Midazolam,122,inf,h,578,ng*h/mL,arith. mean,142,ng*h/mL,arith. SD,AUC_inf,88,ng/mL,arith. mean,15,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
380,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 1 (po) with Perpetrator (Fluconazole),Midazolam,2,74,h,274,ng*h/mL,arith. mean,99,ng*h/mL,arith. SD,AUC_inf,70,ng/mL,arith. mean,28,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
381,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 4 (iv) with Perpetrator (Fluconazole),Midazolam,74,122,h,,,,,,,,,,,,,,,4.3,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
382,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 6 (po) with Perpetrator (Fluconazole),Midazolam,122,inf,h,313,ng*h/mL,arith. mean,117,ng*h/mL,arith. SD,AUC_inf,61,ng/mL,arith. mean,16,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
369,Olkkola 1994,https://www.ncbi.nlm.nih.gov/pubmed/8181191,po Control (Perpetrator Placebo),Midazolam,0,inf,h,3.9,µg*min/mL,arith. mean,0.6,µg*min/mL,arith. SEM,AUC_inf,22,ng/mL,arith. mean,6,ng/mL,arith. SEM,Cmax,,,,,,,,
370,Olkkola 1994,https://www.ncbi.nlm.nih.gov/pubmed/8181191,po with Perpetrator (Itraconazole),Midazolam,73,inf,h,42,µg*min/mL,arith. mean,6,µg*min/mL,arith. SEM,AUC_inf,75,ng/mL,arith. mean,7,ng/mL,arith. SEM,Cmax,,,,,,,,
371,Olkkola 1994,https://www.ncbi.nlm.nih.gov/pubmed/8181191,po with Perpetrator (Ketoconazole,Midazolam,73,inf,h,62,µg*min/mL,arith. mean,6,µg*min/mL,arith. SEM,AUC_inf,90,ng/mL,arith. mean,7,ng/mL,arith. SEM,Cmax,,,,,,,,
365,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,po Control (Perpetrator Placebo),Midazolam,0,inf,h,12,µg*min/mL,arith. mean,1,µg*min/mL,arith. SEM,AUC_inf,70,ng/mL,arith. mean,9,ng/mL,arith. SEM,Cmax,,,,,,,,
366,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,po with Perpetrator (Erythromycin),Midazolam,128,inf,h,53,µg*min/mL,arith. mean,7,µg*min/mL,arith. SEM,AUC_inf,189,ng/mL,arith. mean,16,ng/mL,arith. SEM,Cmax,,,,,,,,
367,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,7.8,mL/min/kg,arith. mean,0.6,mL/min/kg,arith. SEM,CLiv,
368,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,iv with Perpetrator (Erythromycin),Midazolam,128,inf,h,,,,,,,,,,,,,,,3.6,mL/min/kg,arith. mean,0.3,mL/min/kg,arith. SEM,CLiv,
361,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 0 Control (Perpetrator Placebo),Midazolam,0,inf,h,35.8,ng*h/mL,arith. mean,7.8,ng*h/mL,arith. SD,AUC_inf,11,ng/mL,arith. mean,2.6,ng/mL,arith. SD,Cmax,19.3,mL/min/kg,arith. mean,5.5,mL/min/kg,arith. SD,CL/F,
362,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 2 with Perpetrator (Erythromycin),Midazolam,25,73,h,83.1,ng*h/mL,arith. mean,37.7,ng*h/mL,arith. SD,AUC_inf,20,ng/mL,arith. mean,5.9,ng/mL,arith. SD,Cmax,9.4,mL/min/kg,arith. mean,4.2,mL/min/kg,arith. SD,CL/F,
363,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 4 with Perpetrator (Erythromycin),Midazolam,73,145,h,118.7,ng*h/mL,arith. mean,57,ng*h/mL,arith. SD,AUC_inf,26.4,ng/mL,arith. mean,8.7,ng/mL,arith. SD,Cmax,6.5,mL/min/kg,arith. mean,2.5,mL/min/kg,arith. SD,CL/F,
364,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 7 with Perpetrator (Erythromycin),Midazolam,145,inf,h,119.2,ng*h/mL,arith. mean,50.8,ng*h/mL,arith. SD,AUC_inf,25.8,ng/mL,arith. mean,9.9,ng/mL,arith. SD,Cmax,6.6,mL/min/kg,arith. mean,3,mL/min/kg,arith. SD,CL/F,
351,Majumdar 2007,https://www.ncbi.nlm.nih.gov/pubmed/17463213,po Control (Perpetrator Placebo),Midazolam,0,inf,h,75.4,ng*h/mL,arith. mean,8.57,ng*h/mL,arith. SD,AUC_inf,71.6,ng/mL,arith. mean,48.1,ng/mL,arith. SD,Cmax,447.11,mL/min,arith. mean,50.65,mL/min,arith. SD,CLiv,
352,Majumdar 2007,https://www.ncbi.nlm.nih.gov/pubmed/17463213,po with Perpetrator (Aprepitant),Midazolam,1,inf,h,112.4,ng*h/mL,arith. mean,23.66,ng*h/mL,arith. SD,AUC_inf,108.1,ng/mL,arith. mean,113.2,ng/mL,arith. SD,Cmax,307.51,mL/min,arith. mean,58.44,mL/min,arith. SD,CLiv,
30,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 1 (600 mg, 3 h infusion)",Rifampicin,0,inf,h,51,mg*h/mL,individual,,,,AUC_inf,,,,,,,,11.76,mL/h,individual,,,,,CL=dose/AUC
31,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 2 (600 mg, 3 h infusion)",Rifampicin,0,inf,h,59.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,10.05,mL/h,individual,,,,,CL=dose/AUC
32,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 3 (600 mg, 2 h infusion)",Rifampicin,0,inf,h,49.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,12.07,mL/h,individual,,,,,CL=dose/AUC
33,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 4 (600 mg, 2 h infusion)",Rifampicin,0,inf,h,16.1,mg*h/mL,individual,,,,AUC_inf,,,,,,,,37.26,mL/h,individual,,,,,CL=dose/AUC
34,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 5 (600 mg, 1 h infusion)",Rifampicin,0,inf,h,79.1,mg*h/mL,individual,,,,AUC_inf,,,,,,,,7.58,mL/h,individual,,,,,CL=dose/AUC
35,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 6 (600 mg, 1 h infusion)",Rifampicin,0,inf,h,60.6,mg*h/mL,individual,,,,AUC_inf,,,,,,,,9.9,mL/h,individual,,,,,CL=dose/AUC
36,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 7 (900 mg, 3 h infusion)",Rifampicin,0,inf,h,59.3,mg*h/mL,individual,,,,AUC_inf,,,,,,,,15.17,mL/h,individual,,,,,CL=dose/AUC
37,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 8 (900 mg, 3 h infusion)",Rifampicin,0,inf,h,72.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,12.38,mL/h,individual,,,,,CL=dose/AUC
38,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 9 (900 mg, 2 h infusion)",Rifampicin,0,inf,h,105.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,8.51,mL/h,individual,,,,,CL=dose/AUC
39,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 10 (900 mg, 2 h infusion)",Rifampicin,0,inf,h,79.2,mg*h/mL,individual,,,,AUC_inf,,,,,,,,11.51,mL/h,individual,,,,,CL=dose/AUC
40,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 11 (900 mg, 1 h infusion)",Rifampicin,0,inf,h,93.3,mg*h/mL,individual,,,,AUC_inf,,,,,,,,9.65,mL/h,individual,,,,,CL=dose/AUC
41,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 12 (900 mg, 1 h infusion)",Rifampicin,0,inf,h,145.4,mg*h/mL,individual,,,,AUC_inf,,,,,,,,6.19,mL/h,individual,,,,,CL=dose/AUC
42,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 13 (1200 mg, 3 h infusion)",Rifampicin,0,inf,h,97.8,mg*h/mL,individual,,,,AUC_inf,,,,,,,,12.26,mL/h,individual,,,,,CL=dose/AUC
43,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 14 (1200 mg, 3 h infusion)",Rifampicin,0,inf,h,201.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,5.95,mL/h,individual,,,,,CL=dose/AUC
44,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 15 (1200 mg, 2 h infusion)",Rifampicin,0,inf,h,90.4,mg*h/mL,individual,,,,AUC_inf,,,,,,,,13.27,mL/h,individual,,,,,CL=dose/AUC
45,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 16 (1200 mg, 2 h infusion)",Rifampicin,0,inf,h,107.3,mg*h/mL,individual,,,,AUC_inf,,,,,,,,11.18,mL/h,individual,,,,,CL=dose/AUC
46,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 17 (1200 mg, 1 h infusion)",Rifampicin,0,inf,h,231.4,mg*h/mL,individual,,,,AUC_inf,,,,,,,,5.18,mL/h,individual,,,,,CL=dose/AUC
47,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 18 (1200 mg, 1 h infusion)",Rifampicin,0,inf,h,267.9,mg*h/mL,individual,,,,AUC_inf,,,,,,,,4.48,mL/h,individual,,,,,CL=dose/AUC
5197,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,6m-2y,Itraconazole,0,24,h,2121,ng*h/mL,arith. Mean,1231,ng*h/mL,arith. SD,AUC_tau,827,ng/mL,arith. mean,859,ng/mL,arith. SD,Cmax_total,1143,mL/h/kg,arith. Mean,513,mL/h/kg,arith. Mean,CL total,
5198,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,2-6y,Itraconazole,0,24,h,9510,ng*h/mL,arith. Mean,11316,ng*h/mL,arith. SD,AUC_tau,1553,ng/mL,arith. mean,918,ng/mL,arith. SD,Cmax_total,529,mL/h/kg,arith. Mean,611,mL/h/kg,arith. Mean,CL total,
5199,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,6-12y,Itraconazole,0,24,h,3765,ng*h/mL,arith. Mean,1711,ng*h/mL,arith. SD,AUC_tau,785,ng/mL,arith. mean,301,ng/mL,arith. SD,Cmax_total,621,mL/h/kg,arith. Mean,340,mL/h/kg,arith. Mean,CL total,
5200,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,12-16y,Itraconazole,0,24,h,2669,ng*h/mL,arith. Mean,1076,ng*h/mL,arith. SD,AUC_tau,806,ng/mL,arith. mean,381,ng/mL,arith. SD,Cmax_total,777,mL/h/kg,arith. Mean,455,mL/h/kg,arith. Mean,CL total,
49,Ahonen 1995,http://www.ncbi.nlm.nih.gov/pubmed/8527290,Control (Perpetrator Placebo),Midazolam,0,inf,h,102,µg*min/mL,arith. mean,10,µg*min/mL,arith. SEM,AUC_inf,34,ng/mL,arith. mean,5,ng/mL,arith. SEM,Cmax,,,,,,,,
50,Ahonen 1995,http://www.ncbi.nlm.nih.gov/pubmed/8527290,with Perpetrator (Itraconazole),Midazolam,74,inf,h,586,µg*min/mL,arith. mean,73,µg*min/mL,arith. SEM,AUC_inf,87,ng/mL,arith. mean,11,ng/mL,arith. SEM,Cmax,,,,,,,,
128,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,0.075 mg Control (Perpetrator Placebo),Midazolam,0,inf,h,0.68,ng*h/mL,arith. mean,0.25,ng*h/mL,arith. SD,AUC_inf,0.31,ng/mL,arith. mean,0.09,ng/mL,arith. SD,Cmax,128,L/h,arith. mean,60,L/h,arith. SD,CL/F,
129,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,0.075 mg with Perpetrator (Rifampicin),Midazolam,90,inf,h,0.3,ng*h/mL,arith. mean,0.11,ng*h/mL,arith. SD,AUC_inf,0.07,ng/mL,arith. mean,0.02,ng/mL,arith. SD,Cmax,1089,L/h,arith. mean,1619,L/h,arith. SD,CL/F,
130,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,0.075 mg with Perpetrator (Ketoconazole),Midazolam,48,inf,h,4.4,ng*h/mL,arith. mean,1.6,ng*h/mL,arith. SD,AUC_inf,1.16,ng/mL,arith. mean,0.21,ng/mL,arith. SD,Cmax,19,L/h,arith. mean,7,L/h,arith. SD,CL/F,
131,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,7.5 mg Control (Perpetrator Placebo),Midazolam,0,inf,h,67,ng*h/mL,arith. mean,30,ng*h/mL,arith. SD,AUC_inf,26,ng/mL,arith. mean,11,ng/mL,arith. SD,Cmax,129,L/h,arith. mean,44,L/h,arith. SD,CL/F,
132,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,7.5 mg with Perpetrator (Rifampicin),Midazolam,114,inf,h,3.5,ng*h/mL,arith. mean,0.2,ng*h/mL,arith. SD,AUC_inf,2.9,ng/mL,arith. mean,0.5,ng/mL,arith. SD,Cmax,2179,L/h,arith. mean,148,L/h,arith. SD,CL/F,
60,Baneyx 2014,https://www.ncbi.nlm.nih.gov/pubmed/24530864,Day 4 - 600 mg po MD,Rifampicin,72,inf,h,60.8,µg*h/mL,arith. mean,22.1,µg*h/mL,arith. SD,AUC_inf,12.5,µg/mL,arith. mean,3.4,µg/mL,arith. SD,Cmax,,,,,,,,
549,Baneyx 2014,https://www.ncbi.nlm.nih.gov/pubmed/24530864,Day 7 - 600 mg po MD,Rifampicin,144,inf,h,47.3,µg*h/mL,arith. mean,19.7,µg*h/mL,arith. SD,AUC_inf,11,µg/mL,arith. mean,2.9,µg/mL,arith. SD,Cmax,,,,,,,,
104,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,1 h after a meal,Midazolam,1,inf,h,184,ng*h/mL,arith. mean,73,ng*h/mL,arith. SD,AUC_inf,48,ng/mL,arith. mean,19,ng/mL,arith. SD,Cmax,,,,,,,,
105,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,1 h before a meal,Midazolam,0,inf,h,197,ng*h/mL,arith. mean,57,ng*h/mL,arith. SD,AUC_inf,80,ng/mL,arith. mean,34,ng/mL,arith. SD,Cmax,,,,,,,,
106,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,with a meal,Midazolam,0,inf,h,207,ng*h/mL,arith. mean,96,ng*h/mL,arith. SD,AUC_inf,63,ng/mL,arith. mean,36,ng/mL,arith. SD,Cmax,,,,,,,,
107,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,fasting condition,Midazolam,0,inf,h,215,ng*h/mL,arith. mean,78,ng*h/mL,arith. SD,AUC_inf,69,ng/mL,arith. mean,26,ng/mL,arith. SD,Cmax,,,,,,,,
345,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,oral day 2 (Patient 4),Rifampicin,24,inf,h,67.6,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,9.8,L/h,arith. mean,,,,CL/F,
346,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,oral day 9 (Patient 4),Rifampicin,192,inf,h,57,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,11.7,L/h,arith. mean,,,,CL/F,
347,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,oral day 23 (Patient 4),Rifampicin,528,inf,h,18.4,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,34.5,L/h,arith. mean,,,,CL/F,
348,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,iv day 1 (Patient 4),Rifampicin,0,inf,h,110.4,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,5.43,L/h,arith. mean,,,,CLiv,
349,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,iv day 8 (Patient 4),Rifampicin,168,inf,h,95.4,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,6.29,L/h,arith. mean,,,,CLiv,
350,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,iv day 22 (Patient 4),Rifampicin,504,inf,h,69.6,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,8.63,L/h,arith. mean,,,,CLiv,
313,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 1 - Staggered Administration Control,Digoxin,0,inf,h,8.66,ng*h/mL,arith. mean,2.57,ng*h/mL,arith. SD,AUC_inf,1.34,ng/mL,arith. mean,0.53,ng/mL,arith. SD,Cmax,146,mL/min,arith. mean,43.3,mL/min,arith. SD,CL/F,
314,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 1 - Staggered Administration with RIF,Digoxin,324,inf,h,6.83,ng*h/mL,arith. mean,1.68,ng*h/mL,arith. SD,AUC_inf,1.02,ng/mL,arith. mean,0.38,ng/mL,arith. SD,Cmax,162,mL/min,arith. mean,51.4,mL/min,arith. SD,CL/F,
315,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 2 - Simultaneous Administration Control,Digoxin,0,inf,h,5.45,ng*h/mL,arith. mean,1.99,ng*h/mL,arith. SD,AUC_inf,1.24,ng/mL,arith. mean,0.35,ng/mL,arith. SD,Cmax,258,mL/min,arith. mean,64.9,mL/min,arith. SD,CL/F,
316,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 2 - Simultaneous Administration with RIF,Digoxin,360,inf,h,7.08,ng*h/mL,arith. mean,3.25,ng*h/mL,arith. SD,AUC_inf,2.12,ng/mL,arith. mean,1.04,ng/mL,arith. SD,Cmax,225,mL/min,arith. mean,59.8,mL/min,arith. SD,CL/F,
336,Larsen 2007,https://www.ncbi.nlm.nih.gov/pubmed/17365992,Control (Perpetrator Placebo),Digoxin,0,inf,h,980,nmol*min/mL,arith. mean,,,,AUC_inf,,,,,,,,,,,,,,,
337,Larsen 2007,https://www.ncbi.nlm.nih.gov/pubmed/17365992,with Perpetrator (Rifampicin),Digoxin,144,inf,h,801,nmol*min/mL,arith. mean,,,,AUC_inf,,,,,,,,,,,,,,,
338,Larsen 2007,https://www.ncbi.nlm.nih.gov/pubmed/17365992,with Perpetrator (Ketoconazole),Digoxin,96,inf,h,1070,nmol*min/mL,arith. mean,,,,AUC_inf,,,,,,,,,,,,,,,
419,Swart 2002,https://www.ncbi.nlm.nih.gov/pubmed/11851636 ,day 5 Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,3.8,mL/min/kg,arith. mean,0.8,mL/min/kg,arith. SD,,
420,Swart 2002,https://www.ncbi.nlm.nih.gov/pubmed/11851636 ,day 10 Control with Perpetrator (Erythromycin),Midazolam,96,inf,h,,,,,,,,,,,,,,,2.5,mL/min/kg,arith. mean,0.9,mL/min/kg,arith. SD,,
155,"Eon Labs Manufacturing, Inc. 1997",https://www.accessdata.fda.gov/drugsatfda_docs/anda/97/064150review.pdf,2X300mg Tab (Eon),Rifampicin,0,inf,h,59.91,µg*h/mL,arith. Mean,30,%,arith. CV,AUC_inf,10.78,µg/mL,arith. mean,24,%,arith. CV,Cmax,,,,,,,,
156,"Eon Labs Manufacturing, Inc. 1997",https://www.accessdata.fda.gov/drugsatfda_docs/anda/97/064150review.pdf,2X300mg Rifadine Tab,Rifampicin,0,inf,h,58.52,µg*h/mL,arith. Mean,27,%,arith. CV,AUC_inf,10.72,µg/mL,arith. mean,23,%,arith. CV,Cmax,,,,,,,,
48,Acocella 1985,https://www.ncbi.nlm.nih.gov/pubmed/4037525,R alone,Rifampicin,0,inf,h,36,,arith. mean,5.5,,arith. SE,AUC_inf,6.3,µg/mL,arith. mean,0.5,µg/mL,arith. SE,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: mcg/ml/h (not in list; might be wrong)
270,Jalava 1997,https://www.ncbi.nlm.nih.gov/pubmed/9421099,po Control (Perpetrator Placebo),Digoxin,0,inf,h,31,nmol*h/L,arith. mean,2,nmol*h/L,arith. SEM,AUC_inf,3.5,nmol/L,arith. mean,0.5,nmol/L,arith. SEM,Cmax,2.19,mL/min/kg,arith. mean,0.11,mL/min/kg,arith. SD,,CL is here CLR: amount excreted in urine in 72 h / AUC
271,Jalava 1997,https://www.ncbi.nlm.nih.gov/pubmed/9421099,po with Perpetrator (Itraconazole),Digoxin,49,inf,h,52,nmol*h/L,arith. mean,5,nmol*h/L,arith. SEM,AUC_inf,4.7,nmol/L,arith. mean,0.4,nmol/L,arith. SEM,Cmax,1.75,mL/min/kg,arith. mean,0.06,mL/min/kg,arith. SD,,CL is here CLR: amount excreted in urine in 72 h / AUC
272,Jalava 1997,https://www.ncbi.nlm.nih.gov/pubmed/9421099,po with Perpetrator (Itraconazole),Itraconazole,48,72,h,5312,nmol*h/L,arith. Mean,1840.530117,nmol*h/L,arith. SD,AUC_tau,526.7,nmol/L,arith. mean,219.8444147,nmol/L,arith. SD,Cmax,,,,,,,,
588,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 1 - fasted with 50 mL of water,Mefenamic acid,0,inf,h,9.95,µg*h/mL,arith. Mean,2.46,µg*h/mL,arith. SD,AUC_inf,3.62,µg/mL,arith. mean,0.98,µg/mL,arith. SD,Cmax,,,,,,,,
589,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 2 - fasted with 200 mL of water,Mefenamic acid,0,inf,h,8.55,µg*h/mL,arith. Mean,2.15,µg*h/mL,arith. SD,AUC_inf,2.74,µg/mL,arith. mean,0.5,µg/mL,arith. SD,Cmax,,,,,,,,
590,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 3 - fasted with 500 mL of water,Mefenamic acid,0,inf,h,4.4,µg*h/mL,arith. Mean,0.85,µg*h/mL,arith. SD,AUC_inf,1.26,µg/mL,arith. mean,2.46,µg/mL,arith. SD,Cmax,,,,,,,,
591,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 4 - fed with 50 mL of water,Mefenamic acid,0,inf,h,9.69,µg*h/mL,arith. Mean,1.07,µg*h/mL,arith. SD,AUC_inf,3.83,µg/mL,arith. mean,0.33,µg/mL,arith. SD,Cmax,,,,,,,,
629,Boulton 2013,https://www.ncbi.nlm.nih.gov/pubmed/22823746,14C-dapagliflozin iv,Dapagliflozin,1,inf,h,6.8,ng*h/mL,geo. mean,20,%,geo. CV,AUC_inf,10.2,ng/mL,geo. mean,49,%,geo. CV,Cmax,207,mL/min,geo. mean,23,%,geo. CV,CLiv,
630,Boulton 2013,https://www.ncbi.nlm.nih.gov/pubmed/22823746,Dapagliflozin po,Dapagliflozin,0,inf,h,628,ng*h/mL,geo. mean,17,%,geo. CV,AUC_inf,143,ng/mL,geo. mean,29,%,geo. CV,Cmax,,,,,,,,
633,Imamura 2013,https://www.ncbi.nlm.nih.gov/pubmed/23307267,Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,539,ng*h/mL,geo. mean,21.7,%,geo. CV,AUC_inf,180,ng/mL,geo. mean,29.5,%,geo. CV,Cmax,,,,,,,,
634,Kasichayanula 2011a,https://www.ncbi.nlm.nih.gov/pubmed/21435141,fasted,Dapagliflozin,0,inf,h,497,ng*h/mL,geo. mean,19,%,geo. CV,AUC_inf,136,ng/mL,geo. mean,22,%,geo. CV,Cmax,,,,,,,,
635,Kasichayanula 2011a,https://www.ncbi.nlm.nih.gov/pubmed/21435141,fed,Dapagliflozin,0,inf,h,507,ng*h/mL,geo. mean,16,%,geo. CV,AUC_inf,94,ng/mL,geo. mean,33,%,geo. CV,Cmax,,,,,,,,
636,Kasichayanula 2011b,https://www.ncbi.nlm.nih.gov/pubmed/21114603,Study 1: 50 mg Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,2303,ng*h/mL,geo. mean,,,,AUC_inf,551,ng/mL,geo. mean,,,,Cmax,,,,,,,,
637,Kasichayanula 2011b,https://www.ncbi.nlm.nih.gov/pubmed/21114603,Study 2: 20 mg Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,947,ng*h/mL,geo. mean,,,,AUC_inf,134,ng/mL,geo. mean,,,,Cmax,,,,,,,,
638,Kasichayanula 2011b,https://www.ncbi.nlm.nih.gov/pubmed/21114603,Study 3: 20 mg Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,1139,ng*h/mL,geo. mean,,,,AUC_inf,151,ng/mL,geo. mean,,,,Cmax,,,,,,,,
639,Kasichayanula 2012,https://www.ncbi.nlm.nih.gov/pubmed/22271159,Study 1: Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,928,ng*h/mL,geo. mean,,,,AUC_inf,251,ng/mL,geo. mean,,,,Cmax,,,,,,,,
640,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 1: Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,635,ng*h/mL,geo. mean,25,%,geo. CV,AUC_inf,160,ng/mL,geo. mean,34,%,geo. CV,Cmax,,,,,,,,
643,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 1: with Perpetrator (Rifampicin),Dapagliflozin,120,inf,h,556.6,ng*h/mL,geo. mean,15,%,geo. CV,AUC_inf,164.4,ng/mL,geo. mean,17,%,geo. CV,Cmax,,,,,,,,
641,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 2: Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,905,ng*h/mL,geo. mean,28,%,geo. CV,AUC_inf,193,ng/mL,geo. mean,34,%,geo. CV,Cmax,,,,,,,,
642,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 2: with Perpetrator (Mefenamic Acid),Dapagliflozin,24,inf,h,709,ng*h/mL,geo. mean,28,%,geo. CV,AUC_inf,114,ng/mL,geo. mean,28,%,geo. CV,Cmax,,,,,,,,
644,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,Healthy subjects with normal kidney function,Dapagliflozin,0,inf,h,2880,ng*h/mL,geo. mean,27,%,geo. CV,AUC_inf,710,ng/mL,geo. mean,31,%,geo. CV,Cmax,289,mL/min,geo. Mean,26,%,geo. CV,CL/F,
645,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with normal kidney function,Dapagliflozin,0,inf,h,2504,ng*h/mL,geo. mean,30,%,geo. CV,AUC_inf,647,ng/mL,geo. mean,37,%,geo. CV,Cmax,333,mL/min,geo. Mean,26,%,geo. CV,CL/F,
646,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with mild renal impairment,Dapagliflozin,0,inf,h,4018,ng*h/mL,geo. mean,26,%,geo. CV,AUC_inf,902,ng/mL,geo. mean,35,%,geo. CV,Cmax,207,mL/min,geo. Mean,25,%,geo. CV,CL/F,
647,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with moderate renal impairment,Dapagliflozin,0,inf,h,5182,ng*h/mL,geo. mean,38,%,geo. CV,AUC_inf,897,ng/mL,geo. mean,41,%,geo. CV,Cmax,161,mL/min,geo. Mean,26,%,geo. CV,CL/F,
648,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with severe renal impairment,Dapagliflozin,0,inf,h,4884,ng*h/mL,geo. mean,10,%,geo. CV,AUC_inf,772,ng/mL,geo. mean,11,%,geo. CV,Cmax,171,mL/min,geo. Mean,10,%,geo. CV,CL/F,
649,Vakkalagadda 2016,https://www.ncbi.nlm.nih.gov/pubmed/27491280,Dapagliflozin,Dapagliflozin,0,inf,h,542,ng*h/mL,geo. mean,23,%,geo. CV,AUC_inf,133,ng/mL,geo. mean,23,%,geo. CV,Cmax,305,mL/min,geo. Mean,24,%,geo. CV,CL/F,
650,DeFronzo 2013,https://www.ncbi.nlm.nih.gov/pubmed/23735727,Healthy Subjects,Dapagliflozin,144,168,h,343,ng*h/mL,arith. mean,89,ng*h/mL,arith. SD,AUC_tau,62.9,ng/mL,arith. mean,29.1,ng/mL,arith. SD,Cmax,,,,,,,,
651,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Healthy Volunteers,Dapagliflozin,0,inf,h,465,ng*h/mL,geo. mean,34,%,geo. CV,AUC_inf,136,ng/mL,geo. mean,31,%,geo. CV,Cmax,,,,,,,,
652,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Mild hepatic impairment,Dapagliflozin,0,inf,h,480,ng*h/mL,geo. mean,26,%,geo. CV,AUC_inf,120,ng/mL,geo. mean,28,%,geo. CV,Cmax,,,,,,,,
653,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Moderate hepatic impairment,Dapagliflozin,0,inf,h,632,ng*h/mL,geo. mean,40,%,geo. CV,AUC_inf,153,ng/mL,geo. mean,51,%,geo. CV,Cmax,,,,,,,,
654,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Severe hepatic impairment,Dapagliflozin,0,inf,h,776,ng*h/mL,geo. mean,22,%,geo. CV,AUC_inf,190,ng/mL,geo. mean,40,%,geo. CV,Cmax,,,,,,,,
661,Komoroski 2009,https://www.ncbi.nlm.nih.gov/pubmed/19129748,SAD 250 mg fasted,Dapagliflozin,0,inf,h,13337,ng*h/mL,geo. mean,28,%,geo. CV,AUC_inf,2510,ng/mL,geo. mean,31,%,geo. CV,Cmax,,,,,,,,
663,Komoroski 2009,https://www.ncbi.nlm.nih.gov/pubmed/19129748,SAD 250 mg fed,Dapagliflozin,0,inf,h,12455,ng*h/mL,geo. mean,31,%,geo. CV,AUC_inf,1532,ng/mL,geo. mean,24,%,geo. CV,Cmax,,,,,,,,
5295,Iwamoto 2008,https://www.ncbi.nlm.nih.gov/pubmed/19143531,400mg FCT,Raltegravir,0,24,h,11,µmol*h/L,geo. mean,122,%,CV%,AUC_inf,2.88,µmol/L,geom.mean,184,µmol/L,CV%,Cmax,,,,,,,,
5296,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,100mg FCT MD,Raltegravir,0,12,h,5.7,µmol*h/L,geo. mean,,,,AUC_tau,2.1,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5297,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,200mg FCT MD,Raltegravir,0,12,h,9.2,µmol*h/L,geo. mean,,,,AUC_tau,3.5,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5298,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,400mg FCT MD,Raltegravir,0,12,h,14.2,µmol*h/L,geo. mean,,,,AUC_tau,4.5,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5299,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,600mg FCT MD,Raltegravir,0,12,h,14.6,µmol*h/L,geo. mean,,,,AUC_tau,3.8,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5300,Kassahun 2007,https://www.ncbi.nlm.nih.gov/pubmed/17591678,200mg FCT SD,Raltegravir,0,22,h,11.28,µmol*h/L,arith. Mean,4.36,µmol*h/L,arith. SD,AUC_tau,4.94,µmol/L,arith. mean,1.8,µmol/L,arith. SD,Cmax,,,,,,,,t_end a mean of 22 (from reported 20-24h) was inputed
5301,Rizk 2015,https://www.ncbi.nlm.nih.gov/pubmed/25753401,3.5m,Raltegravir,0,12,h,21.6,µmol*h/L,geo. mean,40,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5302,Rizk 2015,https://www.ncbi.nlm.nih.gov/pubmed/25753401,15m,Raltegravir,0,12,h,19.8,µmol*h/L,geo. mean,34,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5303,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 1,Raltegravir,0,12,h,10.2,mg*h/L,arith. Mean,10,mg*h/L,arith. SD,AUC_tend,2813.1,ng/mL,arith. mean,2673.9,ng/mL,arith. SD,Cmax,71.7,L/h,arith.mean,56.7,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5304,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 2a,Raltegravir,0,12,h,13.4,mg*h/L,arith. Mean,16.1,mg*h/L,arith. SD,AUC_tend,4055.7,ng/mL,arith. mean,5269.5,ng/mL,arith. SD,Cmax,112.8,L/h,arith.mean,161.4,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5305,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 2b,Raltegravir,0,12,h,10.5,mg*h/L,arith. Mean,3.5,mg*h/L,arith. SD,AUC_tend,5314.2,ng/mL,arith. mean,2842.6,ng/mL,arith. SD,Cmax,23.6,L/h,arith.mean,8.9,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5306,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 3,Raltegravir,0,12,h,9.5,mg*h/L,arith. Mean,5.5,mg*h/L,arith. SD,AUC_tend,5204.8,ng/mL,arith. mean,2640.6,ng/mL,arith. SD,Cmax,13.3,L/h,arith.mean,10.1,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5307,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,3y,Raltegravir,0,12,h,18,µmol*h/L,geo. mean,59,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5308,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,9y,Raltegravir,0,12,h,22.6,µmol*h/L,geo. mean,34,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5309,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,10.5y,Raltegravir,0,12,h,15.8,µmol*h/L,geo. mean,120,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5433,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,15y,Raltegravir,0,12,h,15.7,µmol*h/L,geo. mean,98,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5435,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,Chewable tablet fasted,Raltegravir,0,24,h,34.2,µmol*h/L,geo. mean,,,,AUC_inf,16.1,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5436,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,Chewable tablet fed,Raltegravir,0,24,h,32.3,µmol*h/L,geo. mean,,,,AUC_inf,6.14,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5437,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,granules suspension,Raltegravir,0,24,h,50.4,µmol*h/L,geo. mean,,,,AUC_inf,23.2,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5438,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,filmcoated tablet,Raltegravir,0,24,h,19.2,µmol*h/L,geo. mean,,,,AUC_inf,5,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5439,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",10mg ,Raltegravir,0,12,h,0.82,µmol*h/L,geo. mean,,,,AUC_inf,0.58,µmol/L,Geom.mean,,,,Cmax,51.62,mL/min,arith.mean,,,,,
5440,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",25mg,Raltegravir,0,12,h,1.69,µmol*h/L,geo. mean,,,,AUC_inf,1.17,µmol/L,Geom.mean,,,,Cmax,78.4,mL/min,arith.mean,,,,,
5441,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",50mg,Raltegravir,0,12,h,4.49,µmol*h/L,geo. mean,,,,AUC_inf,2.37,µmol/L,Geom.mean,,,,Cmax,53.92,mL/min,arith.mean,,,,,
5442,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",100mg,Raltegravir,0,12,h,6.12,µmol*h/L,geo. mean,,,,AUC_inf,2.75,µmol/L,Geom.mean,,,,Cmax,59,mL/min,arith.mean,,,,,
5443,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",200mg,Raltegravir,0,12,h,16.9,µmol*h/L,geo. mean,,,,AUC_inf,5.83,µmol/L,Geom.mean,,,,Cmax,46.53,mL/min,arith.mean,,,,,
5444,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",400mg,Raltegravir,0,12,h,24.61,µmol*h/L,geo. mean,,,,AUC_inf,10.63,µmol/L,Geom.mean,,,,Cmax,60.88,mL/min,arith.mean,,,,,
5445,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",800mg,Raltegravir,0,12,h,63.11,µmol*h/L,geo. mean,,,,AUC_inf,24.67,µmol/L,Geom.mean,,,,Cmax,48.52,mL/min,arith.mean,,,,,
5446,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",1200mg,Raltegravir,0,12,h,84.01,µmol*h/L,geo. mean,,,,AUC_inf,30.96,µmol/L,Geom.mean,,,,Cmax,42.22,mL/min,arith.mean,,,,,
5447,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",1600mg,Raltegravir,0,12,h,95.6,µmol*h/L,geo. mean,,,,AUC_inf,36.06,µmol/L,Geom.mean,,,,Cmax,43.52,mL/min,arith.mean,,,,,
5448,Wenning 2009,"https://www.ncbi.nlm.nih.gov/pubmed/19433563
",400mg ,Raltegravir,0,12,h,27.57,µmol*h/L,geo. mean,,,,AUC_inf,8.61,µmol/L,Geom.mean,,,,,,,,,,,,
592,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,250 mg over 3 min (Regimen 1),Erythromycin,0,inf,h,,,,,,,,,,,,,,,26.3,L/h,arith. mean,7.5,L/h,arith. SD,CLiv,"CLiv=Cls total body clearance (serum). Cl_R = ""renal clearance"" also available: Avg: 3.4; Var: 2.4, Unit: l/h"
593,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,125 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,4.6,mg*h/L,arith. Mean,0.9,mg*h/L,arith. SD,AUC_inf,,,,,,,,28.1,L/h,arith. mean,5.9,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
594,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,250 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,10.5,mg*h/L,arith. Mean,3,mg*h/L,arith. SD,AUC_inf,,,,,,,,28.9,L/h,arith. mean,14.4,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
595,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,500 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,19.4,mg*h/L,arith. Mean,3.3,mg*h/L,arith. SD,AUC_inf,,,,,,,,25.3,L/h,arith. mean,4.3,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
596,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,900 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,41,mg*h/L,arith. Mean,23.1,mg*h/L,arith. SD,AUC_inf,,,,,,,,26.3,L/h,arith. mean,11.8,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
597,Barre 1987,https://www.ncbi.nlm.nih.gov/pubmed/3606934,"500 mg over 30 min, total concentrations",Erythromycin,0,inf,h,,,,,,,,,,,,,,,34.2,L/h,arith. mean,12.1,L/h,1 s.d.,CLiv,CLiv=CLt clearance of total drug (serum)
598,Barre 1987,https://www.ncbi.nlm.nih.gov/pubmed/3606934,"500 mg over 30 min, unbound concentrations",Erythromycin,0,inf,h,,,,,,,,,,,,,,,113.2,L/h,arith. mean,44.2,L/h,1 s.d.,Cliv_unbound,Cliv_unbound=CLu clearance of unbound drug (serum)
601,DiSanto 1981,https://www.ncbi.nlm.nih.gov/pubmed/7283417,"Overnight fast, enteric-coated erythromycin tablets (study 1) ",Erythromycin,0,14,h,4.88,µg*h/mL,arith. Mean,,,,AUC_tend,1.01,µg/mL,arith. Mean,,,,Cmax,,,,,,,,
602,DiSanto 1981,https://www.ncbi.nlm.nih.gov/pubmed/7283417,"2h fast, enteric-coated erythromycin tablets (study 2)",Erythromycin,0,12,h,4.96,µg*h/mL,arith. Mean,,,,AUC_tend,0.79,µg/mL,arith. Mean,,,,Cmax,,,,,,,,
603,Huppertz 2011,https://www.ncbi.nlm.nih.gov/pubmed/21274983,"Treatment group, erythromycin",Erythromycin,,,,,,,,,,,,,,,,,,,,,,,,,no data available
604,Iliopoulou 1982,https://www.ncbi.nlm.nih.gov/pubmed/7138734,"fourth day, before theophylline administration",Erythromycin,72,inf,h,7.2,µg*h/mL,arith. Mean,3.6,µg*h/mL,arith. SD,AUC_inf,1.45,µg/mL,arith. Mean,0.87,µg/mL,SEM,Cmax,,,,,,,,Cmax=observed maximum steady state serum concentration. Also available: AUC (0-8h) = 6.1 +/-3.2 µg*h/mL
609,Kavi 1988,https://www.ncbi.nlm.nih.gov/pubmed/3182434,Serum levels,Erythromycin,0,inf,h,7.3,mg*h/L,arith. Mean,3.9,mg*h/L,arith. SD,AUC_inf,2.1,mg/L,arith. Mean,1.2,mg/L,arith. SD,Cmax,,,,,,,,
610,Kroboth 1982,https://www.ncbi.nlm.nih.gov/pubmed/7081971,Normal subjects,Erythromycin,0,24,h,9,µg*h/mL,arith. Mean,5.9,µg*h/mL,arith. SD,AUC_tend,1.5,µg/mL,arith. mean,0.91,µg/mL,arith. SD,Cmax,,,,,,,,Also available: AUC (0-12h) = 7.4 +/- 5.1 µg*h/mL
611,Malmborg 1978,https://www.tandfonline.com/doi/abs/10.1185/03007997809110243,Single dose after overnight fast,Erythromycin,0,inf,h,5.6,µg*h/mL,arith. Mean,0.4,µg*h/mL,SEM,AUC_inf,1.3,µg/mL,arith. Mean,0.1,µg/mL,SEM,Cmax,,,,,,,,
612,Malmborg 1978,https://www.tandfonline.com/doi/abs/10.1185/03007997809110243,Single dose before standardized breakfast,Erythromycin,0,inf,h,7.4,µg*h/mL,arith. Mean,0.8,µg*h/mL,SEM,AUC_inf,2.8,µg/mL,arith. Mean,0.3,µg/mL,SEM,Cmax,,,,,,,,
613,Malmborg 1978,https://www.tandfonline.com/doi/abs/10.1185/03007997809110243,"Day 7, every 8 h",Erythromycin,168,inf,h,12.4,µg*h/mL,arith. Mean,1.7,µg*h/mL,SEM,AUC_inf,2.9,µg/mL,arith. Mean,0.5,µg/mL,SEM,Cmax,,,,,,,,
614,Miglioli 1990,https://www.ncbi.nlm.nih.gov/pubmed/2253666,"First dose, young subjects",Erythromycin,0,inf,h,29.1,mg*h/L,arith. mean,4.7,mg*h/L,SEM,AUC_inf,8,mg/L,arith. mean,1.3,mg/L,SEM,Cmax,0.64,L/h/kg,arith. Mean,0.14,L/h/kg,SEM,CL/F,
615,Miglioli 1990,https://www.ncbi.nlm.nih.gov/pubmed/2253666,"Seventh dose, young subjects",Erythromycin,72,84,h,25.1,mg*h/L,arith. mean,4.8,mg*h/L,SEM,AUC_tau,6.8,mg/L,arith. mean,0.7,mg/L,SEM,Cmax,0.69,L/h/kg,arith. Mean,0.11,L/h/kg,SEM,CL/F,
616,Pasic 1987,https://www.ncbi.nlm.nih.gov/pubmed/3604256,Without oral theophylline co-administration,Erythromycin,0,inf,h,,,,,,,,3.6,mg/L,arith. mean,1,mg/L,arith. SD,Cmax,,,,,,,,"Available serum concentration data in the text do not clearly state assignment of values to the ""with"" or ""without theophylline"" group. Given serum concentration values are: mean 3.5 ± 0.9 and 3.6 ± 1.0 mg/l. We assume the second mentioned value is the ""without theophylline"" group."
617,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation A1 (film-coated tabet, ery stearate), fasted",Erythromycin,0,7.5,h,5.91,mg*h/L,arith. mean,2.17,mg*h/L,SD,AUC_tend,1.8,mg/L,arith. mean,0.7,mg/L,SD,Cmax,,,,,,,,
618,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation E (enteric-coated tablets, ery base), fasted",Erythromycin,0,7.5,h,4.7,mg*h/L,arith. mean,2.21,mg*h/L,SD,AUC_tend,1.54,mg/L,arith. mean,0.7,mg/L,SD,Cmax,,,,,,,,
619,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation A2 (film-coated tabet, ery stearate), study 2",Erythromycin,0,8,h,7.4,mg*h/L,arith. mean,5.57,mg*h/L,SD,AUC_tend,2.45,mg/L,arith. mean,1.63,mg/L,SD,Cmax,,,,,,,,
620,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation RN (film-coated tabet, ery stearate), study 2",Erythromycin,0,8,h,11.55,mg*h/L,arith. mean,5.22,mg*h/L,SD,AUC_tend,3.5,mg/L,arith. mean,1.61,mg/L,SD,Cmax,,,,,,,,
621,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part I, stearate tablet",Erythromycin,0,inf,h,8.3,mg*h/L,arith. mean,0.8,mg*h/L,SE,AUC_inf,2,mg/L,arith. mean,0.3,mg/L,SE,Cmax,,,,,,,,"values are for N = 14, since 2 subjects were excluded, see column ""comment population"""
622,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part I, base (enteric-coated pellets)",Erythromycin,0,inf,h,10.6,mg*h/L,arith. mean,1.1,mg*h/L,SE,AUC_inf,1.5,mg/L,arith. mean,0.5,mg/L,SE,Cmax,,,,,,,,"values are for N = 14, since 2 subjects were excluded, see column ""comment population"""
623,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part II, stearate tablet",Erythromycin,0,inf,h,7.4,mg*h/L,arith. mean,1.2,mg*h/L,SE,AUC_inf,2.2,mg/L,arith. mean,0.4,mg/L,SE,Cmax,,,,,,,,
624,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part II, base (enteric-coated pellets)",Erythromycin,0,inf,h,8.8,mg*h/L,arith. mean,1.2,mg*h/L,SE,AUC_inf,1.5,mg/L,arith. mean,0.2,mg/L,SE,Cmax,,,,,,,,
625,Sun 2010,https://www.ncbi.nlm.nih.gov/pubmed/20090676,Subjects with normal renal function,Erythromycin,0,inf,h,3580,µg*h/L,arith. mean,1020,µg*h/L,SD,AUC_inf,,,,,,,,0.53,L/h/kg,arith. mean,0.13,L/h/kg,SD,CL/F,CL=total clearance; Also available: AUC adjusted by dose weight: AUC/D (mean ± SD): 1.89 ± 0.54 kg*h/L; Renal clearance: CLr (mean ± SD): 0.03 ± 0.01  L/h/kg; Hepatic clearance: CLh (mean ± SD): 0.51 ± 0.13 L/h/kg
626,Yakatan 1980,https://www.ncbi.nlm.nih.gov/pubmed/7229110,"Stearate, single dose",Erythromycin,0,12,h,3.9,µg*h/mL,arith. mean,3.53,µg*h/mL,SD,AUC_tend,1.01,µg/mL,arith. mean,1.1,µg/mL,SD,Cmax,,,,,,,,"discrepancy in Cmax value within the paper: in text and table II 1.01 ± 1.10 µg/ml, but in table III: 1.28 ± 1.12 µg/ml"
627,Yakatan 1980,https://www.ncbi.nlm.nih.gov/pubmed/7229110,"Stearate, five doses, every 6 h",Erythromycin,0,inf,h,16.03,µg*h/mL,arith. mean,,,,AUC_inf,1.51,µg/mL,arith. mean,0.96,µg/mL,SD,Cmax,,,,,,,,Mean AUC (dose 1+2+3+5) taken from table VI. Cmax taken from PK time profile. The fourth-dose AUC was not included as samples were not drawn during that dosing interval.
628,Yakatan 1980,https://www.ncbi.nlm.nih.gov/pubmed/7229110,"Base, five doses, every 6 h",Erythromycin,0,inf,h,24.44,µg*h/mL,arith. mean,,,,AUC_inf,1.81,µg/mL,arith. mean,1.49,µg/mL,SD,Cmax,,,,,,,,Mean AUC (dose 1+2+3+5) taken from table VI. Cmax taken from PK time profile. The fourth-dose AUC was not included as samples were not drawn during that dosing interval.
599,Birkett 1990,https://www.ncbi.nlm.nih.gov/pubmed/2305423,"250 mg erythromycin, single dose",Erythromycin,0,inf,h,4.68,mg*h/L,arith. mean,1.99,mg*h/L,SD,AUC_inf,1.74,mg/L,arith. mean,0.9,mg/L,SD,Cmax,,,,,,,,
600,Birkett 1990,https://www.ncbi.nlm.nih.gov/pubmed/2305423,"250 mg erythromycin, multiple dose",Erythromycin,96,102,h,10.83,mg*h/L,arith. mean,3.38,mg*h/L,SD,AUC_tau,2.87,mg/L,arith. mean,0.83,mg/L,SD,Cmax,,,,,,,,
605,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin base 250 mg,Erythromycin,0,inf,h,4.5,mg*h/L,arith. Mean,1.7,mg*h/L,arith. SD,AUC_inf,1.9,mg/L,arith. mean,0.8,mg/L,arith. SD,Cmax,3,L/h,arith. mean,1.2,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group. CL/F=renal clearance
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
606,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin base 500 mg,Erythromycin,0,inf,h,11.2,mg*h/L,arith. Mean,4.3,mg*h/L,arith. SD,AUC_inf,3.8,mg/L,arith. mean,1.4,mg/L,arith. SD,Cmax,3.5,L/h,arith. mean,1.6,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group.
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
607,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin base 1000 mg,Erythromycin,0,inf,h,27.2,mg*h/L,arith. Mean,10.6,mg*h/L,arith. SD,AUC_inf,6.5,mg/L,arith. mean,2.9,mg/L,arith. SD,Cmax,2.9,L/h,arith. mean,1.4,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group.
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
608,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin stearate 500 mg (base equivalent),Erythromycin,0,inf,h,7.5,mg*h/L,arith. Mean,3.4,mg*h/L,arith. SD,AUC_inf,2.9,mg/L,arith. mean,1.7,mg/L,arith. SD,Cmax,2.7,L/h,arith. mean,1.1,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group.
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
758,Ferrier 1985,https://www.ncbi.nlm.nih.gov/pubmed/3920934,healthy control patients,Alfentanil,#TODO#,#TODO#,h,,,,,,,,,,,,,,,3.1,mL/min/kg,arith. mean,1.3,mL/min/kg,arith. SD,CL/F,
759,Ferrier 1985,https://www.ncbi.nlm.nih.gov/pubmed/3920934,cirrhosis patients patients,Alfentanil,#TODO#,#TODO#,h,,,,,,,,,,,,,,,1.5,mL/min/kg,arith. mean,1,mL/min/kg,arith. SD,CL/F,
760,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Control sequential,Alfentanil,#TODO#,#TODO#,h,59,ng*h/mL,arith. Mean,27,ng*h/mL,arith. SD,AUC_inf,80,ng/mL,arith. mean,40,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
761,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Grapefruit coadmin sequential,Alfentanil,#TODO#,#TODO#,h,57,ng*h/mL,arith. Mean,30,ng*h/mL,arith. SD,AUC_inf,59,ng/mL,arith. mean,31,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
762,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Ketoconazole coadmin sequential,Alfentanil,#TODO#,#TODO#,h,145.5,ng*h/mL,arith. Mean,79.5,ng*h/mL,arith. SD,AUC_inf,36.5,ng/mL,arith. mean,9.5,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
763,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Rifampin coadmin sequential,Alfentanil,#TODO#,#TODO#,h,21,ng*h/mL,arith. Mean,8,ng*h/mL,arith. SD,AUC_inf,54,ng/mL,arith. mean,10,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
764,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Control simultaneous,Alfentanil,#TODO#,#TODO#,h,51,ng*h/mL,arith. Mean,19,ng*h/mL,arith. SD,AUC_inf,58,ng/mL,arith. mean,15,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
765,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Grapefruit coadmin simultaneous,Alfentanil,#TODO#,#TODO#,h,58,ng*h/mL,arith. Mean,22,ng*h/mL,arith. SD,AUC_inf,55,ng/mL,arith. mean,12,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
766,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Ketoconazole coadmin simultaneous,Alfentanil,#TODO#,#TODO#,h,151,ng*h/mL,arith. Mean,122,ng*h/mL,arith. SD,AUC_inf,36.5,ng/mL,arith. mean,13,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
767,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Rifampin coadmin simultaneous,Alfentanil,#TODO#,#TODO#,h,18,ng*h/mL,arith. Mean,3,ng*h/mL,arith. SD,AUC_inf,57,ng/mL,arith. mean,8,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
768,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Control sequential,Alfentanil,#TODO#,#TODO#,h,108,ng*h/mL,arith. Mean,68,ng*h/mL,arith. SD,AUC_inf,48,ng/mL,arith. mean,24,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
769,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Grapefruit coadmin sequential,Alfentanil,#TODO#,#TODO#,h,180,ng*h/mL,arith. Mean,108,ng*h/mL,arith. SD,AUC_inf,52,ng/mL,arith. mean,28,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
770,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Ketoconazole coadmin sequential,Alfentanil,#TODO#,#TODO#,h,253,ng*h/mL,arith. Mean,178,ng*h/mL,arith. SD,AUC_inf,33,ng/mL,arith. mean,10,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
771,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Rifampin coadmin sequential,Alfentanil,#TODO#,#TODO#,h,6.4,ng*h/mL,arith. Mean,3.2,ng*h/mL,arith. SD,AUC_inf,6,ng/mL,arith. mean,3.6,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
772,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Control simultaneous,Alfentanil,#TODO#,#TODO#,h,88,ng*h/mL,arith. Mean,56,ng*h/mL,arith. SD,AUC_inf,28.4,ng/mL,arith. mean,12,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
773,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Grapefruit coadmin simultaneous,Alfentanil,#TODO#,#TODO#,h,184,ng*h/mL,arith. Mean,84,ng*h/mL,arith. SD,AUC_inf,52,ng/mL,arith. mean,36,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
774,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Ketoconazole coadmin simultaneous,Alfentanil,#TODO#,#TODO#,h,298,ng*h/mL,arith. Mean,255,ng*h/mL,arith. SD,AUC_inf,36,ng/mL,arith. mean,20,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
775,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Rifampin coadmin simultaneous,Alfentanil,#TODO#,#TODO#,h,4.4,ng*h/mL,arith. Mean,2,ng*h/mL,arith. SD,AUC_inf,3.6,ng/mL,arith. mean,2,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
2014,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam post treatment with fluvoxamine (28 days of fluvoxamine) Male,Midazolam,336,inf,h,,,,,,,,,,,,,,,4.7,mL/min/kg,arith. Mean,0.9,mL/min/kg,arith. SD,CLiv,Values were pooled of visits 7–8 for each subject. 
2015,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam at baseline female,Midazolam,0,inf,h,,,,,,,,,,,,,,,8.1,mL/min/kg,arith. Mean,2.4,mL/min/kg,arith. SD,CLiv,Values were pooled of visits 1–6 for each subject.
2016,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam post treatment with fluvoxamine (28 days of fluvoxamine) female,Midazolam,336,inf,h,,,,,,,,,,,,,,,5.9,mL/min/kg,arith. Mean,2.7,mL/min/kg,arith. SD,CLiv,Values were pooled of visits 7–8 for each subject. 
2034,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam alone Male,Midazolam,0,inf,h,36.21,ng*h/mL,arith. Mean,11.47,ng*h/mL,arith. SD,AUC_inf,,,,,,,,30.8,L/h,arith. Mean,9.04,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2035,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Ketoconazole Male,Midazolam,72,inf,h,102.54,ng*h/mL,arith. Mean,22.48,ng*h/mL,arith. SD,AUC_inf,,,,,,,,10.26,L/h,arith. Mean,2.59,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2036,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Rifampicin Male,Midazolam,216,inf,h,40.375,ng*h/mL,arith. Mean,7.7,ng*h/mL,arith. SD,AUC_inf,,,,,,,,64.16,L/h,arith. Mean,12.44,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2037,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam alone Female,Midazolam,0,inf,h,43.22,ng*h/mL,arith. Mean,8.29,ng*h/mL,arith. SD,AUC_inf,,,,,,,,23.1,L/h,arith. Mean,4.26,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2038,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Ketoconazole Female,Midazolam,72,inf,h,211.58,ng*h/mL,arith. Mean,42.97,ng*h/mL,arith. SD,AUC_inf,,,,,,,,5.01,L/h,arith. Mean,1.19,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2039,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Rifampicin Female,Midazolam,216,inf,h,53.9,ng*h/mL,arith. Mean,9.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,47.8,L/h,arith. Mean,9.05,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2008,Gashaw 2003,https://www.ncbi.nlm.nih.gov/pubmed/?term=14586385,"Alprazolam 10h concentration before Rifampin treatment (control conditions, day 2)",Alprazolam,0,inf,h,,,,,,,,,,,,,,,3.3,L/h,arith. mean,0.8,L/h,arith. SD,CL/F,"No Cmax available, only 10-h concentration values in plasma (µg/L) in mean (SD) given: 8.4 (1.9); CL= estimated oral clearance: CLoral (L/h) = Dose (mg)/[0.038 * Plasma alprazolam concentration10h (µg/L) – 0.001]"
2009,Gashaw 2003,https://www.ncbi.nlm.nih.gov/pubmed/?term=14586385,"Alprazolam 10h concentration after Rifampin treatment (5 day rifampin treatment, day 7)",Alprazolam,100,inf,h,,,,,,,,,,,,,,,18.4,L/h,arith. mean,10.9,L/h,arith. SD,CL/F,"No Cmax available, only 10-h concentration values in plasma (µg/L) in mean (SD) given: 1.8 (0.8); CL= estimated oral clearance: CLoral (L/h) = Dose (mg)/[0.038 * Plasma alprazolam concentration10h (µg/L) – 0.001]"
2010,Gashaw 2003,https://www.ncbi.nlm.nih.gov/pubmed/?term=14586385,Alprazolam 10h concentration after wash out (day 22),Alprazolam,436,inf,h,,,,,,,,,,,,,,,3.6,L/h,arith. mean,0.9,L/h,arith. SD,CL/F,"No Cmax available, only 10-h concentration values in plasma (µg/L) in mean (SD) given: 7.8 (1.9); CL= estimated oral clearance: CLoral (L/h) = Dose (mg)/[0.038 * Plasma alprazolam concentration10h (µg/L) – 0.001]"
2019,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control iv Midazolam Female,Midazolam,0,inf,h,118,µg*h/L,arith. Mean,"96, 140",µg*h/L,95% CI,AUC_inf,58,µg/L,arith. Mean,"48, 68",µg/L,95% CI,Cmax,36,L/h,arith. Mean,"29.5, 42.8",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2020,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control iv Midazolam Male,Midazolam,0,inf,h,142,µg*h/L,arith. Mean,"112, 171",µg*h/L,95% CI,AUC_inf,59,µg/L,arith. Mean,"53, 64",µg/L,95% CI,Cmax,30.4,L/h,arith. Mean,"24.5, 36.3",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2021,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control iv Midazolam All,Midazolam,0,inf,h,130,µg*h/L,arith. Mean,"111, 149",µg*h/L,95% CI,AUC_inf,58,µg/L,arith. Mean,"53, 64",µg/L,95% CI,Cmax,33.2,L/h,arith. Mean,"28.7, 37.8",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2022,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control po Midazolam Female,Midazolam,0,inf,h,46,µg*h/L,arith. Mean,"27, 65",µg*h/L,95% CI,AUC_inf,12,µg/L,arith. Mean,"7.2, 17",µg/L,95% CI,Cmax,124,L/h,arith. Mean,"71, 177",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2023,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control po Midazolam Male,Midazolam,0,inf,h,48,µg*h/L,arith. Mean,"21, 75",µg*h/L,95% CI,AUC_inf,12,µg/L,arith. Mean,"8.0, 15",µg/L,95% CI,Cmax,119,L/h,arith. Mean,"76, 161",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2024,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control po Midazolam All,Midazolam,0,inf,h,47,µg*h/L,arith. Mean,"31, 63",µg*h/L,95% CI,AUC_inf,12,µg/L,arith. Mean,"9.0, 15",µg/L,95% CI,Cmax,121,L/h,arith. Mean,"88, 154",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2025,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,iv Midazolam Female after clarithromycin,Midazolam,146,inf,h,409,µg*h/L,arith. Mean,"311, 507",µg*h/L,95% CI,AUC_inf,70,µg/L,arith. Mean,"54, 85",µg/L,95% CI,Cmax,10.6,L/h,arith. Mean,"8.6, 12.6",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2026,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,iv Midazolam Male after clarithromycin,Midazolam,146,inf,h,397,µg*h/L,arith. Mean,"291, 503",µg*h/L,95% CI,AUC_inf,66,µg/L,arith. Mean,"50, 82",µg/L,95% CI,Cmax,12.4,L/h,arith. Mean,"7.0, 17.9",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2027,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,iv Midazolam All after clarithromycin,Midazolam,146,inf,h,403,µg*h/L,arith. Mean,"333, 473",µg*h/L,95% CI,AUC_inf,68,µg/L,arith. Mean,"57, 79",µg/L,95% CI,Cmax,11.5,L/h,arith. Mean,"8.7, 14.4",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2028,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,po Midazolam Female after clarithromycin,Midazolam,146,inf,h,304,µg*h/L,arith. Mean,"183, 426",µg*h/L,95% CI,AUC_inf,34,µg/L,arith. Mean,"28, 40",µg/L,95% CI,Cmax,16.2,L/h,arith. Mean,"11.6, 20.7",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2029,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,po Midazolam Male after clarithromycin,Midazolam,146,inf,h,290,µg*h/L,arith. Mean,"205, 375",µg*h/L,95% CI,AUC_inf,31,µg/L,arith. Mean,"27, 35",µg/L,95% CI,Cmax,18.6,L/h,arith. Mean,"9.2, 28.0",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2030,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,po Midazolam All after clarithromycin,Midazolam,146,inf,h,297,µg*h/L,arith. Mean,"226, 369",µg*h/L,95% CI,AUC_inf,33,µg/L,arith. Mean,"29, 36",µg/L,95% CI,Cmax,17.4,L/h,arith. Mean,"12.3, 22.5",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2031,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Clarithromycin,Clarithromycin,144,156,h,38.7,µmol*h/L,arith. Mean,"33.0, 44.4",µmol*h/L,95% CI,AUC_tau,,,,,,,,10.9,L/h,arith. Mean,"8.5, 13.2",L/h,95% CI,CL/F,AUC unit displayed in the paper is: AUC0-12 ( µM h-1) - no available unit present in dropdown here
2032,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,14-hydroxyclarithromycin,14-hydroxyclarithromycin,144,156,h,5.7,µmol*h/L,arith. Mean,"4.9, 6.6",µmol*h/L,95% CI,AUC_tau,,,,,,,,,,,,,,,AUC unit displayed in the paper is: AUC0-12 ( µM h-1) - no available unit present in dropdown here
2033,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,N-desmethylclarithromycin,N-desmethylclarithromycin,144,156,h,5.5,µmol*h/L,arith. Mean,"4.0, 7.0",µmol*h/L,95% CI,AUC_tau,,,,,,,,,,,,,,,AUC unit displayed in the paper is: AUC0-12 ( µM h-1) - no available unit present in dropdown here
2000,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in Caucasian at baseline ,Midazolam,0,6,h,1057,µg*min/L,geom. Mean,880-1270,µg*min/L,95% CI,AUC_tend,7.2,µg/L,geom. Mean,5.5-8.9,µg/L,95% CI,Cmax,,,,,,,,
2001,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in South Asian at baseline,Midazolam,0,6,h,768,µg*min/L,geom. Mean,648-1037,µg*min/L,95% CI,AUC_tend,5.5,µg/L,geom. Mean,4.3-6.8,µg/L,95% CI,Cmax,,,,,,,,
2002,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in Caucasian following 7d of Rifampicin (between day 1 and 8),Midazolam,156,162,h,308,µg*min/L,geom. Mean,150-464,µg*min/L,95% CI,AUC_tend,2.7,µg/L,geom. Mean,1.7-3.6,µg/L,95% CI,Cmax,,,,,,,,
2003,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in South Asian following 7d of Rifampicin (between day 1 and 8),Midazolam,156,162,h,154,µg*min/L,geom. Mean,74-234,µg*min/L,95% CI,AUC_tend,1.2,µg/L,geom. Mean,0.7-1.7,µg/L,95% CI,Cmax,,,,,,,,
2004,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in Caucasian following 3d of Clarithromycin (between day 12 and 14),Midazolam,72,78,h,1834,µg*min/L,geom. Mean,1209-2460,µg*min/L,95% CI,AUC_tend,12.6,µg/L,geom. Mean,7.6-17.7,µg/L,95% CI,Cmax,,,,,,,,
2005,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in South Asian following 3d of Clarithromycin (between day 12 and 14),Midazolam,72,78,h,1079,µg*min/L,geom. Mean,"632, 1526",µg*min/L,95% CI,AUC_tend,8.3,µg/L,geom. Mean,"4.6, 11.9",µg/L,95% CI,Cmax,,,,,,,,
2006,Kashuba 1998,https://www.ncbi.nlm.nih.gov/pubmed/9757149,Midazolam at baseline,Midazolam,0,inf,h,,,,,,,,,,,,,,,0.0081,L/min/kg,arith. Mean,0.0024,L/min/kg,arith. SD,CLiv,Mean ± SD of six measures (visit 1-6)
2007,Kashuba 1998,https://www.ncbi.nlm.nih.gov/pubmed/9757149,Midazolam after Fluvoxamine,Midazolam,339,inf,h,,,,,,,,,,,,,,,0.0054,L/min/kg,arith. Mean,0.0021,L/min/kg,arith. SD,CLiv,Mean ± SD of two measures (visit 7-8)
749,Schmider 1999,https://www.ncbi.nlm.nih.gov/pubmed/10634135,Alprazolam alone,Alprazolam,0,inf,h,242.2,µg*h/L,arith. Mean,37.9,µg*h/L,SE,AUC_inf,15.2,µg/L,arith. Mean,1.5,µg/L,SE,Cmax,1.1,mL/min/kg,arith. Mean,0.1,mL/min/kg,SE,CL/F,CL = CL_(oral/kg)
1001,Schmider 1999,https://www.ncbi.nlm.nih.gov/pubmed/10634135,Alprazolam + Rifampin,Alprazolam,96,inf,h,28.4,µg*h/L,arith. Mean,3.4,µg*h/L,SE,AUC_inf,9.7,µg/L,arith. Mean,2.6,µg/L,SE,Cmax,8.3,mL/min/kg,arith. Mean,1.6,mL/min/kg,SE,CL/F,CL = CL_(oral/kg)
1002,Schmider 1999,https://www.ncbi.nlm.nih.gov/pubmed/10634135,Alprazolam + Ketoconazole,Alprazolam,48,inf,h,426.2,µg*h/L,arith. Mean,43.1,µg*h/L,SE,AUC_inf,16.4,µg/L,arith. Mean,2.9,µg/L,SE,Cmax,0.6,mL/min/kg,arith. Mean,0.1,mL/min/kg,SE,CL/F,CL = CL_(oral/kg)
726,Villikka 1997,https://www.ncbi.nlm.nih.gov/pubmed/9024169,Triazolam + placebo,Triazolam,0,inf,h,14.8,ng*h/mL,arith. Mean,1,ng*h/mL,SEM,AUC_inf,2.9,ng/mL,arith. Mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-10) (mean +/- SEM in ng*h/ml): 13.2 +/- 0.9
1004,Villikka 1997,https://www.ncbi.nlm.nih.gov/pubmed/9024169,"Treatment arm (pretreatment with rifampin, 600 mg, 5 days)",Triazolam,113,inf,h,0.74,ng*h/mL,arith. Mean,0.14,ng*h/mL,SEM,AUC_inf,0.36,ng/mL,arith. Mean,0.06,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-10) (mean +/- SEM in ng*h/ml): 0.74 +/- 0.14
1025,Yasui 1998,https://www.ncbi.nlm.nih.gov/pubmed/9784084,Alprazolam with placebo,Alprazolam,0,inf,h,252,ng*h/mL,arith. Mean,47,ng*h/mL,arith. SD,AUC_inf,12.9,ng/mL,arith. mean,2.3,ng/mL,arith. SD,Cmax,0.89,mL/min/kg,arith. Mean,0.21,mL/min/kg,arith. SD,CL/F,Also available: AUC(0-48): (mean ± SD in ng*h/ml): 221 ± 33
1026,Yasui 1998,https://www.ncbi.nlm.nih.gov/pubmed/9784084,Alprazolam with itraconazole,Alprazolam,73,inf,h,671,ng*h/mL,arith. Mean,205,ng*h/mL,arith. SD,AUC_inf,16.6,ng/mL,arith. mean,5.2,ng/mL,arith. SD,Cmax,0.35,mL/min/kg,arith. Mean,0.1,mL/min/kg,arith. SD,CL/F,Also available: AUC(0-48): (mean ± SD in ng*h/ml): 357 ± 69
1077,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Control phase (Triazolam without Itraconazole),Triazolam,0,inf,h,12.3,ng*h/mL,arith. Mean,0.8,ng*h/mL,SEM,AUC_inf,1.7,ng/mL,arith. mean,0.1,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 11.5 ± 0.7
1078,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ simultaneously),Triazolam,0,inf,h,38.2,ng*h/mL,arith. Mean,3.7,ng*h/mL,SEM,AUC_inf,2.4,ng/mL,arith. mean,0.1,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 24.1 ± 1.2
1079,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ 3 hr before),Triazolam,3,inf,h,55.1,ng*h/mL,arith. Mean,5.7,ng*h/mL,SEM,AUC_inf,3,ng/mL,arith. mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 32.5 ± 2.3
1080,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ 12 hr before),Triazolam,12,inf,h,53.2,ng*h/mL,arith. Mean,6.2,ng*h/mL,SEM,AUC_inf,3,ng/mL,arith. mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 33.7 ± 2.9
1081,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ 24 hr before),Triazolam,24,inf,h,43.9,ng*h/mL,arith. Mean,4.3,ng*h/mL,SEM,AUC_inf,2.9,ng/mL,arith. mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 29.6 ± 9.5
1082,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ simultaneously with triazolam,Itraconazole,0,17,h,897,ng*h/mL,arith. Mean,79,ng*h/mL,SEM,AUC_tend,98.9,ng/mL,arith. mean,8.3,ng/mL,SEM,Cmax,,,,,,,,
1083,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ 3 hr before triazolam,Itraconazole,3,20,h,1634,ng*h/mL,arith. Mean,279,ng*h/mL,SEM,AUC_tend,175,ng/mL,arith. mean,30,ng/mL,SEM,Cmax,,,,,,,,
1084,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ 12 hr before triazolam,Itraconazole,12,29,h,528,ng*h/mL,arith. Mean,78,ng*h/mL,SEM,AUC_tend,55.2,ng/mL,arith. mean,8.5,ng/mL,SEM,Cmax,,,,,,,,
1085,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ 24 hr before triazolam,Itraconazole,24,41,h,499,ng*h/mL,arith. Mean,77,ng*h/mL,SEM,AUC_tend,45.3,ng/mL,arith. mean,6.8,ng/mL,SEM,Cmax,,,,,,,,
1086,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam before Ketoconazole,Midazolam,0,inf,h,195,ng*h/mL,arith. Mean,115,ng*h/mL,arith. SD,AUC_inf,64.7,ng/mL,arith. Mean,32.3,ng/mL,arith. SD,Cmax,78.4,L/h,arith. Mean,58.2,L/h,arith. SD,CL/F,
1087,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam after Ketoconazole,Midazolam,265,inf,h,1280,ng*h/mL,arith. Mean,617,ng*h/mL,arith. SD,AUC_inf,193,ng/mL,arith. Mean,55.1,ng/mL,arith. SD,Cmax,9.5,L/h,arith. Mean,4.3,L/h,arith. SD,CL/F,
1088,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam before Fluvoxamine,Midazolam,0,inf,h,203,ng*h/mL,arith. Mean,136,ng*h/mL,arith. SD,AUC_inf,85,ng/mL,arith. Mean,33.5,ng/mL,arith. SD,Cmax,69.2,L/h,arith. Mean,36.4,L/h,arith. SD,CL/F,
1089,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam after Fluvoxamine,Midazolam,265,inf,h,283,ng*h/mL,arith. Mean,129,ng*h/mL,arith. SD,AUC_inf,117,ng/mL,arith. Mean,56.6,ng/mL,arith. SD,Cmax,43,L/h,arith. Mean,20.6,L/h,arith. SD,CL/F,
1090,Shin 2013,https://www.ncbi.nlm.nih.gov/pubmed/23784264,Control phase (Midazolam alone),Midazolam,0,inf,h,36.21,µg*h/L,arith. Mean,11.47,µg*h/L,arith. SD,AUC_inf,,,,,,,,30.08,L/h,arith. Mean,9.04,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1091,Shin 2013,https://www.ncbi.nlm.nih.gov/pubmed/23784264,CYP3A4 inhibited phase (Midazolam + ketoconazole),Midazolam,73,inf,h,102.54,µg*h/L,arith. Mean,22.48,µg*h/L,arith. SD,AUC_inf,,,,,,,,10.26,L/h,arith. Mean,2.59,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1092,Shin 2013,https://www.ncbi.nlm.nih.gov/pubmed/23784264,CYP3A4 induced phase (Midazolam + rifampicin),Midazolam,216,inf,h,40.375,µg*h/L,arith. Mean,7.7,µg*h/L,arith. SD,AUC_inf,,,,,,,,64.16,L/h,arith. Mean,12.44,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1093,Shin 2016,https://www.ncbi.nlm.nih.gov/pubmed/27317471,Midazolam alone,Midazolam,0,inf,h,42.7,µg*h/L,arith. Mean,8.76,µg*h/L,arith. SD,AUC_inf,28.1,ng/mL,arith. Mean,3.11,ng/mL,arith. SD,Cmax,23.1,L/h,arith. Mean,4.26,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1094,Shin 2016,https://www.ncbi.nlm.nih.gov/pubmed/27317471,Midazolam + ketoconazole,Midazolam,73,inf,h,204.2,µg*h/L,arith. Mean,43.1,µg*h/L,arith. SD,AUC_inf,40.7,ng/mL,arith. Mean,3.19,ng/mL,arith. SD,Cmax,5.01,L/h,arith. Mean,1.19,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1095,Shin 2016,https://www.ncbi.nlm.nih.gov/pubmed/27317471,Midazolam + rifampicin,Midazolam,216,inf,h,52.25,µg*h/L,arith. Mean,8.95,µg*h/L,arith. SD,AUC_inf,50.6,ng/mL,arith. Mean,8.45,ng/mL,arith. SD,Cmax,47.8,L/h,arith. Mean,9.05,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1096,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail alone,Midazolam,0,inf,h,197,pg*h/mL,geom. Mean,122 - 319,pg*h/mL,95% CI,AUC_inf,55.7,pg/mL,geom. Mean,49 - 63.2,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 198 (128 - 309)
1097,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail + Itraconazole,Midazolam,72,inf,h,1390,pg*h/mL,geom. Mean,864 - 2230,pg*h/mL,95% CI,AUC_inf,207,pg/mL,geom. Mean,173 - 247,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 1350 (834 - 2170)
1098,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail + Rifampin,Midazolam,0,inf,h,186,pg*h/mL,geom. Mean,114 - 303,pg*h/mL,95% CI,AUC_inf,72.6,pg/mL,geom. Mean,64.9 - 81.3,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 171 (106 - 276)
1099,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail + Clarithromycin,Midazolam,72,inf,h,955,pg*h/mL,geom. Mean,653 - 1400,pg*h/mL,95% CI,AUC_inf,150,pg/mL,geom. Mean,135 - 166,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 933 (634 - 1370)
1103,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam alone,Alprazolam,0,5,h,48.6,ng*h/mL,arith. Mean,9.9,ng*h/mL,arith. SD,AUC_tend,13,ng/mL,arith. Mean,2.26,ng/mL,arith. SD,Cmax,,,,,,,,
1103,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam alone,Alprazolam,216,240,h,1058,ng*h/mL,arith. Mean,224,ng*h/mL,arith. SD,AUC_tend,53.6,ng/mL,arith. Mean,11.4,ng/mL,arith. SD,Cmax,3.97,L/h,arith. Mean,0.96,L/h,arith. SD,CL/F,CLpo= oral clearance
1104,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam + fluvoxamine,Alprazolam,144,149,h,61,ng*h/mL,arith. Mean,9.86,ng*h/mL,arith. SD,AUC_tend,15.3,ng/mL,arith. Mean,2.07,ng/mL,arith. SD,Cmax,,,,,,,,
1113,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam + fluvoxamine (day 10),Alprazolam,216,240,h,2077,ng*h/mL,arith. Mean,460,ng*h/mL,arith. SD,AUC_tend,99.8,ng/mL,arith. Mean,21.6,ng/mL,arith. SD,Cmax,2.03,L/h,arith. Mean,0.513,L/h,arith. SD,CL/F,CLpo= oral clearance
1105,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine alone,Fluvoxamine,0,24,h,328,ng*h/mL,arith. Mean,84.6,ng*h/mL,arith. SD,AUC_tend,21.5,ng/mL,arith. Mean,4.89,ng/mL,arith. SD,Cmax,,,,,,,,
1105,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine alone,Fluvoxamine,216,240,h,1762,ng*h/mL,arith. Mean,737,ng*h/mL,arith. SD,AUC_tend,99.3,ng/mL,arith. Mean,35,ng/mL,arith. SD,Cmax,,,,,,,,
1106,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine + alprazolam,Fluvoxamine,0,24,h,302,ng*h/mL,arith. Mean,111,ng*h/mL,arith. SD,AUC_tend,20.7,ng/mL,arith. Mean,10.4,ng/mL,arith. SD,Cmax,,,,,,,,
1114,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine + alprazolam (day 10),Fluvoxamine,216,240,h,1341,ng*h/mL,arith. Mean,547,ng*h/mL,arith. SD,AUC_tend,78.2,ng/mL,arith. Mean,25.3,ng/mL,arith. SD,Cmax,,,,,,,,
1107,Backman 1994,https://www.ncbi.nlm.nih.gov/pubmed/8198928,Midazolam with placebo,Midazolam,0,inf,h,12,µg*min/mL,arithm. Mean,1,µg*min/mL,SEM,AUC_inf,65,ng/ml,arithm. Mean,9,ng/ml,SEM,Cmax,,,,,,,,
1108,Backman 1994,https://www.ncbi.nlm.nih.gov/pubmed/8198928,Midazolam with verapamil,Midazolam,25,inf,h,35,µg*min/mL,arithm. Mean,5,µg*min/mL,SEM,AUC_inf,128,ng/ml,arithm. Mean,16,ng/ml,SEM,Cmax,,,,,,,,
704,Greenblatt 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9757151,Triazolam + Placebo (Trial B),Triazolam,0,inf,h,5.5,ng*h/mL,arithm. Mean,0.5,ng*h/mL,SE,AUC_inf,1.25,ng/mL,arithm. Mean,0.14,ng/mL,SE,Cmax,413,mL/min,arithm. Mean,39,mL/min,SE,CL/F,
781,Greenblatt 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9757151,Triazolam + Erythromycin (Trial D),Triazolam,25,inf,h,20.9,ng*h/mL,arithm. Mean,3,ng*h/mL,SE,AUC_inf,2.21,ng/mL,arithm. Mean,0.24,ng/mL,SE,Cmax,146,mL/min,arithm. Mean,32,mL/min,SE,CL/F,
1102,Greenblatt 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9757151,Triazolam + Clarithromycin (Trial E),Triazolam,25,inf,h,28.9,ng*h/mL,arithm. Mean,4,ng*h/mL,SE,AUC_inf,2.46,ng/mL,arithm. Mean,0.26,ng/mL,SE,Cmax,95,mL/min,arithm. Mean,17,mL/min,SE,CL/F,
1027,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo,Triazolam,0,inf,h,5.9,ng*h/mL,arith. Mean,0.7,ng*h/mL,SEM,AUC_inf,1.5,ng/mL,arith. Mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1028,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole,Triazolam,73,inf,h,132,ng*h/mL,arith. Mean,25,ng*h/mL,SEM,AUC_inf,4.6,ng/mL,arith. Mean,0.5,ng/mL,SEM,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1029,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole,Triazolam,73,inf,h,160,ng*h/mL,arith. Mean,68,ng*h/mL,SEM,AUC_inf,4.2,ng/mL,arith. Mean,0.9,ng/mL,SEM,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1030,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4,Ketoconazole,0,inf,h,,,,,,,,7.311111111,µg/mL,arith. Mean,,,,Cmax,,,,,,,,
1031,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 1,Ketoconazole,0,inf,h,,,,,,,,8.7,µg/mL,individual,,,,Cmax,,,,,,,,
1032,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 2,Ketoconazole,0,inf,h,,,,,,,,8.2,µg/mL,individual,,,,Cmax,,,,,,,,
1033,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 3,Ketoconazole,0,inf,h,,,,,,,,4.8,µg/mL,individual,,,,Cmax,,,,,,,,
1034,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 4,Ketoconazole,0,inf,h,,,,,,,,7.1,µg/mL,individual,,,,Cmax,,,,,,,,
1035,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 5,Ketoconazole,0,inf,h,,,,,,,,6.6,µg/mL,individual,,,,Cmax,,,,,,,,
1036,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 6,Ketoconazole,0,inf,h,,,,,,,,7.7,µg/mL,individual,,,,Cmax,,,,,,,,
1037,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 7,Ketoconazole,0,inf,h,,,,,,,,11.1,µg/mL,individual,,,,Cmax,,,,,,,,
1038,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 8,Ketoconazole,0,inf,h,,,,,,,,1,µg/mL,individual,,,,Cmax,,,,,,,,
1039,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 9,Ketoconazole,0,inf,h,,,,,,,,10.6,µg/mL,individual,,,,Cmax,,,,,,,,
1040,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4,Itraconazole,0,inf,h,,,,,,,,337.6666667,ng/mL,arith. Mean,,,,Cmax,,,,,,,,
1041,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 1,Itraconazole,0,inf,h,,,,,,,,410,ng/mL,individual,,,,Cmax,,,,,,,,
1042,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 2,Itraconazole,0,inf,h,,,,,,,,546,ng/mL,individual,,,,Cmax,,,,,,,,
1043,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 3,Itraconazole,0,inf,h,,,,,,,,307,ng/mL,individual,,,,Cmax,,,,,,,,
1044,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 4,Itraconazole,0,inf,h,,,,,,,,205,ng/mL,individual,,,,Cmax,,,,,,,,
1045,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 5,Itraconazole,0,inf,h,,,,,,,,492,ng/mL,individual,,,,Cmax,,,,,,,,
1046,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 6,Itraconazole,0,inf,h,,,,,,,,173,ng/mL,individual,,,,Cmax,,,,,,,,
1047,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 7,Itraconazole,0,inf,h,,,,,,,,142,ng/mL,individual,,,,Cmax,,,,,,,,
1048,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 8,Itraconazole,0,inf,h,,,,,,,,252,ng/mL,individual,,,,Cmax,,,,,,,,
1049,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 9,Itraconazole,0,inf,h,,,,,,,,512,ng/mL,individual,,,,Cmax,,,,,,,,
1050,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 1,Triazolam,0,inf,h,3.8,ng*h/mL,individual,,,,AUC_inf,1.1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1051,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 2,Triazolam,0,inf,h,6.7,ng*h/mL,individual,,,,AUC_inf,1.9,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1052,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 3,Triazolam,0,inf,h,10.5,ng*h/mL,individual,,,,AUC_inf,2.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1053,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 4,Triazolam,0,inf,h,7.7,ng*h/mL,individual,,,,AUC_inf,1.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1054,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 5,Triazolam,0,inf,h,5.5,ng*h/mL,individual,,,,AUC_inf,1.3,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1055,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 6,Triazolam,0,inf,h,3.4,ng*h/mL,individual,,,,AUC_inf,1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1056,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 7,Triazolam,0,inf,h,5.5,ng*h/mL,individual,,,,AUC_inf,1.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1057,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 8,Triazolam,0,inf,h,6.2,ng*h/mL,individual,,,,AUC_inf,1.7,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1058,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 9,Triazolam,0,inf,h,4.1,ng*h/mL,individual,,,,AUC_inf,1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1059,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 1,Triazolam,73,inf,h,270,ng*h/mL,individual,,,,AUC_inf,4.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1060,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 2,Triazolam,73,inf,h,127,ng*h/mL,individual,,,,AUC_inf,7.9,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1061,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 3,Triazolam,73,inf,h,133,ng*h/mL,individual,,,,AUC_inf,3.5,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1062,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 4,Triazolam,73,inf,h,224,ng*h/mL,individual,,,,AUC_inf,4.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1063,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 5,Triazolam,73,inf,h,90,ng*h/mL,individual,,,,AUC_inf,2.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1064,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 6,Triazolam,73,inf,h,72,ng*h/mL,individual,,,,AUC_inf,3.2,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1065,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 7,Triazolam,73,inf,h,141,ng*h/mL,individual,,,,AUC_inf,5.5,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1066,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 8,Triazolam,73,inf,h,31,ng*h/mL,individual,,,,AUC_inf,4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1067,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 9,Triazolam,73,inf,h,98,ng*h/mL,individual,,,,AUC_inf,5.1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1068,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 1,Triazolam,73,inf,h,689,ng*h/mL,individual,,,,AUC_inf,11.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1069,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 2,Triazolam,73,inf,h,161,ng*h/mL,individual,,,,AUC_inf,3.2,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1070,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 3,Triazolam,73,inf,h,76,ng*h/mL,individual,,,,AUC_inf,2.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1071,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 4,Triazolam,73,inf,h,185,ng*h/mL,individual,,,,AUC_inf,3.7,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1072,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 5,Triazolam,73,inf,h,72,ng*h/mL,individual,,,,AUC_inf,3.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1073,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 6,Triazolam,73,inf,h,54,ng*h/mL,individual,,,,AUC_inf,2.5,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1074,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 7,Triazolam,73,inf,h,54,ng*h/mL,individual,,,,AUC_inf,3.6,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1075,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 8,Triazolam,73,inf,h,64,ng*h/mL,individual,,,,AUC_inf,3.7,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1076,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 9,Triazolam,73,inf,h,84,ng*h/mL,individual,,,,AUC_inf,3.3,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1110,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam before treatment,Midazolam,0,inf,h,,,,,,,,,,,,,,,24.4,L/h,arith. Mean,9.1,L/h,arith. SD,CL/F,
1111,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam after VER treatment,Midazolam,168,inf,h,,,,,,,,,,,,,,,16.8,L/h,arith. Mean,10.3,L/h,arith. SD,CL/F,
1115,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam before treatment,Midazolam,0,inf,h,,,,,,,,,,,,,,,93.6,L/h,arith. Mean,67.7,L/h,arith. SD,CLiv,
1116,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam after VER treatment,Midazolam,192,inf,h,,,,,,,,,,,,,,,26.7,L/h,arith. Mean,17.1,L/h,arith. SD,CLiv,
2011,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam at baseline overall,Midazolam,,,,,,,,,,,,,,,,,,7.9,mL/min/kg,arith. Mean,1.8,mL/min/kg,arith. SD,CLiv,
2012,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam post treatment with fluvoxamine (28 days of fluvoxamine) overall,Midazolam,,,,,,,,,,,,,,,,,,5.3,mL/min/kg,arith. Mean,2,mL/min/kg,arith. SD,CLiv,
2013,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam at baseline Male,Midazolam,,,,,,,,,,,,,,,,,,7.6,mL/min/kg,arith. Mean,0.9,mL/min/kg,arith. SD,CLiv,
2042,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Midazolam control PO,Midazolam,0,6,h,50.8,ng*h/mL,geom. Mean,42.5-60.6,ng*h/mL,95% CI,AUC_tend,,,,,,,,1313,mL/min,arith. Mean,1100-1568,mL/min,arith. SD,CL/F,
2043,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Midazolam control IV,Midazolam,6,14,h,84.8,ng*h/mL,geom. Mean,76.3-94.4,ng*h/mL,95% CI,AUC_tend,,,,,,,,393,mL/min,arith. Mean,353-437,mL/min,arith. SD,CLiv,
2044,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 1,Midazolam,12,18,h,30,ng*h/mL,geom. Mean,22.9-39.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,2231,mL/min,arith. Mean,1708-2915,mL/min,arith. SD,CL/F,
2045,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 1,Midazolam,18,26,h,66.6,ng*h/mL,geom. Mean,57.7-77.6,ng*h/mL,95% CI,AUC_tend,,,,,,,,500,mL/min,arith. Mean,430-583,mL/min,arith. SD,CLiv,
2047,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 6,Midazolam,132,138,h,31.2,ng*h/mL,geom. Mean,27.0-36.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,2138,mL/min,arith. Mean,1852-2468,mL/min,arith. SD,CL/F,
2048,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 6,Midazolam,138,146,h,65.9,ng*h/mL,geom. Mean,56.5-77.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,506,mL/min,arith. Mean,433-590,mL/min,arith. SD,CLiv,
2049,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 11,Midazolam,252,258,h,39.1,ng*h/mL,geom. Mean,33.3-46.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,1703,mL/min,arith. Mean,1449-2002,mL/min,arith. SD,CL/F,
2050,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 11,Midazolam,258,266,h,79.5,ng*h/mL,geom. Mean,69.2-91.3,ng*h/mL,95% CI,AUC_tend,,,,,,,,420,mL/min,arith. Mean,365-482,mL/min,arith. SD,CLiv,
2051,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 16,Midazolam,372,378,h,38,ng*h/mL,geom. Mean,31.4-45.9,ng*h/mL,95% CI,AUC_tend,,,,,,,,1755,mL/min,arith. Mean,1452-2123,mL/min,arith. SD,CL/F,
2052,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 16,Midazolam,378,386,h,72.4,ng*h/mL,geom. Mean,62.6-83.6,ng*h/mL,95% CI,AUC_tend,,,,,,,,461,mL/min,arith. Mean,399-532,mL/min,arith. SD,CLiv,
2053,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO  day 22,Midazolam,516,522,h,42.6,ng*h/mL,geom. Mean,33.3-54.5,ng*h/mL,95% CI,AUC_tend,,,,,,,,1564,mL/min,arith. Mean,1223-2001,mL/min,arith. SD,CL/F,
2054,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV  day 22,Midazolam,522,530,h,78.2,ng*h/mL,geom. Mean,65.8-93.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,426,mL/min,arith. Mean,359-507,mL/min,arith. SD,CLiv,
194,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Control CYP3A5*1/*1,Midazolam,0,inf,h,,,,,,,,,,,,,,,32.5,L/h,arith. Mean,10.2,L/h,arith. SD,Cliv,reported values are L/h/70kg
195,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Control CYP3A5*1/*3,Midazolam,0,inf,h,,,,,,,,,,,,,,,32.1,L/h,arith. Mean,14.5,L/h,arith. SD,Cliv,reported values are L/h/70kg
196,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Control CYP3A5*3/*3,Midazolam,0,inf,h,,,,,,,,,,,,,,,28.4,L/h,arith. Mean,12.5,L/h,arith. SD,Cliv,reported values are L/h/70kg
197,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Itraconazole CYP3A5*1/*1,Midazolam,72,inf,h,,,,,,,,,,,,,,,13.5,L/h,arith. Mean,2.7,L/h,arith. SD,Cliv,reported values are L/h/70kg
198,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Itraconazole CYP3A5*1/*3,Midazolam,72,inf,h,,,,,,,,,,,,,,,11.5,L/h,arith. Mean,4.5,L/h,arith. SD,Cliv,reported values are L/h/70kg
199,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Itraconazole CYP3A5*3/*3,Midazolam,72,inf,h,,,,,,,,,,,,,,,8.5,L/h,arith. Mean,3.8,L/h,arith. SD,Cliv,reported values are L/h/70kg
200,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Rifampicin CYP3A5*1/*1,Midazolam,240,inf,h,,,,,,,,,,,,,,,62.3,L/h,arith. Mean,35.9,L/h,arith. SD,Cliv,reported values are L/h/70kg
201,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Rifampicin CYP3A5*1/*3,Midazolam,240,inf,h,,,,,,,,,,,,,,,75.6,L/h,arith. Mean,35.9,L/h,arith. SD,Cliv,reported values are L/h/70kg
202,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Rifampicin CYP3A5*3/*3,Midazolam,240,inf,h,,,,,,,,,,,,,,,65.3,L/h,arith. Mean,32.4,L/h,arith. SD,Cliv,reported values are L/h/70kg
203,Wiesinger 2020,https://www.ncbi.nlm.nih.gov/pubmed/32275771,Control phase (no RIF),Midazolam,0,inf,h,12.7,µg*h/L,geom. Mean,36.7,%,geom. CV,AUC_inf,4.9,µg/L,geom. Mean,33,%,geom. CV,,,,,,,,,
204,Wiesinger 2020,https://www.ncbi.nlm.nih.gov/pubmed/32275771,Weak-induction phase (RIF 10 mg),Midazolam,180,444,h,6.84,µg*h/L,geom. Mean,37.3,%,geom. CV,AUC_inf,3.1,µg/L,geom. Mean,38.6,%,geom. CV,,,,,,,,,
205,Wiesinger 2020,https://www.ncbi.nlm.nih.gov/pubmed/32275771,Strong-induction phase (RIF 600 mg),Midazolam,444,9999,h,1.73,µg*h/L,geom. Mean,49.3,%,geom. CV,AUC_inf,0.919,µg/L,geom. Mean,46.2,%,geom. CV,,,,,,,,,
2055,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil IV control,Verapamil,0,inf,h,173.7,ng*h/mL,arith. Mean,29.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,991,mL/min,arith. Mean,185.4,mL/min,arith. SD,CLiv,
2056,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil IV after 2 weeks of Rifampicin therapy,Verapamil,300,inf,h,142.2,ng*h/mL,arith. Mean,30.4,ng*h/mL,arith. SD,AUC_inf,,,,,,,,1228.2,mL/min,arith. Mean,267.8,mL/min,arith. SD,CLiv,
2057,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil PO control,Verapamil,0,inf,h,526.8,ng*h/mL,arith. Mean,173.8,ng*h/mL,arith. SD,AUC_inf,194.8,ng/mL,arith. Mean,107.8,ng/mL,arith. SD,Cmax,,,,,,,,
2058,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil PO after 2 weeks of Rifampicin therapy,Verapamil,348,inf,h,34.3,ng*h/mL,arith. Mean,16.2,ng*h/mL,arith. SD,AUC_inf,7.2,ng/mL,arith. Mean,4.2,ng/mL,arith. SD,Cmax,,,,,,,,
2065,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 0.1 mg,Verapamil,0,inf,h,0.139,ng*h/mL,arith. Mean,0.09,ng*h/mL,arith. SD,AUC_inf,0.0338,ng/mL,arith. Mean,0.0292,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 0.132 +/- 0.087
2066,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 3 mg,Verapamil,0,inf,h,4.95,ng*h/mL,arith. Mean,2.68,ng*h/mL,arith. SD,AUC_inf,1.03,ng/mL,arith. Mean,0.64,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 4.54 +/- 2.48
2067,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 16 mg,Verapamil,0,inf,h,40.8,ng*h/mL,arith. Mean,43.9,ng*h/mL,arith. SD,AUC_inf,10.4,ng/mL,arith. Mean,12.6,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 38.1 +/- 41.3
2068,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 80 mg,Verapamil,0,inf,h,256,ng*h/mL,arith. Mean,143,ng*h/mL,arith. SD,AUC_inf,63.3,ng/mL,arith. Mean,34.2,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 236 +/- 131
2072,Jorgensen 1988,https://www.ncbi.nlm.nih.gov/pubmed/3186615,Conventional Verapamil 120 mg BID (day 8),Verapamil,168,192,h,2487.8,µg*h/L,arith. Mean,841.8,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,AUC_tend = AUC(0-24)
2074,Jorgensen 1988,https://www.ncbi.nlm.nih.gov/pubmed/3186615,Sustained release Verapamil 240 mg OD (day 8),Verapamil,168,192,h,2169.4,µg*h/L,arith. Mean,764,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,AUC_tend = AUC(0-24)
2077,Shand 1981,https://www.ncbi.nlm.nih.gov/pubmed/7297027,Verapamil day 1,Verapamil,0,inf,h,788,ng*h/mL,arith. Mean,224,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
2078,Shand 1981,https://www.ncbi.nlm.nih.gov/pubmed/7297027,Verapamil day 3 (after 7th dose),Verapamil,48,56,h,1999,ng*h/mL,arith. Mean,435,ng*h/mL,arith. SD,AUC_tend,,,,,,,,,,,,,,,AUC_tend = AUC(0-8)
2079,Johnson 2001,https://www.ncbi.nlm.nih.gov/pubmed/11697758,Verapamil Steady State,Verapamil,48,56,h,829,ng*h/mL,geom. Mean,472,ng*h/mL,geom. SD,AUC_tend,230,ng/mL,geom. Mean,122,ng/mL,geom. SD,Cmax,,,,,,,,AUC_tend = AUC(0-8); also available AUC(0-4): geom. mean +/- SD in (ng*h*ml-1): 519 +/- 280
2069,Hla 1987,https://www.ncbi.nlm.nih.gov/pubmed/3435694,conventional Verapamil 120mg once daily (day 1),Verapamil,0,inf,h,450,ng*h/mL,arith. Mean,130,ng*h/mL,arith. SD,AUC_inf,123,ng/mL,arith. Mean,43,ng/mL,arith. SD,Cmax,,,,,,,,
2070,Hla 1987,https://www.ncbi.nlm.nih.gov/pubmed/3435694,conventional Verapamil 120mg twice daily (day 10),Verapamil,216,240,h,1107,ng*h/mL,arith. Mean,411,ng*h/mL,arith. SD,AUC_tend,272,ng/mL,arith. Mean,117,ng/mL,arith. SD,Cmax,,,,,,,,AUC_tend = AUC(0-24)
2059,Johnston 1981,https://www.ncbi.nlm.nih.gov/pubmed/7295469,Verapamil IV,Verapamil,0,inf,h,118.4,ng*h/mL,arith. Mean,45.1,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
2060,Johnston 1981,https://www.ncbi.nlm.nih.gov/pubmed/7295469,Verapamil PO,Verapamil,0,inf,h,494,ng*h/mL,arith. Mean,316.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
2075,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total IR fasting,Verapamil,0,48,h,1626,ng*h/mL,arith. Mean,53,%,arith. CV,AUC_tend,,,,,,,,,,,,,,,
2076,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total SR fed,Verapamil,0,48,h,1099,ng*h/mL,arith. Mean,48,%,arith. CV,AUC_tend,,,,,,,,,,,,,,,
2075,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total IR fasting,Verapamil,0,inf,h,1656,ng*h/mL,arith. Mean,52,%,arith. CV,AUC_inf,327,ng/mL,arith. Mean,44,%,arith. CV,Cmax,40.8,mL/min/kg,arith. Mean,52,%,arith. CV,CL/F,
2076,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total SR fed,Verapamil,0,inf,h,1215,ng*h/mL,arith. Mean,44,%,arith. CV,AUC_inf,73.5,ng/mL,arith. Mean,58,%,arith. CV,Cmax,,,,,,,,
2061,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 10 mg IV,Verapamil,0,inf,h,214.6,ng*h/mL,arith. Mean,66.8,ng*h/mL,arith. SD,AUC_inf,80.4,ng/mL,arith. Mean,43.1,ng/mL,arith. SD,Cmax,0.71,L/h/kg,arith. Mean,0.3,L/h/kg,arith. SD,CL/F,
2062,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 80 mg PO,Verapamil,0,inf,h,34.5,ng*h/mL,arith. Mean,14.5,ng*h/mL,arith. SD,AUC_inf,49.3,ng/mL,arith. Mean,25.2,ng/mL,arith. SD,Cmax,0.82,L/h/kg,arith. Mean,0.3,L/h/kg,arith. SD,CL/F,
2063,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 120 mg PO,Verapamil,0,inf,h,37.1,ng*h/mL,arith. Mean,23.3,ng*h/mL,arith. SD,AUC_inf,85,ng/mL,arith. Mean,50.3,ng/mL,arith. SD,Cmax,0.86,L/h/kg,arith. Mean,0.3,L/h/kg,arith. SD,CL/F,
2064,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 160 mg PO,Verapamil,0,inf,h,38.7,ng*h/mL,arith. Mean,18.5,ng*h/mL,arith. SD,AUC_inf,108.3,ng/mL,arith. Mean,44.5,ng/mL,arith. SD,Cmax,0.83,L/h/kg,arith. Mean,0.4,L/h/kg,arith. SD,CL/F,
2080,Streit 2005,https://pubmed.ncbi.nlm.nih.gov/15692829/,intravenous verapamil during normoxia (5 mg),Verapamil,0,14,h,58.7,ng*h/mL,arith. Mean,10.5,ng*h/mL,arith. SD,AUC_tend,72.1,ng/mL,arith. Mean,25.1,ng/mL,arith. SD,Cmax,87.7,L/h,arith. Mean,16.1,L/h,arith. SD,CLiv,
1207,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, Individual LH",Cimetidine,0,inf,h,1.1,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,1.15,L/h/kg,arith. Mean,,,,CLiv,
1208,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, Individual KN",Cimetidine,0,inf,h,2.4,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,0.65,L/h/kg,arith. Mean,,,,CLiv,
1209,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, Individual LOE",Cimetidine,0,inf,h,1.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,1,L/h/kg,arith. Mean,,,,CLiv,
1210,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, urine mean % of dose",Cimetidine,0,inf,h,2.2,µg*h/mL,arith. Mean,0.6,µg*h/mL,arith. SD,AUC_inf,,,,,,,,0.74,L/h/kg,arith. Mean,0.2,L/h/kg,arith. SD,CLiv,
1211,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, Individual LH",Cimetidine,0,inf,h,9.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1212,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, Individual LOE",Cimetidine,0,inf,h,8.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1213,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, Individual UB",Cimetidine,0,inf,h,7.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1214,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, urine mean % of dose",Cimetidine,0,inf,h,10.4,µg*h/mL,arith. Mean,2,µg*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
1215,Larsson 1982,https://pubmed.ncbi.nlm.nih.gov/7059413/,IV 200 mg in normal renal function group,Cimetidine,0,inf,h,5.04,µg*h/mL,arith. Mean,0.47,µg*h/mL,SEM,AUC_inf,,,,,,,,718,mL/min,arith. Mean,80,mL/min,SEM,CLiv,CL: Total plasma clearance; Renal clearance: 326 +/- 40; Non-renal clearance: 392 +/- 72
1216,Larsson 1982,https://pubmed.ncbi.nlm.nih.gov/7059413/,IV 200 mg in normal renal function group,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1217,Mihaly 1984,https://pubmed.ncbi.nlm.nih.gov/6318788/,"IV 200 mg, beginning of treatment",Cimetidine,0,inf,h,4369,ng*h/mL,arith. Mean,944,ng*h/mL,arith. SD,AUC_inf,,,,,,,,30.7,L/h,arith. Mean,10.9,L/h,arith. SD,CLiv,"CL: CL_R; CL_syst: 46,8 +/- 8,7"
1218,Mihaly 1984,https://pubmed.ncbi.nlm.nih.gov/6318788/,"PO 200 mg, beginning of treatment",Cimetidine,0,inf,h,3460,ng*h/mL,arith. Mean,1008,ng*h/mL,arith. SD,AUC_inf,,,,,,,,29,L/h,arith. Mean,11.9,L/h,arith. SD,CL/F,"CL: CL_R; CL_syst: 46,8 +/- 8,7"
1219,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,IV 200 mg,Cimetidine,0,inf,h,5.296,µg*h/mL,arith. Mean,0.526,µg*h/mL,SE,AUC_inf,,,,,,,,655.2,mL/min,arith. Mean,54.7,mL/min,SE,CLiv,
1220,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,PO 200 mg,Cimetidine,0,inf,h,4.112,µg*h/mL,arith. Mean,0.42,µg*h/mL,SE,AUC_inf,1.06,µg/mL,arith. Mean,0.1,µg/mL,SE,Cmax,,,,,,,,
1221,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,PO 400 mg,Cimetidine,0,inf,h,8.429,µg*h/mL,arith. Mean,0.984,µg*h/mL,SE,AUC_inf,2.27,µg/mL,arith. Mean,0.22,µg/mL,SE,Cmax,,,,,,,,
1222,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,PO 800 mg,Cimetidine,0,inf,h,17.887,µg*h/mL,arith. Mean,2.438,µg*h/mL,SE,AUC_inf,4.45,µg/mL,arith. Mean,0.61,µg/mL,SE,Cmax,,,,,,,,
1223,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"IV 200 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1224,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"PO 200 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1225,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"PO 400 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1226,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"PO 800 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1227,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 200 mg,Cimetidine,0,inf,h,373.5,µg*h/mL,arith. Mean,19.3,µg*h/mL,arith. SEM,AUC_inf,1.03,µg/mL,arith. Mean,0.24,µg/mL,SEM,Cmax,,,,,,,,"AUC Unit: µg h kg ml-1; AUC corrected to kg body weight; Cmax = 1-120min; Cmax(120-300min): 1,01 +/- 0,12"
1228,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 400 mg,Cimetidine,0,inf,h,764.2,µg*h/mL,arith. Mean,8.7,µg*h/mL,arith. SEM,AUC_inf,1.84,µg/mL,arith. Mean,0.31,µg/mL,SEM,Cmax,,,,,,,,"AUC Unit: µg h kg ml-1; AUC corrected to kg body weight; Cmax = 1-120min; Cmax(120-300min): 2,12 +/- 0,27"
1229,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 200 mg fasted,Cimetidine,0,inf,h,406.6,µg*h/mL,arith. Mean,33.87,µg*h/mL,arith. SEM,AUC_inf,1.18,µg/mL,arith. Mean,0.14,µg/mL,SEM,Cmax,,,,,,,,"AUC Unit: µg h kg ml-1; AUC corrected to kg body weight; Cmax = 1-120min; Cmax(120-300min): 0,97 +/- 0,07"
1230,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 200 mg fed,Cimetidine,0,inf,h,371.7,µg*h/mL,arith. Mean,29.03,µg*h/mL,arith. SEM,AUC_inf,1.09,µg/mL,arith. Mean,0.1,µg/mL,SEM,Cmax,,,,,,,,AUC Unit: µg h kg ml-1; AUC corrected to kg body weight
1231,Morgan 1983,https://pubmed.ncbi.nlm.nih.gov/6617722/,IV 200 mg 5 min,Cimetidine,0,inf,h,,,,,,,,7.33,µg/mL,arith. Mean,1.38,µg/mL,arith. SD,Cmax,,,,,,,,Cmax: Obtained from AUTOAN fit of 5min infusion study data
1232,Morgan 1983,https://pubmed.ncbi.nlm.nih.gov/6617722/,IV 200 mg 30 min,Cimetidine,0,inf,h,,,,,,,,4.57,µg/mL,arith. Mean,0.53,µg/mL,arith. SD,Cmax,,,,,,,,
1233,Lebert 1981,https://pubmed.ncbi.nlm.nih.gov/6269789/,IV 300 mg,Cimetidine,0,inf,h,8.16,µg*h/mL,arith. Mean,0.65,µg*h/mL,arith. SEM,AUC_inf,,,,,,,,0.55,L/h/kg,arith. Mean,0.05,L/h/kg,SEM,CLiv,
1234,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1235,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1236,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1237,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1238,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1239,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1240,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1241,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1242,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1243,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1244,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1245,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1246,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1247,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1248,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1249,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1250,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1251,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1252,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1253,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1254,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1255,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1256,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1257,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1258,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 13,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1259,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 14,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1260,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 15,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1261,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 16,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1262,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 17,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1263,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 18,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1264,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 19,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1265,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 20,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1266,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 21,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1267,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 22,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1268,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 23,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1269,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 24,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1270,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 13,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1271,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 14,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1272,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 15,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1273,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 16,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1274,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 17,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1275,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 18,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1276,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 19,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1277,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 20,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1278,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 21,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1279,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 22,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1280,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 23,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1281,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 24,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1282,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1283,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1284,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1285,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1286,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1287,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1288,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1289,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1290,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1291,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1292,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1293,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1294,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1295,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1296,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1297,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1298,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1299,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1300,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1301,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1302,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1303,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1304,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1305,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1306,Kanto 1981,https://pubmed.ncbi.nlm.nih.gov/7272182/,PO  200 mg,Cimetidine,0,inf,h,3.52,µg*h/mL,arith. Mean,0.25,µg*h/mL,SEM,AUC_inf,1.12,µg/mL,arith. Mean,0.15,µg/mL,SEM,Cmax,,,,,,,,
1307,Burland 1975,https://pubmed.ncbi.nlm.nih.gov/9952/,PO 200 mg sol,Cimetidine,,,,,,,,,,,2.8,µmol/L,average,"1,2-4,3",µmol/L,range,Cmax,,,,,,,,
1308,Burland 1975,https://pubmed.ncbi.nlm.nih.gov/9952/,PO 200 mg caps,Cimetidine,,,,,,,,,,,2.8,µmol/L,average,"1,2-4,3",µmol/L,range,Cmax,,,,,,,,
1309,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 1,Cimetidine,0,inf,h,3.36,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1310,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 2,Cimetidine,0,inf,h,6.43,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1311,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 3,Cimetidine,0,inf,h,8.75,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1312,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 4,Cimetidine,0,inf,h,7.01,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1313,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 5,Cimetidine,0,inf,h,7.11,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1314,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 6,Cimetidine,0,inf,h,6.27,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1315,Barbhaiya 1995,https://pubmed.ncbi.nlm.nih.gov/8562300/,PO 300 mg QID,Cimetidine,144,150,h,4390,ng*h/mL,arith. Mean,1107,ng*h/mL,arith. SD,AUC_tau,1315,ng/mL,arith. Mean,365,ng/mL,arith. SD,Cmax,,,,,,,,
1316,Somogyi 1981,https://pubmed.ncbi.nlm.nih.gov/7238562/,PO 400 mg tab,Cimetidine,0,inf,h,11.91,µg*h/mL,arith. Mean,32.8,%,%CV,AUC_inf,2.99,µg/mL,arith. Mean,39.5,%,%CV,Cmax,394.2,mL/min,arith. Mean,33.8,%,%CV,CL/F,"CL: Renal clearance; AUC(0-10): 11,41 (32,9)"
1317,Tiseo 1998,https://pubmed.ncbi.nlm.nih.gov/9839762/,PO 800 mg QD,Cimetidine,144,168,h,20.6,ng*h/mL,arith. Mean,1,ng*h/mL,SE,AUC_tend,4,ng/mL,arith. Mean,0.3,ng/mL,SE,Cmax,,,,,,,,
1318,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,5 mg Midazolam IV control,Midazolam,0,inf,h,,,,,,,,,,,,,,,10.8,mL/min/kg,arith. Mean,1.4,mL/min/kg,SEM,CLiv,
1319,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,"300 mg QD Cimetidine, 5 mg Midazolam IV",Midazolam,24,inf,h,,,,,,,,,,,,,,,12.1,mL/min/kg,arith. Mean,0.92,mL/min/kg,SEM,CLiv,
1320,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,15 mg Midazolam PO control,Midazolam,0,inf,h,297,ng*h/mL,arith. Mean,114,ng*h/mL,SEM,AUC_inf,90,ng/mL,arith. Mean,27,ng/mL,SEM,Cmax,16.2,mL/min/kg,arith. Mean,4.4,mL/min/kg,SEM,CL/F,CL: Apparent oral clearance
1321,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,"300 mg QD Cimetidine, 15 mg Midazolam PO",Midazolam,24,inf,h,267,ng*h/mL,arith. Mean,45,ng*h/mL,SEM,AUC_inf,95,ng/mL,arith. Mean,30,ng/mL,SEM,Cmax,14.3,mL/min/kg,arith. Mean,3,mL/min/kg,SEM,CL/F,CL: Apparent oral clearance
1322,Martinez 1999,https://pubmed.ncbi.nlm.nih.gov/10223772/,"800 mg Cimetidine, 7.5 mg Midazolam PO",Midazolam,0,inf,h,786.1,nmol*min/mL,arith. Mean,365.2,nmol*min/mL,arith. SD,AUC_inf,,,,,,,,425.9,mL/min,arith. Mean,185,mL/min,arith. SD,CLiv,AUC(0-12): 507.0 ± 265.1
1323,Fee 1987,https://pubmed.ncbi.nlm.nih.gov/3802710/,15 mg Midazolam control,Midazolam,0,inf,h,298,ng*h/mL,arith. Mean,124.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,"Midazolam, 10mg: CL (L/kg/hr): 0.366 ± 0.201"
1324,Fee 1987,https://pubmed.ncbi.nlm.nih.gov/3802710/,"400 mg BID Cimetidine, 15 mg Midazolam",Midazolam,25,inf,h,401,ng*h/mL,arith. Mean,157,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
1325,Salonen 1986,https://pubmed.ncbi.nlm.nih.gov/2939688/,15 mg Midazolam PO control,Midazolam,0,inf,h,212.4,ng*h/mL,arith. Mean,58.2,ng*h/mL,arith. SD,AUC_inf,76.9,ng/mL,arith. Mean,17.6,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-2): 51,6 ± 33,2"
1326,Salonen 1986,https://pubmed.ncbi.nlm.nih.gov/2939688/,"400 mg Cimetidine, 15 mg Midazolam",Midazolam,2,inf,h,289.9,ng*h/mL,arith. Mean,102.6,ng*h/mL,arith. SD,AUC_inf,105.6,ng/mL,arith. Mean,30.2,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-2): 85,9 ± 41,1"
1327,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,IV 10 mg Verapamil control,Verapamil,0,inf,h,130,ng*h/mL,arith. Mean,81,ng*h/mL,arith. SD,AUC_inf,368,ng/mL,arith. Mean,187,ng/mL,arith. SD,Cmax,1908,mL/min,arith. Mean,1263,mL/min,arith. SD,CLiv,
1328,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,IV 10 mg Verapamil + Cimetidine,Verapamil,168 or 192,inf,h,92,ng*h/mL,arith. Mean,56,ng*h/mL,arith. SD,AUC_inf,353,ng/mL,arith. Mean,192,ng/mL,arith. SD,Cmax,2261,mL/min,arith. Mean,893,mL/min,arith. SD,CLiv,
1329,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,PO 120 mg Verapamil control,Verapamil,0,inf,h,376,ng*h/mL,arith. Mean,282,ng*h/mL,arith. SD,AUC_inf,150,ng/mL,arith. Mean,116,ng/mL,arith. SD,Cmax,8713,mL/min,arith. Mean,6145,mL/min,arith. SD,CL/F,
1330,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,PO 120 mg Verapamil + Cimetidine,Verapamil,168 or 192,inf,h,515,ng*h/mL,arith. Mean,416,ng*h/mL,arith. SD,AUC_inf,170,ng/mL,arith. Mean,79,ng/mL,arith. SD,Cmax,5320,mL/min,arith. Mean,2344,mL/min,arith. SD,CL/F,
1331,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Alprazolam control,Alprazolam,0,inf,h,,,,,,,,15.5,ng/mL,arith. Mean,"6,6-39,4",ng/mL,range,Cmax,1.66,mL/min/kg,arith. Mean,"0,57-2,96",mL/min/kg,range,CL/F,CL: Total clearance
1332,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Alprazolam + Cimetidine,Alprazolam,12,inf,h,,,,,,,,16,ng/mL,arith. Mean,"8,7-39,5",ng/mL,range,Cmax,1.05,mL/min/kg,arith. Mean,"0,38-1,88",mL/min/kg,range,CL/F,CL: Total clearance
1333,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Triazolam control,Triazolam,0,inf,h,24.5,ng*h/mL,arith. Mean,"13,3-37,1",ng*h/mL,range,AUC_inf,4.9,ng/mL,arith. Mean,"2,4-13",ng/mL,range,Cmax,5.9,mL/min/kg,arith. Mean,"2,2-9,7",mL/min/kg,range,CL/F,CL: Total oral clearance
1334,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Triazolam + Cimetidine,Triazolam,12,inf,h,37.8,ng*h/mL,arith. Mean,"13,6-58,3",ng*h/mL,range,AUC_inf,5.9,ng/mL,arith. Mean,"2,1-8,6",ng/mL,range,Cmax,3.9,mL/min/kg,arith. Mean,"1,6-10,4",mL/min/kg,range,CL/F,CL: Total oral clearance
1335,Friedman 1988,https://pubmed.ncbi.nlm.nih.gov/3360971/,Triazolam control,Triazolam,0,inf,h,23.1,ng*h/mL,arith. Mean,4.7,ng*h/mL,arith. SD,AUC_inf,5.7,ng/mL,arith. Mean,1.9,ng/mL,arith. SD,Cmax,,,,,,,,
1336,Friedman 1988,https://pubmed.ncbi.nlm.nih.gov/3360971/,Triazolam + Cimetidine,Triazolam,13,inf,h,35.7,ng*h/mL,arith. Mean,6,ng*h/mL,arith. SD,AUC_inf,7.7,ng/mL,arith. Mean,1.1,ng/mL,arith. SD,Cmax,,,,,,,,
1337,Cox 1986,https://pubmed.ncbi.nlm.nih.gov/3828486/,triazolam control,Triazolam,0,inf,h,16.1,ng*h/mL,arith. Mean,2.3,ng*h/mL,arith. SD,AUC_inf,3.87,ng/mL,arith. Mean,0.32,ng/mL,arith. SD,Cmax,668,mL/min,arith. Mean,68,mL/min,arith. SD,CL/F,
1338,Cox 1986,https://pubmed.ncbi.nlm.nih.gov/3828486/,triazolam + cimetidine,Triazolam,24,inf,h,21.3,ng*h/mL,arith. Mean,2.5,ng*h/mL,arith. SD,AUC_inf,5.38,ng/mL,arith. Mean,0.43,ng/mL,arith. SD,Cmax,485,mL/min,arith. Mean,53,mL/min,arith. SD,CL/F,
1339,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Alprazolam control,Alprazolam,168,inf,h,294,ng*h/mL,arith. Mean,134,ng*h/mL,arith. SD,AUC_inf,18.2,ng/mL,arith. Mean,8.65,ng/mL,arith. SD,Cmax,5.35,mL/min/kg,arith. Mean,1.38,mL/min/kg,arith. SD,,"AUC(0-8): 101 +/- 33,7; AUC(0-72): 279 +/- 128"
1340,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Alprazolam + Cimetidine,Alprazolam,336,inf,h,508,ng*h/mL,arith. Mean,168,ng*h/mL,arith. SD,AUC_inf,33.1,ng/mL,arith. Mean,7.29,ng/mL,arith. SD,Cmax,3.09,mL/min/kg,arith. Mean,0.52,mL/min/kg,arith. SD,,"AUC(0-8): 166 +/- 29,4; AUC(0-72): 483 +/- 147"
1341,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Triazolam control,Triazolam,144,inf,h,31.3,ng*h/mL,arith. Mean,12.6,ng*h/mL,arith. SD,AUC_inf,7.81,ng/mL,arith. Mean,2.59,ng/mL,arith. SD,Cmax,17.9,mL/min/kg,arith. Mean,6.12,mL/min/kg,arith. SD,,"AUC(0-24): 28,6 +/- 10,9"
1342,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Triazolam + Cimetidine,Triazolam,327,inf,h,68.9,ng*h/mL,arith. Mean,26.8,ng*h/mL,arith. SD,AUC_inf,11.8,ng/mL,arith. Mean,4.66,ng/mL,arith. SD,Cmax,8.12,mL/min/kg,arith. Mean,2.67,mL/min/kg,arith. SD,,"AUC(0-24): 59,7 +/- 20,7"
1343,Kienlen 1993,https://link.springer.com/article/10.1007/BF03259596,Alfentanil control,Alfentanil,0,inf,h,,,,,,,,,,,,,,,3.56,mL/min/kg,arith. Mean,1.17,mL/min/kg,arith. SD,CLiv,"CL = total clearance; Unbound fraction of ALF (%): 8,06 +/- 2,86"
1344,Kienlen 1993,https://link.springer.com/article/10.1007/BF03259596,Alfentanil + Cimetidine,Alfentanil,48,inf,h,,,,,,,,,,,,,,,1.27,mL/min/kg,arith. Mean,0.5,mL/min/kg,arith. SD,CLiv,"CL = total clearance; Unbound fraction of ALF (%): 7,73 +/- 2,43"
1345,Elliott 1984,https://pubmed.ncbi.nlm.nih.gov/6152615/,Midazolam/H2O,Midazolam,0,inf,h,187,ng*h/L,arith. Mean,20.3,ng*h/L,SEM,AUC_inf,60,ng/mL,arith. Mean,,,,Cmax,1.2,L/h/kg,arith. Mean,0.13,L/h/kg,SEM,CL/F,
1346,Elliott 1984,https://pubmed.ncbi.nlm.nih.gov/6152615/,Midazolam/cimetidine,Midazolam,26.5,inf,h,377,ng*h/L,arith. Mean,57.8,ng*h/L,SEM,AUC_inf,143,ng/mL,arith. Mean,,,,Cmax,0.62,L/h/kg,arith. Mean,0.08,L/h/kg,SEM,CL/F,
1347,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,200/400 mg QID,Cimetidine,168,192,h,22.76,µg*h/mL,arith. Mean,2.06,µg*h/mL,SE,AUC_tend,,,,,,,,,,,,,,,"AUC(200mg): 4,118 (2,091-8,616); AUC(400mg): 10,404 (6,161-17,514); Cmax(200mg): 1,43 +/- 0,10 (0,40-3,03); Cmax(400mg): 2,41 +/- 0,29 (1,39-4,35); Cmax(4h after 200mg): 0,64 +/- 0,04 (0,34-1,22)"
210,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Itraconazole),Pravastatin,0,inf,h,188,ng*h/mL,geo. Mean,,,,AUC_inf,64,ng/mL,arith. Mean,,,,,,,,,,,,
211,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Pravastatin with Itraconazole,Pravastatin,696,inf,h,210,ng*h/mL,geo. Mean,,,,AUC_inf,73,ng/mL,arith. Mean,,,,,,,,,,,,
212,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,11187GA subjects,Pravastatin,0,12,h,203.7,,arith. Mean,126.4,,arith. SD,AUC_tend,93.8,ng/mL,arith. mean,60.6,ng/mL,arith. SD,Cmax,,,,,,,,
213,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,11187GG subjects,Pravastatin,0,12,h,102.7,,arith. Mean,69.1,,arith. SD,AUC_tend,45.6,ng/mL,arith. mean,34.3,ng/mL,arith. SD,Cmax,,,,,,,,
241,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,521CC subjects,Pravastatin,0,12,h,140.1,,arith. Mean,39.3,,arith. SD,AUC_tend,51.9,ng/mL,arith. mean,19.0,ng/mL,arith. SD,Cmax,,,,,,,,
242,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,521TC subjects,Pravastatin,0,12,h,184.7,,arith. Mean,105.0,,arith. SD,AUC_tend,84.4,ng/mL,arith. mean,56.6,ng/mL,arith. SD,Cmax,,,,,,,,
408,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,521TT subjects,Pravastatin,0,12,h,89.5,,arith. Mean,64.0,,arith. SD,AUC_tend,40.3,ng/mL,arith. mean,"28,9",ng/mL,arith. SD,Cmax,,,,,,,,
409,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Heterozygous carriers of *15B,Pravastatin,0,12,h,207.8,,arith. Mean,119.3,,arith. SD,AUC_tend,91.9,ng/mL,arith. mean,56.6,ng/mL,arith. SD,Cmax,,,,,,,,
410,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Non-carriers of *15B,Pravastatin,0,12,h,107.7,,arith. Mean,77.4,,arith. SD,AUC_tend,48.4,ng/mL,arith. mean,38.7,ng/mL,arith. SD,Cmax,,,,,,,,
411,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Heterozygous carriers of *17,Pravastatin,0,12,h,246.4,,arith. Mean,72.5,,arith. SD,AUC_tend,120.6,ng/mL,arith. mean,48.2,ng/mL,arith. SD,Cmax,,,,,,,,
412,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Non-carriers of *17,Pravastatin,0,12,h,107.3,,arith. Mean,78.9,,arith. SD,AUC_tend,47.3,ng/mL,arith. mean,37.0,ng/mL,arith. SD,Cmax,,,,,,,,
413,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2125605/,Pravastatin (GC/MS),Pravastatin,0,24,h,152.2,ng*h/mL,arith. Mean,13.5,ng*h/mL,SEM,AUC_tend,64.1,ng/mL,arith. Mean,6.9,ng/mL,SEM,Cmax,,,,,,,,
433,Nishizato 2003,https://pubmed.ncbi.nlm.nih.gov/12811365/,*1b/*1b subjects,Pravastatin,0,24,h,44.2,ng*h/mL,arith. Mean,6.38,ng*h/mL,arith. SD,AUC_tend,14,ng/mL,arith. Mean,,,,,2.39,L/h/kg,arith. Mean,0.44,L/h/kg,arith. SD,,"Cmax data from another paper: Escobar 2005, table II"
434,Nishizato 2003,https://pubmed.ncbi.nlm.nih.gov/12811365/,*1b/*15 subjects,Pravastatin,0,24,h,62.1,ng*h/mL,arith. Mean,21.8,ng*h/mL,arith. SD,AUC_tend,27,ng/mL,arith. Mean,,,,,1.57,L/h/kg,arith. Mean,0.32,L/h/kg,arith. SD,,"Cmax data from another paper: Escobar 2005, table II"
435,Nishizato 2003,https://pubmed.ncbi.nlm.nih.gov/12811365/,*15/*15 subjects,Pravastatin,0,24,h,111.8,ng*h/mL,arith. Mean,,,,AUC_tend,49,ng/mL,arith. Mean,,,,,0.79,L/h/kg,arith. Mean,,,,,"Cmax data from another paper: Escobar 2005, table II"
436,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17047488/,SLCO1B1*17 carriers,Pravastatin,0,12,h,246.4,ng*h/mL,arith. Mean,72.5,ng*h/mL,arith. SD,AUC_tend,120.6,ng/ml,arith. Mean,48.2,ng/ml,arith. SD,Cmax,,,,,,,,
437,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17047488/,SLCO1B1*17 and ABCC2 c.1446C>G noncarriers,Pravastatin,0,12,h,113.4,ng*h/mL,arith. Mean,79.4,ng*h/mL,arith. SD,AUC_tend,50.0,ng/ml,arith. Mean,37.4,ng/ml,arith. SD,Cmax,,,,,,,,
438,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17047488/, ABCC2 c.1446C>G carriers,Pravastatin,0,12,h,36.8,ng*h/mL,arith. Mean,4.3,ng*h/mL,arith. SD,AUC_tend,16.0,ng/ml,arith. Mean,4.3,ng/ml,arith. SD,Cmax,,,,,,,,
439,Bauer 2005,https://pubmed.ncbi.nlm.nih.gov/15734167/,Healthy Volunteers,Pravastatin,,,,,,,,,,,,,,,,,,,,,,,,,
441,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2116260/,5 mg pravastatin twice daily,Pravastatin,660,672,h,21,ng*h/mL,arith. Mean,2.8,ng*h/mL,SEM,AUC_tend,6.1,ng/mL,arith. Mean,0.9,ng/mL,SEM,Cmax,,,,,,,,"Initial PRA dose (week 0): AUC: 15,5 +/- 2,5, Cmax: 4,9 +/- 0,8"
442,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2116260/,10 mg pravastatin twice daily,Pravastatin,660,672,h,30,ng*h/mL,arith. Mean,4,ng*h/mL,SEM,AUC_tend,10.6,ng/mL,arith. Mean,1.4,ng/mL,SEM,Cmax,,,,,,,,"Initial PRA dose (week 0): 31,3 +/- 4,8, Cmax: 11,6 +/- 2"
443,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2116260/,20 mg pravastatin twice daily,Pravastatin,660,672,h,75.4,ng*h/mL,arith. Mean,11.4,ng*h/mL,SEM,AUC_tend,30.6,ng/mL,arith. Mean,7.3,ng/mL,SEM,Cmax,,,,,,,,"Initial PRA dose (week 0): 60,2 +/- 8, Cmax: 26,1 +/- 5,6"
444,Oo 1999,https://link.springer.com/article/10.2165/00044011-199917030-00006,Pravastatin + placebo,Pravastatin,120,132,h,55.6,µg*h/L,arith. Mean,23.5,µg*h/L,arith. SD,AUC_tend,28.8,µg/L,arith. Mean,15.4,µg/L,arith. SD,Cmax,845,L/h,arith. Mean,415,L/h,arith. SD,CL/F,
445,Keskitalo 2009,https://pubmed.ncbi.nlm.nih.gov/19694740/,ABCB1 c.1236T/T-c.2677T/T-c.3435T/T,Pravastatin,0,inf,h,47.8,ng*h/mL,estimated marginal mean,"32,6-70,2",ng*h/mL,95% CI,AUC_inf,22.1,ng/mL,estimated marginal mean,"15-32,6",ng/mL,95% CI,Cmax,,,,,,,,"AUC(0-t): 47,5 (32.4, 69.6)"
446,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,Group C/C,Pravastatin,0,5,h,,,,,,,,,,,,,,,,,,,,,,
447,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,Group T/C,Pravastatin,0,5,h,,,,,,,,,,,,,,,,,,,,,,
448,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,Group T/T,Pravastatin,0,5,h,,,,,,,,,,,,,,,,,,,,,,
449,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,European-Americans,Pravastatin,0,5,h,98.3,ng*h/mL,arith. Mean,60.7,ng*h/mL,arith. SD,AUC_tend,53.3,ng/mL,arith. Mean,33.3,ng/mL,arith. SD,Cmax,,,,,,,,
450,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,African-Americans,Pravastatin,0,5,h,69.5,ng*h/mL,arith. Mean,56.3,ng*h/mL,arith. SD,AUC_tend,37.4,ng/mL,arith. Mean,29.2,ng/mL,arith. SD,Cmax,,,,,,,,
451,Escobar 2005,https://pubmed.ncbi.nlm.nih.gov/24672127/,Mexican subjects,Pravastatin,0,inf,h,35.7,ng*h/mL,arith. Mean,19.7,ng*h/mL,arith. SD,AUC_inf,9.5,ng/mL,arith. Mean,"2,4",ng/mL,arith. SD,Cmax,,,,,,,,
452,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Male subjects test formulation,Pravastatin,0,inf,h,186.5,ng*h/mL,arith. Mean,96.14,ng*h/mL,arith. SD,AUC_inf,102.44,ng/mL,arith. Mean,56.06,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 335.73 +/- 163.98, Cmax: 183.4 +/- 92.34; AUC(last): 330.98 +/- 162.43"
453,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Male subjects reference formulation,Pravastatin,0,inf,h,192.27,ng*h/mL,arith. Mean,82.96,ng*h/mL,arith. SD,AUC_inf,102.49,ng/mL,arith. Mean,46.34,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 348.05 +/- 158.56, Cmax: 185.39 +/- 89.18; AUC(last): 342.94 +/- 158.66"
454,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Female subjects test formulation,Pravastatin,0,inf,h,274.26,ng*h/mL,arith. Mean,97.61,ng*h/mL,arith. SD,AUC_inf,155.43,ng/mL,arith. Mean,58.25,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 401.67 +/- 143.42, Cmax: 227.04 +/- 82.95; AUC(last): 398.33 +/- 144.94"
455,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Female subjects reference formulation,Pravastatin,0,inf,h,250.18,ng*h/mL,arith. Mean,66.66,ng*h/mL,arith. SD,AUC_inf,148.37,ng/mL,arith. Mean,50.74,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 365.30 +/- 90.55, Cmax: 217.61 +/- 75.44; AUC(last): 362.90 +/- 91.04"
456,Ogawa 2003,https://pubmed.ncbi.nlm.nih.gov/14551181/,Japanese subjects,Pravastatin,0,inf,h,36.04,ng*h/mL,arith. Mean,18.6,ng*h/mL,arith. SD,AUC_inf,14.04,ng/mL,arith. Mean,8.93,ng/mL,arith. SD,Cmax,,,,,,,,
1117,Mwinyi 2004,https://pubmed.ncbi.nlm.nih.gov/15116054/,Group 1 OATP-C *1a/*1a,Pravastatin,0,6,h,114.5,µg*h/L,arith. Mean,68.5,µg*h/L,arith. SD,AUC_tend,58.3,µg/L,arith. Mean,37.7,µg/L,arith. SD,Cmax,,,,,,,,
1118,Mwinyi 2004,https://pubmed.ncbi.nlm.nih.gov/15116054/,Group 3 OATP-C *1a/*5,Pravastatin,0,6,h,163,µg*h/L,arith. Mean,64.6,µg*h/L,arith. SD,AUC_tend,84.3,µg/L,arith. Mean,32.1,µg/L,arith. SD,Cmax,,,,,,,,
1119,Mwinyi 2004,https://pubmed.ncbi.nlm.nih.gov/15116054/,Group 2 OATP-C *1a/*1b; *1b/*1b,Pravastatin,0,6,h,74.8,µg*h/L,arith. Mean,35.6,µg*h/L,arith. SD,AUC_tend,36.7,µg/L,arith. Mean,21.4,µg/L,arith. SD,Cmax,,,,,,,,
1120,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17015053/,SLCO1B1 c.521CC,Pravastatin,0,inf,h,287.4,ng*h/mL,arith. Mean,102.9,ng*h/mL,arith. SD,AUC_inf,141.6,ng/mL,arith. Mean,46.8,ng/mL,arith. SD,Cmax,,,,,,,,
1121,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17015053/,SLCO1B1 c.521TC,Pravastatin,0,inf,h,164.8,ng*h/mL,arith. Mean,85.7,ng*h/mL,arith. SD,AUC_inf,73.8,ng/mL,arith. Mean,42.2,ng/mL,arith. SD,Cmax,,,,,,,,
1122,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17015053/,SLCO1B1 c.521TT,Pravastatin,0,inf,h,150.3,ng*h/mL,arith. Mean,78.1,ng*h/mL,arith. SD,AUC_inf,68.5,ng/mL,arith. Mean,38.9,ng/mL,arith. SD,Cmax,,,,,,,,
1123,Neuvonen 1998,https://pubmed.ncbi.nlm.nih.gov/9542477/,Pravastatin without Itraconzaole (placebo),Pravastatin,0,inf,h,88.6,ng*h/mL,arith. Mean,32.9,ng*h/mL,SEM,AUC_inf,36.9,ng/mL,arith. Mean,12.6,ng/mL,SEM,Cmax,,,,,,,,
1124,Neuvonen 1998,https://pubmed.ncbi.nlm.nih.gov/9542477/,Pravastatin with Itraconazole,Pravastatin,74,inf,h,152,ng*h/mL,arith. Mean,46.5,ng*h/mL,SEM,AUC_inf,66.4,ng/mL,arith. Mean,23.4,ng/mL,SEM,Cmax,,,,,,,,
1125,Kantola 2000,https://pubmed.ncbi.nlm.nih.gov/10952477/,Pravastatin without Fluconazole (placebo),Pravastatin,0,inf,h,109,ng*h/mL,arith. Mean,85.4,ng*h/mL,arith. SD,AUC_inf,49.5,ng/mL,arith. Mean,39.1,ng/mL,arith. SD,Cmax,,,,,,,,
1126,Kantola 2000,https://pubmed.ncbi.nlm.nih.gov/10952477/,Pravastatin with Fluconazole,Pravastatin,73,inf,h,148,ng*h/mL,arith. Mean,126,ng*h/mL,arith. SD,AUC_inf,66.1,ng/mL,arith. Mean,64.3,ng/mL,arith. SD,Cmax,,,,,,,,
1127,Aberg 2006,https://pubmed.ncbi.nlm.nih.gov/16514303/,Pravastatin without Nelfinivir (placebo),Pravastatin,48,72,h,86.5,ng*h/mL,median,,,,AUC_tend,27.9,ng/mL,median,,,,Cmax,,,,,,,,
1128,Maeda 2011,https://pubmed.ncbi.nlm.nih.gov/21832990/,Pravastatin alone (control),Pravastatin,0,8,h,5.97,pg*h/mL,arith. Mean,2.42,pg*h/mL,arith. SD,AUC_tend,,,,,,,,21.7,L/h,arith. Mean,5.1,L/h,arith. SD,CL/F,"AUC = AUC(0-t)/dose, area under the plasma concentration-time curve from time 0 to t hours normalized by dose in each phase; CL: Renal clearance in relation to plasma concentration"
1129,Maeda 2011,https://pubmed.ncbi.nlm.nih.gov/21832990/,Pravastatin with Itraconazole,Pravastatin,1,9,h,8.79,pg*h/mL,arith. Mean,5.79,pg*h/mL,arith. SD,AUC_tend,,,,,,,,20.7,L/h,arith. Mean,8.6,L/h,arith. SD,CLiv,"AUC = AUC(0-t)/dose, area under the plasma concentration-time curve from time 0 to t hours normalized by dose in each phase; CL: Renal clearance in relation to plasma concentration"
1130,Maeda 2011,https://pubmed.ncbi.nlm.nih.gov/21832990/,Pravastatin with Rifampicin,Pravastatin,0,8,h,27.7,pg*h/mL,arith. Mean,5.2,pg*h/mL,arith. SD,AUC_tend,,,,,,,,18.4,L/h,arith. Mean,1.7,L/h,arith. SD,CL/F,"AUC = AUC(0-t)/dose, area under the plasma concentration-time curve from time 0 to t hours normalized by dose in each phase; CL: Renal clearance in relation to plasma concentration"
1134,Pan 1991,https://pubmed.ncbi.nlm.nih.gov/1907839/,Pravastatin 20 mg,Pravastatin,0,24,h,90.2,ng*h/mL,arith. Mean,11,ng*h/mL,SEM,AUC_tend,38.4,ng/mL,arith. Mean,5.5,ng/mL,SEM,Cmax,,,,,,,,
1135,Keskitalo 2009,https://pubmed.ncbi.nlm.nih.gov/19694740/,ABCB1 c.1236C/C-c.2677G/G-c.3435C/C,Pravastatin,0,inf,h,51.7,ng*h/mL,geom. Mean,,,,AUC_inf,24,ng/mL,geom. Mean,,,,Cmax,,,,,,,,"AUC(0-t): 51.2 (34.9, 75.0); AUC(0-inf): 51.7 (35.2, 75.9); Cmax: (16.3, 35.3)"
1136,Igel 2006,https://pubmed.ncbi.nlm.nih.gov/16678544/,Control,Pravastatin,480,490,h,144.9,ng*h/mL,arith. Mean,48.2,ng*h/mL,arith. SD,AUC_tend,52.7,ng/mL,arith. Mean,22.1,ng/mL,arith. SD,Cmax,23.3,L/h,arith. Mean,9.8,L/h,arith. SD,,CL_R: renal clearance
1137,Igel 2006,https://pubmed.ncbi.nlm.nih.gov/16678544/,Variant,Pravastatin,480,490,h,305,ng*h/mL,arith. Mean,149.4,ng*h/mL,arith. SD,AUC_tend,174.5,ng/mL,arith. Mean,98.6,ng/mL,arith. SD,Cmax,25.9,L/h,arith. Mean,18,L/h,arith. SD,,CL_R: renal clearance
1138,Fukazawa 2003,https://pubmed.ncbi.nlm.nih.gov/15025743/,Water intake group,Pravastatin,0,inf,h,40,ng*h/mL,arith. Mean,,,,AUC_inf,13.3,ng/mL,arith. Mean,,,,Cmax,287,L/h,arith. Mean,,,,CL/F,"AUC(0-24): 37,2(25,6, 54); AUC(0-inf): 40(28,1, 57), Cmax: 13,3(8,2, 21,3), CL/F: 287(140, 434)"
1139,Fukazawa 2003,https://pubmed.ncbi.nlm.nih.gov/15025743/,GFJ intake group,Pravastatin,0,inf,h,39.9,ng*h/mL,arith. Mean,,,,AUC_inf,11.6,ng/mL,arith. Mean,,,,Cmax,264,L/h,arith. Mean,,,,CL/F,"AUC(0-24): 37,1(29,3, 46,8); AUC(0-inf): 39,9(31,4, 50,5), Cmax: 11,6(9,3, 14,5), CL/F: 264(199, 328)"
1140,Koitabashi 2006,https://pubmed.ncbi.nlm.nih.gov/16412477/,Control,Pravastatin,0,4,h,9.5,ng*h/mL,arith. Mean,1.6,ng*h/mL,SEM,AUC_tend,7.6,ng/mL,arith. Mean,1.7,ng/mL,SEM,Cmax,,,,,,,,
1141,Koitabashi 2006,https://pubmed.ncbi.nlm.nih.gov/16412477/,Orange Juice,Pravastatin,0,4,h,14.4,ng*h/mL,arith. Mean,2.1,ng*h/mL,SEM,AUC_tend,9.5,ng/mL,arith. Mean,1.4,ng/mL,SEM,Cmax,,,,,,,,
1142,Liu 2018,https://pubmed.ncbi.nlm.nih.gov/29786857/,Pravastatin alone,Pravastatin,0,inf,h,15.6,ng*h/mL,geom. Mean,62.1,,CV%,AUC_inf,6.1,ng/mL,geom. Mean,61.8,,CV%,Cmax,610,L/h,geo. Mean,62.1,,CV%,CL/F,"AUC(0-t): 15(63,3)"
1143,Ieiri 2014,https://pubmed.ncbi.nlm.nih.gov/23381882/,Control (without Ritonavir),Pravastatin,0,24,h,432,pg*h/mL,arith. Mean,278,pg*h/mL,arith. SD,AUC_tend,142,pg/mL,arith. Mean,108,pg/mL,arith. SD,Cmax,265,L/h,arith. Mean,105,L/h,arith. SD,CL/F,
1145,Azie 1998,https://pubmed.ncbi.nlm.nih.gov/9797793/,Control (without Diltiazem),Pravastatin,0,inf,h,74,ng*min/mL,arith. Mean,58,ng*min/mL,arith. SD,AUC_inf,33,ng/mL,arith. Mean,24,ng/mL,arith. SD,Cmax,,,,,,,,"Table II: (Control): AUC: 2,128-7,330; Cmax: 3-10"
1146,Azie 1998,https://pubmed.ncbi.nlm.nih.gov/9797793/,with Diltiazem,Pravastatin,325,inf,h,76,ng*min/mL,arith. Mean,58,ng*min/mL,arith. SD,AUC_inf,43,ng/mL,arith. Mean,34,ng/mL,arith. SD,Cmax,,,,,,,,"Table II: (Diltiazem): AUC: 6,360-29,834; Cmax: 14-43"
1147,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, Control",Pravastatin,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1148,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, Control",Pravastatin,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1149,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 2 mg Rifampicin",Pravastatin,17,inf,h,,,,,,,,,,,,,,,,,,,,,,
1150,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 10 mg Rifampicin",Pravastatin,18,inf,h,,,,,,,,,,,,,,,,,,,,,,
1151,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 75 mg Rifampicin",Pravastatin,19,inf,h,,,,,,,,,,,,,,,,,,,,,,
1152,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 600 mg Rifampicin",Pravastatin,20,inf,h,,,,,,,,,,,,,,,,,,,,,,
1165,Sugimoto 2001,https://pubmed.ncbi.nlm.nih.gov/11753267/,Control (without St John's Wort),Pravastatin,0,24,h,109.4,ng*h/mL,arith. Mean,17.4,ng*h/mL,SE,AUC_tend,36.5,ng/mL,arith. Mean,5.7,ng/mL,SE,Cmax,,,,,,,,
1166,Kovarik 2002,https://pubmed.ncbi.nlm.nih.gov/11831546/,Control (without Everolimus),Pravastatin,0,inf,h,72,ng*h/mL,arith. Mean,40,ng*h/mL,arith. SD,AUC_inf,24.4,ng/mL,arith. Mean,19.4,ng/mL,arith. SD,Cmax,,,,,,,,
1167,Wu 2012,https://pubmed.ncbi.nlm.nih.gov/22114872/,Control (with Placebo),Pravastatin,0,10,h,354.6,ng*h/mL,arith. Mean,89.6,ng*h/mL,arith. SD,AUC_tend,123.2,ng/mL,arith. Mean,48.3,ng/mL,arith. SD,Cmax,119.5,L/h,geo. Mean,29.2,L/h,arith. SD,CL/F,
1168,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Verapamil),Pravastatin,0,24,h,76,ng*h/mL,geom. Mean,,,,AUC_tend,32,ng/mL,geom. Mean,,,,Cmax,,,,,,,,
1169,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Pravastatin with Verapamil,Pravastatin,72,96,h,100,ng*h/mL,geom. Mean,,,,AUC_tend,45,ng/mL,geom. Mean,,,,Cmax,,,,,,,,
1170,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Mibefradil),Pravastatin,144,154,h,60,ng*h/mL,arith. Mean,,,,AUC_tend,19,ng/mL,median,,,,,,,,,,,,
1171,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Clarithromycin),Pravastatin,144,154,h,54,ng*h/mL,geom. Mean,,,,AUC_tend,18,ng/mL,geom. Mean,,,,,,,,,,,,
1172,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Pravastatin with Clarithromycin,Pravastatin,168,181.5,h,114,ng*h/mL,geom. Mean,,,,AUC_tend,41,ng/mL,geom. Mean,,,,,,,,,,,,
1173,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Control (without Cyclosporin),Pravastatin,0,12,h,162,ng*h/mL,arith. Mean,129,ng*h/mL,arith. SD,AUC_tend,106,ng/mL,arith. Mean,100,ng/mL,arith. SD,Cmax,5.17,L/h/kg,arith. Mean,4.44,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 61.8 +/- 64.6; Cmax: 39.2 +/- 53.1
1174,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Pravastatin with Cyclosporin,Pravastatin,11,23,h,554,ng*h/mL,arith. Mean,380,ng*h/mL,arith. SD,AUC_tend,339,ng/mL,arith. Mean,266,ng/mL,arith. SD,Cmax,1.34,L/h/kg,arith. Mean,0.85,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 169 +/- 126; Cmax: 122 +/- 112
1175,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TT (without Cyclosporin),Pravastatin,0,12,h,154,ng*h/mL,arith. Mean,153,ng*h/mL,arith. SD,AUC_tend,98.8,ng/mL,arith. Mean,114,ng/mL,arith. SD,Cmax,6.12,L/h/kg,arith. Mean,5.34,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 43.3 +/- 14.7; Cmax: 22 +/- 9.3
1176,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TC (without Cyclosporin),Pravastatin,0,12,h,124,ng*h/mL,arith. Mean,58,ng*h/mL,arith. SD,AUC_tend,79.1,ng/mL,arith. Mean,50,ng/mL,arith. SD,Cmax,5.42,L/h/kg,arith. Mean,3.77,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 48 +/- 23.2; Cmax: 31.4 +/- 19
1177,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype CC (without Cyclosporin),Pravastatin,0,12,h,290,ng*h/mL,arith. Mean,148,ng*h/mL,arith. SD,AUC_tend,201,ng/mL,arith. Mean,136,ng/mL,arith. SD,Cmax,1.65,L/h/kg,arith. Mean,0.68,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 154 +/- 147; Cmax: 111 +/- 126
1178,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TT (with Cyclosporin),Pravastatin,11,23,h,572,ng*h/mL,arith. Mean,488,ng*h/mL,arith. SD,AUC_tend,364,ng/mL,arith. Mean,360,ng/mL,arith. SD,Cmax,1.47,L/h/kg,arith. Mean,0.98,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 187 +/- 175; Cmax: 136 +/- 158
1179,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TC (with Cyclosporin),Pravastatin,11,23,h,436,ng*h/mL,arith. Mean,198,ng*h/mL,arith. SD,AUC_tend,266,ng/mL,arith. Mean,153,ng/mL,arith. SD,Cmax,1.45,L/h/kg,arith. Mean,0.74,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 131 +/- 57.9; Cmax: 99.5 +/- 52.3
1180,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype CC (with Cyclosporin),Pravastatin,11,23,h,818,ng*h/mL,arith. Mean,351,ng*h/mL,arith. SD,AUC_tend,458,ng/mL,arith. Mean,166,ng/mL,arith. SD,Cmax,0.64,L/h/kg,arith. Mean,0.48,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 212 +/- 89.8; Cmax: 143 +/- 87.6
1181,Becquemont 1999,https://pubmed.ncbi.nlm.nih.gov/10226769/,Control Day 1 (without Mibefradil),Pravastatin,0,inf,h,170,ng*h/mL,geom. Mean,,,,AUC_inf,91,ng/mL,geom. Mean,,,,Cmax,,,,,,,,AUC(0-inf): 170(117-395); Cmax: 91(72-200)
1182,Becquemont 2007,https://pubmed.ncbi.nlm.nih.gov/17301736/,Control (without Amiodarone),Pravastatin,0,24,h,137.8,ng*h/mL,arith. Mean,58.8,ng*h/mL,arith. SD,AUC_tend,67.1,ng/mL,arith. Mean,37.7,ng/mL,arith. SD,Cmax,,,,,,,,
1183,Becquemont 2007,https://pubmed.ncbi.nlm.nih.gov/17301736/,with Amiodarone,Pravastatin,72,96,h,124,ng*h/mL,arith. Mean,59.3,ng*h/mL,arith. SD,AUC_tend,51.5,ng/mL,arith. Mean,28.8,ng/mL,arith. SD,Cmax,,,,,,,,
1184,Mazzu 2000,https://pubmed.ncbi.nlm.nih.gov/11061579/,Pravastatin alone,Pravastatin,0,inf,h,50.6,µg*h/L,geom. Mean,60.6,%,%CV,AUC_inf,20.9,µg/L,geom. Mean,73.7,µg/L,% CV,Cmax,,,,,,,,"AUC(0-tn)=48,4 (59,5) : Geo mean (%CV)"
1185,Mazzu 2000,https://pubmed.ncbi.nlm.nih.gov/11061579/,Pravastatin + Itraconazole,Pravastatin,100,inf,h,75.2,µg*h/L,geom. Mean,60.6,%,%CV,AUC_inf,25.9,µg/L,geom. Mean,78,µg/L,% CV,Cmax,,,,,,,,"AUC(0-tn)=75,4 (61,6) : Geo mean (%CV)"
1186,Lilja 1999,https://pubmed.ncbi.nlm.nih.gov/10460065/,Water,Pravastatin,0,inf,h,112.3,ng*h/mL,arith. Mean,66.3,ng*h/mL,arith. SD,AUC_inf,45.3,ng/mL,arith. Mean,28,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-24): 111,7 +/- 68,1"
1187,Lilja 1999,https://pubmed.ncbi.nlm.nih.gov/10460065/,GFJ,Pravastatin,0,inf,h,103,ng*h/mL,arith. Mean,48.4,ng*h/mL,arith. SD,AUC_inf,42.6,ng/mL,arith. Mean,25.3,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-24): 102,8 +/- 49,6(49-193)"
1188,Pan 2000,https://pubmed.ncbi.nlm.nih.gov/10709162/,Pravastatin (without Fenofibrate),Pravastatin,0,inf,h,71.2,ng*h/mL,arith. mean,36.5,ng*h/mL,arith. SD,AUC_inf,35.2,ng/mL,arith. Mean,20.67,ng/mL,arith. SD,Cmax,800,L/h,arith. mean,611.6,L/h,arith. SD,CL/F,
1189,Gustavson 2005,https://pubmed.ncbi.nlm.nih.gov/16027406/,Pravastatin (without Fenofibrate),Pravastatin,96,120,h,61,ng*h/mL,arith. Mean,33.7,ng*h/mL,arith. SD,AUC_tend,24.8,ng/mL,arith. Mean,16.7,ng/mL,arith. SD,Cmax,901.1,L/h,arith. Mean,533.4,L/h,arith. SD,CL/F,
1190,Aquilante 2012,https://pubmed.ncbi.nlm.nih.gov/22174437/,Pravastatin alone Day 4 Group 1,Pravastatin,72,96,h,63,ng*h/mL,arith. Mean,25,ng*h/mL,arith. SD,AUC_tau,28,ng/mL,arith. Mean,15,ng/mL,arith. SD,Cmax,9.1,L/h/kg,arith. Mean,3.5,L/h/kg,arith. SD,CL/F,(n=28); weight-adjusted CL/F
1191,Aquilante 2012,https://pubmed.ncbi.nlm.nih.gov/22174437/,Pravastatin alone Day 4 Group 2,Pravastatin,72,96,h,87,ng*h/mL,arith. Mean,36,ng*h/mL,arith. SD,AUC_tau,33,ng/mL,arith. Mean,17,ng/mL,arith. SD,Cmax,9.9,L/h/kg,arith. Mean,10.3,L/h/kg,arith. SD,CL/F,(n=28); weight-adjusted CL/F
1192,Aquilante 2012,https://pubmed.ncbi.nlm.nih.gov/22174437/,Pravastatin alone Day 4 Group 3,Pravastatin,72,96,h,123,ng*h/mL,arith. Mean,80,ng*h/mL,arith. SD,AUC_tau,46,ng/mL,arith. Mean,39,ng/mL,arith. SD,Cmax,7.3,L/h/kg,arith. Mean,5,L/h/kg,arith. SD,CL/F,(n=28); weight-adjusted CL/F
1193,Van Luin 2010,https://pubmed.ncbi.nlm.nih.gov/20395869/,Pravastatin (without Raltegravir),Pravastatin,72,96,h,157,µg*h/L,geom. Mean,,,,AUC_tend,58.4,µg/L,geom. Mean,,,,Cmax,255,L/h,geo. Mean,,,,CL/F,"95% CI for Geom.Mean: AUC(0-24): 127-194, Cmax: 45.1-75.6, CL/F: 206-315"
1195,Derks 2010,https://pubmed.ncbi.nlm.nih.gov/20489031/,Pravastatin (without Dalcetrapib),Pravastatin,168,192,h,67.9,ng*h/mL,arith. Mean,55.9,ng*h/mL,arith. SD,AUC_tend,27.5,ng/mL,arith. Mean,23.9,ng/mL,arith. SD,Cmax,,,,,,,,
1196,Park 2002,https://pubmed.ncbi.nlm.nih.gov/12395976/,healthy individuals,Pravastatin,0,inf,h,172,ng*h/mL,arith. Mean,128.7,ng*h/mL,arith. SD,AUC_inf,82.3,ng/mL,arith. Mean,64.1,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax: Median = 68,5, Range = 1.0-2.5; AUC(0-inf): Median  =126.0, Range = 54.0-428.0); AUC (0-24): Mean +/- SD = 157.5 +/- 121.9, Median = 119.2, Range = 49.4-388.7"
1197,Kyrklund 2003,https://pubmed.ncbi.nlm.nih.gov/12811363/,with Placebo,Pravastatin,0,inf,h,139,ng*h/mL,arith. mean,67.6,ng*h/mL,arith. SD,AUC_inf,66.3,ng/mL,arith. Mean,43,ng/mL,arith. SD,Cmax,25,L/h,arith. mean,6.3,L/h,arith. SD,CL/F,"AUC(0-24) =138,7 ±  67,6 (Arith mean± SD) (ng*h/ml); CL = CL_renal(0-24)"
1198,Kyrklund 2003,https://pubmed.ncbi.nlm.nih.gov/12811363/,with Gemfibrozil,Pravastatin,49,inf,h,280.6,ng*h/mL,arith. mean,190.1,ng*h/mL,arith. SD,AUC_inf,120,ng/mL,arith. Mean,89.3,ng/mL,arith. SD,Cmax,14.3,L/h,arith. mean,5.6,L/h,arith. SD,CL/F,"AUC(0-24) =279,8 ±  189,5 (Arith mean± SD) (ng*h/ml); CL = CL_renal(0-24)"
1199,Kyrklund 2004,https://pubmed.ncbi.nlm.nih.gov/14748817/,with Placebo,Pravastatin,0,inf,h,142,ng*h/mL,arith. mean,99.6,ng*h/mL,arith. SD,AUC_inf,65.1,ng/mL,arith. Mean,46,ng/mL,arith. SD,Cmax,24.2,L/h,arith. mean,3.5,L/h,arith. SD,CL/F,"Parameter CL is renal clearance from 0-12 h; AUC(0-12) =141 ±  99,6 (Arith mean± SD) (ng*h/ml)"
1200,Kyrklund 2004,https://pubmed.ncbi.nlm.nih.gov/14748817/,with Rifampicin (MD 600 mg),Pravastatin,113,inf,h,98.1,ng*h/mL,arith. mean,79.8,ng*h/mL,arith. SD,AUC_inf,51.3,ng/mL,arith. Mean,44.7,ng/mL,arith. SD,Cmax,26.2,L/h,arith. mean,3.3,L/h,arith. SD,CL/F,"Parameter CL is renal clearance from 0-12 h; AUC(0-12) =97,5 ±  79,5 (Arith mean± SD) (ng*h/ml)"
1201,Deng 2009,https://pubmed.ncbi.nlm.nih.gov/19695392/,with Placebo,Pravastatin,0,inf,h,275.1,ng*h/mL,arith. Mean,58.5,ng*h/mL,arith. SD,AUC_inf,115.8,ng/mL,arith. Mean,77.5,ng/mL,arith. SD,Cmax,1.3,L/h/kg,arith. Mean,0.58,L/h/kg,arith. SD,CL/F,"AUC(0-12): 259(133,4)"
1202,Deng 2009,https://pubmed.ncbi.nlm.nih.gov/19695392/,with Rifampicin (SD 600 mg),Pravastatin,0,inf,h,623.3,ng*h/mL,arith. Mean,248.8,ng*h/mL,arith. SD,AUC_inf,315.7,ng/mL,arith. Mean,227.2,ng/mL,arith. SD,Cmax,0.52,L/h/kg,arith. Mean,0.18,L/h/kg,arith. SD,CL/F,"AUC(0-12): 604,8(73,3)"
1203,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,intravenous 9.9 mg,Pravastatin,0,inf,h,171.2,ng*h/mL,arith. mean,28.7,ng*h/mL,arith. SD,AUC_inf,,,,,,,,13.5,mL/min/kg,arith. Mean,2.4,mL/min/kg,arith. SD,CLiv,"IV dose: Renal clearance: 6,3 +/- 1,0 (mL/min/kg)"
1204,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,oral 19.2 mg,Pravastatin,0,inf,h,66.2,ng*h/mL,arith. mean,32.1,ng*h/mL,arith. SD,AUC_inf,27.4,ng/mL,arith. Mean,10.7,ng/mL,arith. SD,Cmax,,,,,,,,
1205,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,intravenous 9.9 mg (urine),Pravastatin,0,48,h,,,,,,,,,,,,,,,,,,,,,,47% excreted in Urine after 48h
1206,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,oral 19.2 mg (urine),Pravastatin,0,48,h,,,,,,,,,,,,,,,,,,,,,,8% excreted in Urine after 48h
1348,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, Control",Midazolam,inf,inf,h,,,,,,,,,,,,,,,,,,,,,,
1349,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, Control",Midazolam,inf,inf,h,,,,,,,,,,,,,,,,,,,,,,
1350,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 2 mg Rifampicin",Midazolam,66,inf,h,,,,,,,,,,,,,,,,,,,,,,
1351,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 10 mg Rifampicin",Midazolam,67,inf,h,,,,,,,,,,,,,,,,,,,,,,
1352,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 75 mg Rifampicin",Midazolam,68,inf,h,,,,,,,,,,,,,,,,,,,,,,
1353,Lutz 2018a,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 600 mg Rifampicin",Midazolam,69,inf,h,,,,,,,,,,,,,,,,,,,,,,
1361,Chattopadhyay 2018,https://pubmed.ncbi.nlm.nih.gov/30171692/,Control (without Rifampicin),Midazolam,0,inf,h,9750,ng*h/mL,geo. Mean,25,%,%CV,AUC_inf,3470,ng/mL,geo. mean,31.9,%,%CV,Cmax,103,L/h,geo. mean,25,%,%CV,CL/F,
1362,Chattopadhyay 2018,https://pubmed.ncbi.nlm.nih.gov/30171692/,with Perpetrator (Rifampicin),Midazolam,168,inf,h,1420,ng*h/mL,geo. Mean,36.8,%,%CV,AUC_inf,554,ng/mL,geo. mean,43.7,%,%CV,Cmax,702,L/h,geo. mean,36.8,%,%CV,CL/F,
1363,Chattopadhyay 2018,https://pubmed.ncbi.nlm.nih.gov/30171692/,Rifampicin,Rifampicin,,,,,,,,,,,,,,,,,,,,,,,,,
1364,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Fluconazole i.v.,Fluconazole,0,18,h,118,mg*h/L,arith. Mean,7.5,mg*h/L,SEM,AUC_tend,8.4,mg/L,arith. Mean,0.6,mg/L,SEM,Cmax,,,,,,,,
1365,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Fluconazole oral,Fluconazole,0,18,h,121,mg*h/L,arith. Mean,9.5,mg*h/L,SEM,AUC_tend,8.2,mg/L,arith. Mean,0.6,mg/L,SEM,Cmax,,,,,,,,
1366,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole i.v. ,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1367,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole SD 50 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1368,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole MD 200 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1369,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole MD 300 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1370,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole MD 400 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1371,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Fluconazole i.v ,Fluconazole,0,11,h,75,µg*h/mL,arith. Mean,19,µg*h/mL,arith. SD,AUC_tend,8.9,µg/mL,arith. Mean,2.5,µg/mL,arith. SD,Cmax,,,,,,,,
1372,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Fluconazole oral ,Fluconazole,0,11,h,66.8,µg*h/mL,arith. Mean,15.6,µg*h/mL,arith. SD,AUC_tend,7.7,µg/mL,arith. Mean,2,µg/mL,arith. SD,Cmax,,,,,,,,
1373,Ripa 1993,https://pubmed.ncbi.nlm.nih.gov/8444063/,Fluconazole i.v.,Fluconazole,0,inf,h,81.12,mg*h/L,arith. Mean,12.87,mg*h/L,arith. SD,AUC_inf,2.86,µg/mL,arith. Mean,0.51,µg/mL,arith. SD,Cmax,,,,,,,,
1374,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 25 mg,Fluconazole,0,inf,h,19.2,µg*h/mL,arith. Mean,1.3,µg*h/mL,SE,AUC_inf,0.76,µg/mL,arith. Mean,0.08,µg/mL,arith. SD,Cmax,,,,,,,,
1375,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 50 mg,Fluconazole,0,inf,h,39,µg*h/mL,arith. Mean,3.1,µg*h/mL,SE,AUC_inf,1.33,µg/mL,arith. Mean,0.1,µg/mL,arith. SD,Cmax,,,,,,,,
1376,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 25 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1377,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 50 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1378,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 25 mg,Fluconazole,0,inf,h,20.3,µg*h/mL,arith. Mean,0.6,µg*h/mL,SE,AUC_inf,0.53,µg/mL,arith. Mean,0.03,µg/mL,SE,Cmax,,,,,,,,
1379,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 50 mg,Fluconazole,0,inf,h,34.7,µg*h/mL,arith. Mean,1.8,µg*h/mL,SE,AUC_inf,0.92,µg/mL,arith. Mean,0.03,µg/mL,SE,Cmax,,,,,,,,
1380,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 100 mg,Fluconazole,0,inf,h,86.9,µg*h/mL,arith. Mean,4.5,µg*h/mL,SE,AUC_inf,1.88,µg/mL,arith. Mean,0.08,µg/mL,SE,Cmax,,,,,,,,
1381,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 25 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1382,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 50 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1383,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 100 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1384,Sobue 2004,https://pubmed.ncbi.nlm.nih.gov/15206988/,Fluconazole i.v.,Fluconazole,312,336,h,608,µg*h/mL,arith. Mean,115.4,µg*h/mL,arith. SD,AUC_tau,33.6,µg/mL,arith. Mean,6.11,µg/mL,arith. SD,Cmax,23,mL/min,arith. Mean,4,mL/min,arith. SD,CLiv,
1385,Yeates 1994,https://pubmed.ncbi.nlm.nih.gov/7946940/,Fluconazole i.v. healthy,Fluconazole,0,inf,h,,,,,,,,2.8,µg/mL,arith. Mean,0.4,µg/mL,arith. SD,Cmax,,,,,,,,
1386,Brammer 1991,https://pubmed.ncbi.nlm.nih.gov/1680653/,Fluconazole 50 mg oral,Fluconazole,0,inf,h,,,,,,,,1.13,µg/mL,arith. Mean,0.19,µg/mL,arith. SD,Cmax,,,,,,,,
1387,Thorpe 1990,https://pubmed.ncbi.nlm.nih.gov/2291673/,Fluconazole oral without antacida,Fluconazole,0,inf,h,93,µg*h/mL,arith. Mean,13.82,µg*h/mL,arith. SD,AUC_inf,1.7,µg/mL,arith. Mean,0.26,µg/mL,arith. SD,Cmax,,,,,,,,
1388,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Fluconazole 50 mg oral,Fluconazole,72,96,h,,,,,,,,2.2,mg/L,arith. Mean,0.1,mg/L,SEM,Cmax,,,,,,,,
1389,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Fluconazole 100 mg oral,Fluconazole,72,96,h,,,,,,,,4.4,mg/L,arith. Mean,0.3,mg/L,SEM,Cmax,,,,,,,,
1390,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Fluconazole 200 mg oral,Fluconazole,72,96,h,,,,,,,,10.6,mg/L,arith. Mean,0.4,mg/L,SEM,Cmax,,,,,,,,
1391,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Midazolam placebo,Midazolam,1,18,h,112,ng*h/mL,arith. Mean,15.6,ng*h/mL,arith. SD,AUC_tend,37.4,ng/mL,arith. Mean,3.9,ng/mL,arith. SD,Cmax,,,,,,,,
1392,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Midazolam with perpetrator fluconazole i.v,Midazolam,1,18,h,345,ng*h/mL,arith. Mean,30.2,ng*h/mL,arith. SD,AUC_tend,66.8,ng/mL,arith. Mean,8,ng/mL,arith. SD,Cmax,,,,,,,,
1393,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Midazolam with perpetrator fluconazole oral,Midazolam,1,18,h,382,ng*h/mL,arith. Mean,35.4,ng*h/mL,arith. SD,AUC_tend,85.9,ng/mL,arith. Mean,9.8,ng/mL,arith. SD,Cmax,,,,,,,,
1394,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Triazolam with perpetrator fluconazole 50mg ,Triazolam,1,19,h,14.6,ng*h/mL,arith. Mean,1.6,ng*h/mL,SEM,AUC_tend,2.2,ng/mL,arith. Mean,0.3,ng/mL,SEM,Cmax,,,,,,,,
1395,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Triazolam with perpetrator fluconazole 100mg ,Triazolam,1,19,h,18.3,ng*h/mL,arith. Mean,1.4,ng*h/mL,SEM,AUC_tend,2.1,ng/mL,arith. Mean,0.1,ng/mL,SEM,Cmax,,,,,,,,
1396,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Triazolam with perpetrator fluconazole 200mg ,Triazolam,1,19,h,33.6,ng*h/mL,arith. Mean,4,ng*h/mL,SEM,AUC_tend,3.5,ng/mL,arith. Mean,0.4,ng/mL,SEM,Cmax,,,,,,,,
1397,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Alfentanil placebo,Alfentanil,1,11,h,117.8,ng*h/mL,arith. Mean,41.1,ng*h/mL,arith. SD,AUC_tend,65.9,ng/mL,arith. Mean,,,,,,,,,,,,
1398,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Alfentanil with perpetrator fluconazole i.v.,Alfentanil,1,11,h,243.8,ng*h/mL,arith. Mean,49.5,ng*h/mL,arith. SD,AUC_tend,79.1,ng/mL,arith. Mean,,,,,,,,,,,,
1399,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Alfentanil with perpetrator fluconazole po,Alfentanil,1,11,h,231.5,ng*h/mL,arith. Mean,62.2,ng*h/mL,arith. SD,AUC_tend,68.4,ng/mL,arith. Mean,,,,,,,,,,,,
5082,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,mean,Amikacin,0,72,h,,,,,,,,,,,,,,,0.123,L/h/kg,Arith. Mean,52,%,geoSD,CLiv,Table 2
5083,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID1,Amikacin,0,72,h,,,,,,,,,,,,,,,0.053,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5084,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID2,Amikacin,0,72,h,,,,,,,,,,,,,,,0.073,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5085,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID3,Amikacin,0,72,h,,,,,,,,,,,,,,,0.095,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5086,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID4,Amikacin,0,72,h,,,,,,,,,,,,,,,0.106,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5087,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID5,Amikacin,0,72,h,,,,,,,,,,,,,,,0.118,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5088,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID6,Amikacin,0,72,h,,,,,,,,,,,,,,,0.12,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5089,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID7,Amikacin,0,72,h,,,,,,,,,,,,,,,0.127,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5090,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID8,Amikacin,0,72,h,,,,,,,,,,,,,,,0.15,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5091,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID9,Amikacin,0,72,h,,,,,,,,,,,,,,,0.181,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5092,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID10,Amikacin,0,72,h,,,,,,,,,,,,,,,0.19,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5093,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID11,Amikacin,0,72,h,,,,,,,,,,,,,,,0.196,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5094,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID12,Amikacin,0,72,h,,,,,,,,,,,,,,,0.177,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5095,Vogelstein,https://www.ncbi.nlm.nih.gov/pubmed/874697,mean,Amikacin,0,225,min,,,,,,,,,,,,,,,2.49,mL/min/kg,arith. Mean,0.75,mL/min/kg,arith. SD,CLiv,Table 1
5096,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID1,Amikacin,0,225,min,,,,,,,,,,,,,,,1.74,mL/min/kg,individual,,,,CLiv,Table 1
5097,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID2,Amikacin,0,225,min,,,,,,,,,,,,,,,1.44,mL/min/kg,individual,,,,CLiv,Table 1
5098,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID3,Amikacin,0,225,min,,,,,,,,,,,,,,,2.56,mL/min/kg,individual,,,,CLiv,Table 1
5099,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID4,Amikacin,0,225,min,,,,,,,,,,,,,,,1.35,mL/min/kg,individual,,,,CLiv,Table 1
5100,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID5,Amikacin,0,225,min,,,,,,,,,,,,,,,2.64,mL/min/kg,individual,,,,CLiv,Table 1
5101,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID6,Amikacin,0,225,min,,,,,,,,,,,,,,,2.19,mL/min/kg,individual,,,,CLiv,Table 1
5102,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID7,Amikacin,0,225,min,,,,,,,,,,,,,,,4.22,mL/min/kg,individual,,,,CLiv,Table 1
5103,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID8,Amikacin,0,225,min,,,,,,,,,,,,,,,2.63,mL/min/kg,individual,,,,CLiv,Table 1
5104,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID9,Amikacin,0,225,min,,,,,,,,,,,,,,,4.26,mL/min/kg,individual,,,,CLiv,Table 1
5105,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID10,Amikacin,0,225,min,,,,,,,,,,,,,,,2.3,mL/min/kg,individual,,,,CLiv,Table 1
5106,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID11,Amikacin,0,225,min,,,,,,,,,,,,,,,1.91,mL/min/kg,individual,,,,CLiv,Table 1
5107,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID12,Amikacin,0,225,min,,,,,,,,,,,,,,,2.3,mL/min/kg,individual,,,,CLiv,Table 1
5108,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID13,Amikacin,0,225,min,,,,,,,,,,,,,,,2.23,mL/min/kg,individual,,,,CLiv,Table 1
5109,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID14,Amikacin,0,225,min,,,,,,,,,,,,,,,2.58,mL/min/kg,individual,,,,CLiv,Table 1
5110,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID15,Amikacin,0,225,min,,,,,,,,,,,,,,,2.86,mL/min/kg,individual,,,,CLiv,Table 1
5111,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID16,Amikacin,0,225,min,,,,,,,,,,,,,,,2.88,mL/min/kg,individual,,,,CLiv,Table 1
5112,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID17,Amikacin,0,225,min,,,,,,,,,,,,,,,3.31,mL/min/kg,individual,,,,CLiv,Table 1
5113,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID18,Amikacin,0,225,min,,,,,,,,,,,,,,,1.88,mL/min/kg,individual,,,,CLiv,Table 1
5114,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID19,Amikacin,0,225,min,,,,,,,,,,,,,,,2.06,mL/min/kg,individual,,,,CLiv,Table 1
5115,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID20,Amikacin,0,225,min,,,,,,,,,,,,,,,2.47,mL/min/kg,individual,,,,CLiv,Table 1
5116,Belfayol 1996,https://www.ncbi.nlm.nih.gov/pubmed/11866842,mean,Amikacin,0,24,h,,,,,,,,,,,,,,,2.395744681,mL/min/kg,arith. Mean,1.438297872,mL/min/kg,arith. SD,CLiv,Table 1
5399,Walker 1979,https://www.ncbi.nlm.nih.gov/pubmed/762009,Volunteer 9,Amikacin,0,8,h,,,,,,,,,,,,,,,90.1,mL/min,Individual,,,,CLiv,
5400,Walker 1979,https://www.ncbi.nlm.nih.gov/pubmed/762009,population,Amikacin,0,8,h,,,,,,,,,,,,,,,84.6,mL/min,Arith.mean,18,mL/min,arith. SD,CLiv,
5417,Walker 1979,https://www.ncbi.nlm.nih.gov/pubmed/762009,Volunteer 6,Amikacin,0,8,h,,,,,,,,,,,,,,,66,mL/min,Individual,,,,CLiv,
5117,Boekh 1988,https://www.ncbi.nlm.nih.gov/pubmed/3279907,mean 0.5g,vancomycin,0,720,min,,,,,,,,,,,,,,,94.5,mL/min,arith. Mean,15.9,mL/min,arith. SD,CLiv,Table 1
5118,Boekh 1988,https://www.ncbi.nlm.nih.gov/pubmed/3279907,mean 1g,vancomycin,0,720,min,,,,,,,,,,,,,,,96.5,mL/min,arith. Mean,18.1,mL/min,arith. SD,CLiv,Table 1
5119,Healy 1987,https://www.ncbi.nlm.nih.gov/pubmed/3579256,mean 0.5g,vancomycin,0,61.00335,h,,,,,,,,,,,,,,,84.8,mL/min,arith. Mean,11.5,mL/min/1.73m2,arith. SD,CLiv,At steady state (Table 1)
5120,Healy 1987,https://www.ncbi.nlm.nih.gov/pubmed/3579256,mean 1g,vancomycin,0,61.28713,h,,,,,,,,,,,,,,,86.1,mL/min,arith. Mean,8.9,mL/min/1.73m2,arith. SD,CLiv,At steady state (Table 2)
5121,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 1,vancomycin,0,6.5,h,,,,,,,,,,,,,,,1.18619495,mL/min/kg,arith. Mean,,,,CLiv,
5122,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 2,vancomycin,0,7,h,,,,,,,,,,,,,,,1.651527663,mL/min/kg,arith. Mean,,,,CLiv,
5123,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 3,vancomycin,0,7,h,,,,,,,,,,,,,,,2.701200533,mL/min/kg,arith. Mean,,,,CLiv,
5124,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 4,vancomycin,0,7,h,,,,,,,,,,,,,,,3.951146746,mL/min/kg,arith. Mean,,,,CLiv,
5125,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 5,vancomycin,0,7,h,,,,,,,,,,,,,,,2.953179191,mL/min/kg,arith. Mean,,,,CLiv,
5126,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 6,vancomycin,0,8,h,,,,,,,,,,,,,,,2.784958109,mL/min/kg,arith. Mean,,,,CLiv,
5151,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I1,Alfentanil,0,45,min,21.1,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5152,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I2,Alfentanil,0,45,min,14,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5153,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I3,Alfentanil,0,45,min,19.8,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5154,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I4,Alfentanil,0,45,min,18.5,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5155,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I5,Alfentanil,0,45,min,15.9,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5157,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C1,Alfentanil,0,45,min,12.4,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5158,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C2,Alfentanil,0,45,min,24.3,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5159,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C3,Alfentanil,0,45,min,11.3,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5160,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C4,Alfentanil,0,45,min,18.6,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5161,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C5,Alfentanil,0,45,min,20.7,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5162,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C6,Alfentanil,0,45,min,22.7,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5163,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID1,Alfentanil,0,360,min,0.005882353,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.4,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5164,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID2,Alfentanil,0,360,min,0.003389831,mg*min/mL,individual,,,,AUC_tau,,,,,,,,5.9,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5165,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID3,Alfentanil,0,360,min,0.002409639,mg*min/mL,individual,,,,AUC_tau,,,,,,,,8.3,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5166,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID4,Alfentanil,0,360,min,0.004347826,mg*min/mL,individual,,,,AUC_tau,,,,,,,,4.6,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5167,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603 ,ID5,Alfentanil,0,360,min,0.005405405,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.7,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5168,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID6,Alfentanil,0,360,min,0.004166667,mg*min/mL,individual,,,,AUC_tau,,,,,,,,4.8,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5169,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID7,Alfentanil,0,360,min,0.004545455,mg*min/mL,individual,,,,AUC_tau,,,,,,,,4.4,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5170,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID8,Alfentanil,0,360,min,0.007407407,mg*min/mL,individual,,,,AUC_tau,,,,,,,,2.7,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5171,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,mean child,Alfentanil,0,360,min,0.004255319,mg*min/mL,arith. Mean,,,,AUC_tau,,,,,,,,4.7,mL/min/kg,arith. Mean,0.6,mL/min/kg,arith. SD,CLiv,AUCinf imputed based on reported Dose/AUC
5172,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID9,Alfentanil,0,360,min,0.002777778,mg*min/mL,individual,,,,AUC_tau,,,,,,,,7.2,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5173,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID10,Alfentanil,0,360,min,0.005128205,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.9,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5174,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID11,Alfentanil,0,360,min,0.007407407,mg*min/mL,individual,,,,AUC_tau,,,,,,,,2.7,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5175,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID12,Alfentanil,0,360,min,0.005128205,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.9,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5176,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID13,Alfentanil,0,360,min,0.006060606,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.3,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5177,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,mean adult,Alfentanil,0,360,min,0.004761905,mg*min/mL,arith. Mean,,,,AUC_tau,,,,,,,,4.2,mL/min/kg,arith. Mean,1.7,mL/min/kg,arith. SD,CLiv,AUCinf imputed based on reported Dose/AUC
5178,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID1,Alfentanil,0,360,min,5543,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5179,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID2,Alfentanil,0,360,min,4609,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5180,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID3,Alfentanil,0,360,min,5753,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5181,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID4,Alfentanil,0,360,min,8086,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5182,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID5,Alfentanil,0,360,min,6923,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5183,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID6,Alfentanil,0,360,min,6736,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5184,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID7,Alfentanil,0,360,min,6089,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5185,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID8,Alfentanil,0,360,min,5702,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5186,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID9,Alfentanil,0,360,min,6972,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5187,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID10,Alfentanil,0,360,min,9343,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5188,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID11,Alfentanil,0,360,min,4837,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5189,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID12,Alfentanil,0,360,min,5492,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5190,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID13,Alfentanil,0,360,min,9100,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5191,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID14,Alfentanil,0,360,min,14704,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5192,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID15,Alfentanil,0,360,min,11003,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5193,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID16,Alfentanil,0,360,min,17707,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5194,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID17,Alfentanil,0,360,min,140909,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5195,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID18,Alfentanil,0,360,min,21587,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5127,Bovill 1984,https://www.ncbi.nlm.nih.gov/pubmed/6238552,mean,Sufentanil,0,8,h,,,,,,,,,,,,,,,12.66,mL/min/kg,arith. Mean,0.78,mL/kg/min,arith. SEM,CLiv,Table 3
5128,Willsie 2015,https://www.ncbi.nlm.nih.gov/pubmed/25544247,mean,Sufentanil,0,1440,min,273.8,pg*h/mL,arith. Mean,61.1,pg*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,CLiv,
5129,Davis 1987,https://www.ncbi.nlm.nih.gov/pubmed/2950809,mean,Sufentanil,0,120,min,0.000545455,mg*min/mL,arith. Mean,,,,AUC_tau,,,,,,,,27.5,mL/min/kg,arith. Mean,9.3,mL/kg/min,arith. Mean,CLiv,"Table 3, last samples taken 120 OR until the initiation of cardiopulmonary bypass, AUCinf imputed based on reported Dose/CL"
5130,Davis 1987,https://www.ncbi.nlm.nih.gov/pubmed/2950809,mean,Sufentanil,0,120,min,0.000828729,mg*min/mL,individual,,,,AUC_tau,,,,,,,,18.1,mL/min/kg,arith. Mean,10.7,mL/kg/min,arith. Mean,CLiv,"Table 3 ,AUCinf imputed based on reported Dose/CL"
5131,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID1,Sufentanil,0,360,min,0.00010838,mg*min/mL,individual,,,,AUC_tau,,,,,,,,17.9,mL/min/kg,individual,,,,CLiv,"t_end is time to reach limit of quanititation after dose, AUCinf imputed based on reported Dose/CL"
5132,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID2,Sufentanil,0,60,min,0.0000463,mg*min/mL,individual,,,,AUC_tau,,,,,,,,40.6,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5133,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID3,Sufentanil,0,240,min,0.0000892,mg*min/mL,individual,,,,AUC_tau,,,,,,,,39.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5134,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID4,Sufentanil,0,240,min,0.0000826,mg*min/mL,individual,,,,AUC_tau,,,,,,,,34,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5135,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID5,Sufentanil,0,300,min,0.0000663,mg*min/mL,individual,,,,AUC_tau,,,,,,,,29.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5136,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID6,Sufentanil,0,120,min,0.0000673,mg*min/mL,individual,,,,AUC_tau,,,,,,,,29.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5137,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID7,Sufentanil,0,420,min,0.000134872,mg*min/mL,individual,,,,AUC_tau,,,,,,,,19.5,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5138,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID8,Sufentanil,0,240,min,0.0000699,mg*min/mL,individual,,,,AUC_tau,,,,,,,,44.9,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5139,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID9,Sufentanil,0,120,min,0.0000436,mg*min/mL,individual,,,,AUC_tau,,,,,,,,44.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5140,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID10,Sufentanil,0,240,min,0.0000853,mg*min/mL,individual,,,,AUC_tau,,,,,,,,36.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5141,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID11,Sufentanil,0,420,min,0.000135498,mg*min/mL,individual,,,,AUC_tau,,,,,,,,23.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5142,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID12,Sufentanil,0,240,min,0.0000755,mg*min/mL,individual,,,,AUC_tau,,,,,,,,26.5,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5143,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID13,Sufentanil,0,420,min,0.000161538,mg*min/mL,individual,,,,AUC_tau,,,,,,,,18.2,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5144,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID14,Sufentanil,0,420,min,0.000151832,mg*min/mL,individual,,,,AUC_tau,,,,,,,,19.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5145,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID15,Sufentanil,0,180,min,0.000127542,mg*min/mL,individual,,,,AUC_tau,,,,,,,,23.6,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5146,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID16,Sufentanil,0,240,min,0.0000571,mg*min/mL,individual,,,,AUC_tau,,,,,,,,25.9,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5147,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID17,Sufentanil,0,180,min,0.0000617,mg*min/mL,individual,,,,AUC_tau,,,,,,,,32.9,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5148,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID18,Sufentanil,0,180,min,0.000035,mg*min/mL,individual,,,,AUC_tau,,,,,,,,28,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5149,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID19,Sufentanil,0,240,min,0.0000736,mg*min/mL,individual,,,,AUC_tau,,,,,,,,40.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5150,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID20,Sufentanil,0,180,min,0.0000565,mg*min/mL,individual,,,,AUC_tau,,,,,,,,35.2,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5224,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,7-16.8y,Montelukast,0,12,h,4387.2,ng*h/mL,geo. mean,3855.4,ng*h/mL,95%CI,AUC_inf,,,,,,,,,,,,,,,
5225,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID1,Montelukast,0,24,h,30336.98,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5226,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID2,Montelukast,0,24,h,29350.14,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5227,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID3,Montelukast,0,24,h,19481.8,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5228,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID4,Montelukast,0,24,h,15271.04,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5229,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID5,Montelukast,0,24,h,14152.63,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5230,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID6,Montelukast,0,24,h,19490.31,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5231,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID7,Montelukast,0,24,h,17384.8,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5232,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID8,Montelukast,0,24,h,16069.03,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5233,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID9,Montelukast,0,24,h,14555.88,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5234,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID10,Montelukast,0,24,h,12845.36,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5235,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID11,Montelukast,0,24,h,10016.44,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5236,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID12,Montelukast,0,24,h,10024.69,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5237,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID13,Montelukast,0,24,h,8774.445,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5238,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID14,Montelukast,0,24,h,6998.658,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5239,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID15,Montelukast,0,24,h,5419.723,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5240,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID16,Montelukast,0,24,h,5024.989,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5241,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID17,Montelukast,0,24,h,3709.209,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5242,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID18,Montelukast,0,24,h,9835.066,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5243,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID19,Montelukast,0,24,h,6941.125,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5244,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID20,Montelukast,0,24,h,10369.89,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5245,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID21,Montelukast,0,24,h,9843.322,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5246,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID22,Montelukast,0,24,h,6488.084,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5247,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID23,Montelukast,0,24,h,3791.252,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5248,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID24,Montelukast,0,24,h,3462.049,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5249,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID25,Montelukast,0,24,h,6167.911,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5250,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID26,Montelukast,0,24,h,11833.5,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5251,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID27,Montelukast,0,24,h,10986.76,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5252,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID28,Montelukast,0,24,h,10394.92,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5253,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID29,Montelukast,0,24,h,8289.154,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5254,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID30,Montelukast,0,24,h,10534.24,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5255,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID31,Montelukast,0,24,h,4612.969,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5256,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID32,Montelukast,0,24,h,3897.288,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5257,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID33,Montelukast,0,24,h,15879.4,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5258,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID34,Montelukast,0,24,h,13116.26,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5259,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID35,Montelukast,0,24,h,5155.535,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5260,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID36,Montelukast,0,24,h,18848.16,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5261,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID37,Montelukast,0,24,h,7334.827,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5262,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID38,Montelukast,0,24,h,5690.103,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5263,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID39,Montelukast,0,24,h,6167.137,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5264,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID40,Montelukast,0,24,h,11060.03,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5265,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID41,Montelukast,0,24,h,15221.25,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5266,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID42,Montelukast,0,24,h,8642.352,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5267,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID43,Montelukast,0,24,h,7392.36,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5268,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID44,Montelukast,0,24,h,5945.002,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5269,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID45,Montelukast,0,24,h,14374.25,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5270,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID46,Montelukast,0,24,h,11940.31,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5271,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID47,Montelukast,0,24,h,11414,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5272,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID48,Montelukast,0,24,h,10558.23,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5273,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID49,Montelukast,0,24,h,12013.84,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5274,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID50,Montelukast,0,24,h,9250.706,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5288,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,2mg PO CT,Montelukast,0,24,h,575,ng*h/mL,geo. mean,109,ng*h/mL,geo. SD,AUC_inf,92,ng/mL,arith. mean,15,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5289,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,5mg PO CT,Montelukast,0,24,h,1417,ng*h/mL,geo. mean,313,ng*h/mL,geo. SD,AUC_inf,232,ng/mL,arith. mean,50,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5290,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,10mg PO CT,Montelukast,0,24,h,2938,ng*h/mL,geo. mean,583,ng*h/mL,geo. SD,AUC_inf,1.9,ng/mL,arith. mean,83,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5291,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,10mg FCT,Montelukast,0,24,h,2448,ng*h/mL,geo. mean,779,ng*h/mL,geo. SD,AUC_inf,4.4,ng/mL,arith. mean,110,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5292,Zhao 1997,https://www.ncbi.nlm.nih.gov/pubmed/9429741,MD 10mg FCT,Montelukast,0,24,h,3624,ng*h/mL,geo. mean,1258,ng*h/mL,geo. SD,AUC_inf,541.5,ng/mL,geom.mean,172.6,ng/mL,arith. SD,Cmax,,,,,,,,
5293,Fey 2014,https://www.ncbi.nlm.nih.gov/pubmed/25250173,4mg PO granules (Sandoz),Montelukast,0,36,h,1083,ng*h/mL,arith. Mean,293.88,ng*h/mL,arith. SD,AUC_tend,178.04,ng/mL,arith. mean,41.58,ng/mL,arith. SD,Cmax,,,,,,,,
5294,Fey 2014,https://www.ncbi.nlm.nih.gov/pubmed/25250173,4mg PO granules (Singular),Montelukast,0,36,h,1112.84,ng*h/mL,arith. Mean,309.13,ng*h/mL,arith. SD,AUC_tend,196.04,ng/mL,arith. mean,53.25,ng/mL,arith. SD,Cmax,,,,,,,,
5401,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,min,Montelukast,0,12,h,,,,,,,,,,,,,,,,,,,,,,
5402,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,max,Montelukast,0,12,h,,,,,,,,,,,,,,,,,,,,,,
5403,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,Mean ,Montelukast,0,12,h,4387.2,ng*h/mL,geo. mean,1485.1,ng*h/mL,geo.SD,AUC_inf,,,,,,,,,,,,,,,
5404,Knorr 2001,https://www.ncbi.nlm.nih.gov/pubmed/11402629,2-5y,Montelukast,0,24,h,2721,ng*h/mL,geo. mean,164,ng*h/mL,geo.SD,AUC_inf,,,,,,,,,,,,,,,
5405,Knorr 1999,https://www.ncbi.nlm.nih.gov/pubmed/10434229,9-14y GT45kg,Montelukast,0,24,h,3528,ng*h/mL,geo. mean,1883,ng*h/mL,geo.SD,AUC_inf,526,ng/mL,arith. mean,413,ng/mL,arith. SD,Cmax,,,,,,,,
5406,Knorr 1999,https://www.ncbi.nlm.nih.gov/pubmed/10434229,6-8y ,Montelukast,0,24,h,2929,ng*h/mL,geo. mean,994,ng*h/mL,geo.SD,AUC_inf,495,ng/mL,arith. mean,129,ng/mL,arith. SD,Cmax,,,,,,,,
5407,Knorr 1999,https://www.ncbi.nlm.nih.gov/pubmed/10434229,9-14 SE45kg,Montelukast,0,24,h,2928,ng*h/mL,geo. mean,904,ng*h/mL,geo.SD,AUC_inf,444,ng/mL,arith. mean,37,ng/mL,arith. SD,Cmax,,,,,,,,
5408,Knorr 2006,https://www.ncbi.nlm.nih.gov/pubmed/16707408,3-6m,Montelukast,0,24,h,3644.3,ng*h/mL,geo. mean,481.5,ng*h/mL,SEM,AUC_inf,561.1,ng/mL,geom.mean,78,ng/mL,SEM,Cmax,18.3,mL/min,geom. Mean,2.4,mL/min,SEM,CL/F,
5409,Miyoga 2004,https://www.ncbi.nlm.nih.gov/pubmed/15102869,6-12m,Montelukast,0,24,h,2470.9,ng*h/mL,geo. mean,499.3,ng*h/mL,SEM,AUC_inf,583.5,ng/mL,geom.mean,85,ng/mL,SEM,Cmax,19.2,mL/min,geom. Mean,2.8,mL/min,SEM,CL/F,
5410,Miyoga 2004,https://www.ncbi.nlm.nih.gov/pubmed/15102869,12-24m,Montelukast,0,24,h,3629.2,ng*h/mL,geo. mean,243.1,ng*h/mL,SEM,AUC_inf,582.3,ng/mL,geom.mean,47,ng/mL,SEM,Cmax,18.4,mL/min,geom. Mean,1.2,mL/min,SEM,CL/F,
5411,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,3mg IV male,Montelukast,0,24,h,,,,,,,,,,,,,,,50.4,mL/min,harmonic mean,12.1,mL/min,Jacknife SD,CLiv,
5412,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,9mg IV male,Montelukast,0,24,h,,,,,,,,,,,,,,,46,mL/min,harmonic mean,4.2,mL/min,Jacknife SD,CLiv,
5413,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,18mg IV male,Montelukast,0,24,h,,,,,,,,,,,,,,,40.2,mL/min,harmonic mean,6.4,mL/min,Jacknife SD,CLiv,
5414,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,9mg IV Female,Montelukast,0,24,h,,,,,,,,,,,,,,,47.6,mL/min,harmonic mean,16,mL/min,Jacknife SD,CLiv,
5415,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,10mg PO Female,Montelukast,0,24,h,2270,ng*h/mL,Harmonic mean,919,ng*h/mL,Jacknife SD,AUC_tau,350,ng/mL,Harmonic mean,161,ng/mL,Jacknife SD,Cmax,,,,,,,,
5416,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,10mg PO male,Montelukast,0,24,h,2441,ng*h/mL,Harmonic mean,441,ng*h/mL,Jacknife SD,AUC_tau,385,ng/mL,Harmonic mean,85,ng/mL,Jacknife SD,Cmax,,,,,,,,
5452,Taverne 1992,https://pubmed.ncbi.nlm.nih.gov/1387351/,mean,Sufentanil,0,5.64,h,1.5,µg*h/L,arith. Mean,0.4,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,
3000,Ochs 1975,https://pubmed.ncbi.nlm.nih.gov/1227049/,0.5mg Patient 1 with normal colon mucosa,Digoxin,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
3001,Ochs 1978,https://pubmed.ncbi.nlm.nih.gov/742116/,0.5mg,Digoxin,0,inf,h,,,,,,,,,,,,,,,2.38,mL/min/kg,arith. Mean,0.48,mL/min/kg,SE,CLiv,"Renal Clearance: 1,5 +/- 0,24"
3070,Ochs 1978,https://pubmed.ncbi.nlm.nih.gov/742116/,1mg,Digoxin,0,inf,h,,,,,,,,,,,,,,,2.65,mL/min/kg,arith. Mean,0.36,mL/min/kg,SE,CLiv,"Renal Clearance: 2,02 +/- 0,31"
3072,Ochs 1978,https://pubmed.ncbi.nlm.nih.gov/742116/,1.5mg,Digoxin,0,inf,h,,,,,,,,,,,,,,,2.5,mL/min/kg,arith. Mean,0.21,mL/min/kg,SE,CLiv,"Renal Clearance: 1,62 +/- 0,12"
3002,Verstuyft 2003,https://pubmed.ncbi.nlm.nih.gov/12545143/,0.5mg with Placebo,Digoxin,0,48,h,27.18,ng*h/mL,arith. Mean,3.9,ng*h/mL,arith. SD,AUC_tend,3,ng/mL,arith. Mean,0.8,ng/mL,arith. SD,Cmax,5.9,L/h,arith. Mean,0.86,L/h,arith. SD,CL/F,CL = CL_R: renal clearance of digoxin; AUC(0-4): 6.81 ± 1.25 (4.60-9.71); AUC(0-24): 18.53 ± 2.58 (13.56-23.30); Range AUC(0-48): 19.08-34.21
3003,Verstuyft 2003,https://pubmed.ncbi.nlm.nih.gov/12545143/,0.5mg with dipyridamole,Digoxin,48,96,h,29.29,ng*h/mL,arith. Mean,5.13,ng*h/mL,arith. SD,AUC_tend,3.7,ng/mL,arith. Mean,1.4,ng/mL,arith. SD,Cmax,6.36,L/h,arith. Mean,0.7,L/h,arith. SD,CL/F,"CL = CL_R: renal clearance of digoxin, AUC(0-4): 8.14 ± 1.99 (4.32-10.73); AUC(0-24): 20.81 ± 3.42 (16.40-27.31); Range AUC(0-48): 22.57-38.35"
3004,Verstuyft 2003,https://pubmed.ncbi.nlm.nih.gov/12545143/,0.5mg with placebo,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3005,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg iv 1h,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3006,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg iv 3h,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3007,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg iv bolus,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3008,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg po,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3009,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg iv 1h,Digoxin,0,inf,h,30.2,ng*h/mL,Average,27.7,%,CV,AUC_inf,,,,,,,,300,mL/min,Average,35.7,%,CV,CLiv,"CL_R: 157(49,4)"
3010,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg iv 3h,Digoxin,0,inf,h,25.8,ng*h/mL,Average,35.5,%,CV,AUC_inf,,,,,,,,366,mL/min,Average,41.8,%,CV,CLiv,"CL_R: 215(42,3)"
3011,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg iv bolus,Digoxin,0,inf,h,35.55,ng*h/mL,Average,14.8,%,CV,AUC_inf,,,,,,,,239,mL/min,Average,16.2,%,CV,CLiv,"CL_R: 164(10,8)"
3012,Wagner 1981,https://pubmed.ncbi.nlm.nih.gov/7277206/,0.5mg po,Digoxin,0,inf,h,15.47,ng*h/mL,Average,49.9,%,CV,AUC_inf,,,,,,,,675,mL/min,Average,51.5,%,CV,CL/F,"CL_R: 240(50,3)"
3013,Ding 2004,https://pubmed.ncbi.nlm.nih.gov/15229466/,0.5mg iv placebo,Digoxin,0,inf,h,22,ng*h/mL,arith. Mean,9,ng*h/mL,SEM,AUC_inf,,,,,,,,409,mL/min,arithm. Mean,30,mL/min,SEM,,renal clearance: Clr(0-inf): (mL/min) 194 ± 23; non-renal clearance: Clnr(0-inf): (mL/min) 215 ± 15
3014,Ding 2004,https://pubmed.ncbi.nlm.nih.gov/15229466/,0.5mg iv with ritonavir,Digoxin,48.33,inf,h,41,ng*h/mL,arith. Mean,17,ng*h/mL,SEM,AUC_inf,,,,,,,,238,mL/min,arithm. Mean,29,mL/min,SEM,,"renal clearance: Clr(0-inf): (mL/min) 136±21, non-renal clearance: Clnr(0-inf): (mL/min) 112 ± 7"
3019,Koup 1975,https://pubmed.ncbi.nlm.nih.gov/1159622/,0.75mg iv h,Digoxin,0,inf,h,72.65,ng*h/mL,arith. Mean,20.93,ng*h/mL,arith. SD,AUC_inf,,,,,,,,190,mL/min,arith. Mean,55,mL/min,arith. SD,CLiv,CL values are normalized to 1.73 m² body surface area. Renal Clearance ml/min (first 5 subjects) for 10 observations: 141(41); (all subjects) for 16 observations: 141(63); Body Clearance ml/min (first 5 subjects) for 10 obs: 188(44)
3020,Kramer 1979,https://pubmed.ncbi.nlm.nih.gov/458556/,1mg iv bolus,Digoxin,0,inf,h,,,,,,,,,,,,,,,3.6,mL/min/kg,average,,,,CL/F,
3021,Lalonde 1985,https://pubmed.ncbi.nlm.nih.gov/3978996/,0.01mg/kg iv control,Digoxin,0,inf,h,,,,,,,,,,,,,,,12.2,L/h,arith. Mean,2,L/h,arith. SD,CLiv,
3022,Lalonde 1985,https://pubmed.ncbi.nlm.nih.gov/3978996/,0.01mg/kg charcoal,Digoxin,0,40,h,,,,,,,,,,,,,,,18,L/h,arith. Mean,2.9,L/h,arith. SD,CLiv,
16408,Rengelshausen 2003,https://pubmed.ncbi.nlm.nih.gov/12848773/,0.01mg/kg iv with placebo,Digoxin,0,24,h,27,µg*h/L,arith. Mean,5,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,
16409,Rengelshausen 2003,https://pubmed.ncbi.nlm.nih.gov/12848773/,0.01mg/kg iv with clarithromycin,Digoxin,26,50,h,32,µg*h/L,arith. Mean,7.2,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,
16410,Rengelshausen 2003,https://pubmed.ncbi.nlm.nih.gov/12848773/,0.75mg/kg po with placebo,Digoxin,0,24,h,14,µg*h/L,arith. Mean,2.9,µg*h/L,arith. SD,AUC_inf,3.6,µg/L,arith. Mean,1.1,µg/L,arith. SD,Cmax,,,,,,,,"AUC(0,3): 6,1 +/- 1,4; CL: Values calculated for 10 participants: 120 +/- 40"
16411,Rengelshausen 2003,https://pubmed.ncbi.nlm.nih.gov/12848773/,0.75mg/kg po with clarithromycin,Digoxin,24.5,48.5,h,23,µg*h/L,arith. Mean,5.2,µg*h/L,arith. SD,AUC_tend,6.6,µg/L,arith. Mean,2.3,µg/L,arith. SD,Cmax,,,,,,,,"AUC(0,3): 11 +/- 2,5; CL: Values calculated for 10 participants: 100 +/- 36"
3026,Steiness 1982,https://pubmed.ncbi.nlm.nih.gov/7140804/,0.015 mg/kg,Digoxin,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
3027,Tsutsumi 2002,https://pubmed.ncbi.nlm.nih.gov/12362931/,0.5mg iv,Digoxin,0,inf,h,60,ng*h/mL,arith. Mean,5.3,ng*h/mL,arith. SD,AUC_inf,9.1,ng/mL,arith. Mean,1,ng/mL,arith. SD,Cmax,140,mL/min,arith. Mean,13.1,mL/min,arith. SD,CLiv,"CL_R: 98,4 +/- 41,3"
3028,Tsutsumi 2002,https://pubmed.ncbi.nlm.nih.gov/12362931/,0.5mg iv with erythromycin,Digoxin,24,inf,h,57.3,ng*h/mL,arith. Mean,13.5,ng*h/mL,arith. SD,AUC_inf,9,ng/mL,arith. Mean,1.2,ng/mL,arith. SD,Cmax,152.7,mL/min,arith. Mean,35.4,mL/min,arith. SD,CLiv,"CL_R: 137,3 +/- 45"
3029,Tsutsumi 2002,https://pubmed.ncbi.nlm.nih.gov/12362931/,0.5mg iv with clarithromycin,Digoxin,24,inf,h,58.8,ng*h/mL,arith. Mean,12,ng*h/mL,arith. SD,AUC_inf,9,ng/mL,arith. Mean,1.2,ng/mL,arith. SD,Cmax,147.7,mL/min,arith. Mean,33.4,mL/min,arith. SD,CLiv,"CL_R: 133,6 +/- 34,5"
3030,Tsutsumi 2002,https://pubmed.ncbi.nlm.nih.gov/12362931/,0.5mg iv,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3031,Tsutsumi 2002,https://pubmed.ncbi.nlm.nih.gov/12362931/,0.5mg iv with erythromycin,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3032,Tsutsumi 2002,https://pubmed.ncbi.nlm.nih.gov/12362931/,0.5mg iv with clarithromycin,Digoxin,,,,,,,,,,,,,,,,,,,,,,,,,
3033,Becquemont 2001,https://pubmed.ncbi.nlm.nih.gov/11673746/,0.5mg po,Digoxin,0,48,h,20.17,ng*h/mL,arith. Mean,4.16,ng*h/mL,arith. SD,AUC_tend,2.2,ng/mL,arith. Mean,0.4,ng/mL,arith. SD,Cmax,8,L/h,arith. Mean,2,L/h,arith. SD,CL/F,"CL = CL_renal; AUC(0-4): (Control): 5,39 +/- 0,81; AUC(0-24): (Control): 13,87 +/- 2,49"
3034,Becquemont 2001,https://pubmed.ncbi.nlm.nih.gov/11673746/,0.5mg po with grapefruit juice,Digoxin,0.5,48.5,h,21.9,ng*h/mL,arith. Mean,4.7,ng*h/mL,arith. SD,AUC_tend,2.7,ng/mL,arith. Mean,0.9,ng/mL,arith. SD,Cmax,8,L/h,arith. Mean,2,L/h,arith. SD,CL/F,"CL = CL_renal; AUC(0-4): (w/ GJ): 6 +/- 1,2; AUC(0-24): (w/ GJ): 15,2 +/- 3"
3035,Eckermann 2012,https://pubmed.ncbi.nlm.nih.gov/21257799/,0.25mg po,Digoxin,0,inf,h,17046.8,,arith. Mean,"13304,8-21841,3",%,68% range,AUC_inf,1509.79,ng/L,arith. Mean,"1168,71-1950,42",%,68% range,Cmax,,,,,,,,"Unit AUC: ng/(L*h); AUC0-inf (68% range): 90% CI 13304,8 - 21841,3; Cmax (68% range) 90% CI 1168,71-1950,42"
3036,Eckermann 2012,https://pubmed.ncbi.nlm.nih.gov/21257799/,0.25mg po with roflumilast,Digoxin,312,inf,h,16205.9,,arith. Mean,"12664-20738,3",%,68% range,AUC_inf,1733.11,ng/L,arith. Mean,"1362,05-2205,26",%,68% range,Cmax,,,,,,,,Unit AUC: ng/(L*h); AUC0-inf (68% range): 90% CI 12664.0 - 20738.3; Cmax (68% range) 90% CI 1362.05-2205.26
3041,Hawyard 1978,https://pubmed.ncbi.nlm.nih.gov/666950/,1mg po,Digoxin,0,inf,h,14.9,ng*h/mL,arith. Mean,0.6,ng*h/mL,SE,AUC_inf,5.4,ng/mL,arith. Mean,0.8,ng/mL,SE,Cmax,,,,,,,,
3043,Martin 1997,https://pubmed.ncbi.nlm.nih.gov/9205830/,0.6mg po,Digoxin,0,inf,h,32.6,ng*h/mL,geom. Mean,9,ng*h/mL,geom. SD,AUC_inf,2.53,ng/mL,geom. Mean,0.76,ng/mL,geom. SD,Cmax,,,,,,,,"AUC(0,t'): 24.3(5.9)"
3044,Martin 1997,https://pubmed.ncbi.nlm.nih.gov/9205830/,0.6mg po with Eprosartan,Digoxin,72,168,h,33,ng*h/mL,geom. Mean,7.5,ng*h/mL,geom. SD,AUC_tend,2.57,ng/mL,geom. Mean,0.81,ng/mL,geom. SD,Cmax,,,,,,,,"AUC(0,t'): 24.2(5.9)"
3045,Oosterhuis 1991,https://pubmed.ncbi.nlm.nih.gov/1954072/,1mg po,Digoxin,0,inf,h,61.9,µg*h/L,arith. Mean,17.5,µg*h/L,arith. Mean,AUC_inf,3.98,µg/L,arith. Mean,0.96,µg/L,arith. SD,Cmax,,,,,,,,"AUC(0,96): 49.7(11)"
3046,Oosterhuis 1991,https://pubmed.ncbi.nlm.nih.gov/1954072/,1mg po with omeprazole,Digoxin,170,inf,h,70.1,µg*h/L,arith. Mean,19.4,µg*h/L,arith. Mean,AUC_inf,4.2,µg/L,arith. Mean,1.07,µg/L,arith. SD,Cmax,,,,,,,,"AUC(0,96): 55.3(10.5)"
3047,Ragueneau 1999,https://pubmed.ncbi.nlm.nih.gov/10510161/,0.5mg po with placebo,Digoxin,0,inf,h,28.3,ng*h/mL,arith. Mean,6.3,ng*h/mL,arith. Mean,AUC_inf,2.5,ng/mL,arith. Mean,0.7,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0,t): 23,2 +/- 5,2"
3048,Ragueneau 1999,https://pubmed.ncbi.nlm.nih.gov/10510161/,0.5mg po with macrogol 4000,Digoxin,96,inf,h,19.9,ng*h/mL,arith. Mean,4.8,ng*h/mL,arith. Mean,AUC_inf,1.4,ng/mL,arith. Mean,0.4,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0,t): 15,8 +/- 3,9"
3049,Tayrouz 2003,https://pubmed.ncbi.nlm.nih.gov/12732840/,0.5mg po with placebo,Digoxin,0,9,h,5.25,ng*h/mL,median,"(4,72-7,5)",ng*h/mL,range,AUC_tend,2,ng/mL,median,"(1,17-4,7)",ng/mL,range,Cmax,,,,,,,,AUC(0-3): 3.02 (2.17-6.09); AUC(0-5): 3.92 (2.99-6.79); AUC(0-7): 4.89 (3.75-7.17)
3050,Tayrouz 2003,https://pubmed.ncbi.nlm.nih.gov/12732840/,0.5mg po with Cremophor RH40,Digoxin,24,33,h,6.01,ng*h/mL,median,"(4,62-9,72)",ng*h/mL,range,AUC_tend,2.28,ng/mL,median,"(1,5-6,01)",ng/mL,range,Cmax,,,,,,,,AUC(0-3): 3.49 (2.73-6.67); AUC(0-5): 4.76 (3.74-8.54); AUC(0-7): 5.71 (4.22-9.17)
3051,Westphal 2000,https://pubmed.ncbi.nlm.nih.gov/10945310/,0.5mg po,Digoxin,0,72,h,23,ng*h/mL,arith. Mean,3.3,ng*h/mL,arith. SD,AUC_tend,1.93,ng/mL,arith. Mean,0.69,ng/mL,arith. SD,Cmax,214,mL/min,arithm. Mean,59,mL/min,arith. SD,CL/F,AUC(0-6): 5.85 ± 1.49; CL_R: 125 ± 39; CL_NR: 89 ± 66
3052,Westphal 2000,https://pubmed.ncbi.nlm.nih.gov/10945310/,0.5mg po with talinolol p.o.,Digoxin,0,72,h,27.1,ng*h/mL,arith. Mean,3.7,ng*h/mL,arith. SD,AUC_tend,2.79,ng/mL,arith. Mean,0.62,ng/mL,arith. SD,Cmax,198,mL/min,arithm. Mean,59,mL/min,arith. SD,CL/F,AUC(0-6): 7.22 ± 1.29; CL_R: 130 ± 25; CL_NR: 68 ± 60
3053,Westphal 2000,https://pubmed.ncbi.nlm.nih.gov/10945310/,0.5mg po with talinolol i.v.,Digoxin,0,72,h,24.1,ng*h/mL,arith. Mean,5.6,ng*h/mL,arith. SD,AUC_tend,2.12,ng/mL,arith. Mean,0.61,ng/mL,arith. SD,Cmax,226,mL/min,arithm. Mean,98,mL/min,arith. SD,CL/F,AUC(0-6): 5.64 ± 1.06; CL_R: 156 ± 108; CL_NR: 71 ± 126
3054,Sanofi-Aventis 2009,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022425s000_ClinPharm_P2.pdf,0.25mg md QD ,Digoxin,216,240,h,7.73,ng*h/mL,arith. Mean,45,%,CV%,AUC_tend,1.02,ng/mL,arith. Mean,33,%,CV%,Cmax,,,,,,,,"URINE: CL_R(0-24): 14,2 (41%)"
3077,Sanofi-Aventis 2009,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022425s000_ClinPharm_P2.pdf,0.25mg md QD with dronedarone 400mg bid,Digoxin,216,240,h,18,ng*h/mL,arith. Mean,18,%,CV%,AUC_tend,1.71,ng/mL,arith. Mean,17,%,CV%,Cmax,,,,,,,,"URINE: CL_R(0-24): 7,8 (27 %)"
3055,Friedrich 2011,https://pubmed.ncbi.nlm.nih.gov/21340661/,0.25mg po md,Digoxin,240,264,h,15.4,ng*h/mL,gMean,28.1,ng*h/mL,gCV,AUC_tau,1.76,ng/mL,gMean,28.8,ng/mL,gCV,Cmax,271,mL/min,gMean,28.1,mL/min,gCV,CL/F,"CL_R (0-24): renal clearance of the analyte at steady-state determined within the time interval 0-24h: 130 gMean (20,1 gCV)"
3056,Friedrich 2011,https://pubmed.ncbi.nlm.nih.gov/21340661/,0.25mg po md with linagliptin,Digoxin,240,264,h,15.6,ng*h/mL,gMean,23.4,ng*h/mL,gCV,AUC_tau,1.66,ng/mL,gMean,22.8,ng/mL,gCV,Cmax,267,mL/min,gMean,23.4,mL/min,gCV,CL/F,"CL_R (0-24): renal clearance of the analyte at steady-state determined within the time interval 0-24h: 130 gMean (20,6 gCV)"
3057,Johne 1999,https://pubmed.ncbi.nlm.nih.gov/10546917/,0.25mg po md with placebo day 6,Digoxin,120,144,h,18.1,µg*h/L,arith. Mean,2.9,µg*h/L,arith. SD,AUC_tend,1.8,µg/L,arith. Mean,0.4,µg/L,arith. SD,Cmax,,,,,,,,
3058,Johne 1999,https://pubmed.ncbi.nlm.nih.gov/10546917/,0.25mg po md with placebo day 15,Digoxin,336,360,h,17.2,µg*h/L,arith. Mean,4,µg*h/L,arith. SD,AUC_tend,1.9,µg/L,arith. Mean,0.5,µg/L,arith. SD,Cmax,,,,,,,,
3059,Kirch 1986,https://pubmed.ncbi.nlm.nih.gov/3943268/,2x0.25mg po md,Digoxin,1008,1020,h,10.16,ng*h/mL,arith. Mean,0.88,ng*h/mL,SE,AUC_tend,2.06,ng/mL,arith. Mean,0.2,ng/mL,SE,Cmax,4,mL/min/kg,arith. Mean,0.27,mL/min/kg,SE,CL/F,"CL_R: 2,65 +/-0,17; CL_NR: 1,35 +/-0,24"
3060,Kirch 1986,https://pubmed.ncbi.nlm.nih.gov/3943268/,2x0.25mg po md with nifedipine,Digoxin,816,828,h,11.98,ng*h/mL,arith. Mean,1.28,ng*h/mL,SE,AUC_tend,2.23,ng/mL,arith. Mean,0.26,ng/mL,SE,Cmax,3.47,mL/min/kg,arith. Mean,0.27,mL/min/kg,SE,CL/F,"CL_R: 2,44 +/-0,39; CL_NR: 1,12 +/-0,47"
3061,Qiu 2010,https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1038/clpt.2009.277,0.125mg md QD placebo,Digoxin,312,336,h,6.96,ng*h/mL,geom. Mean,18,%,CV%,AUC_tend,0.608,ng/mL,geom. Mean,20,%,CV%,Cmax,7.06,L/h,geom. Mean,18,%,CV%,CL/F,CL = CL_R = Renal clearance; Urine PK parameters only
3078,Qiu 2010,https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1038/clpt.2009.277,0.125mg md QD with dimebon 20mg TID,Digoxin,312,336,h,6.9,ng*h/mL,geom. Mean,20,%,CV%,AUC_tend,0.581,ng/mL,geom. Mean,22,%,CV%,Cmax,6.79,L/h,geom. Mean,17,%,CV%,CL/F,CL = CL_R = Renal clearance; Urine PK parameters only
3062,Rodin 1988,https://pubmed.ncbi.nlm.nih.gov/2967742/,2x0.25mg po md,Digoxin,312,324,h,15.7,ng*h/mL,arith. Mean,1.7,ng*h/mL,arith. Mean,AUC_tend,2.5,ng/mL,arith. Mean,0.7,ng/mL,arith. SD,Cmax,6.8,L/h,arith. Mean,1.8,L/h,arith. SD,CL/F,CL: Renal clearance
3063,Rodin 1988,https://pubmed.ncbi.nlm.nih.gov/2967742/,2x0.25mg po md with verapamil,Digoxin,312,324,h,23.6,ng*h/mL,arith. Mean,2.9,ng*h/mL,arith. Mean,AUC_tend,3.6,ng/mL,arith. Mean,0.8,ng/mL,arith. SD,Cmax,7.1,L/h,arith. Mean,2.2,L/h,arith. SD,CL/F,CL: Renal clearance
3064,Rodin 1988,https://pubmed.ncbi.nlm.nih.gov/2967742/,2x0.25mg po md,Digoxin,312,324,h,15.9,ng*h/mL,arith. Mean,3.6,ng*h/mL,arith. Mean,AUC_tend,2.3,ng/mL,arith. Mean,0.6,ng/mL,arith. SD,Cmax,6.8,L/h,arith. Mean,1.6,L/h,arith. SD,CL/F,CL: Renal clearance
3065,Rodin 1988,https://pubmed.ncbi.nlm.nih.gov/2967742/,2x0.25mg po md with isradipine,Digoxin,312,324,h,17.6,ng*h/mL,arith. Mean,3.5,ng*h/mL,arith. Mean,AUC_tend,2.9,ng/mL,arith. Mean,0.7,ng/mL,arith. SD,Cmax,7.1,L/h,arith. Mean,1.6,L/h,arith. SD,CL/F,CL: Renal clearance
3066,Vaidyanathan 2008,https://pubmed.ncbi.nlm.nih.gov/18784280/,0.25mg po pd,Digoxin,192,inf,h,14.89,ng*h/mL,geom. Mean,,,,AUC_inf,1.43,ng/mL,geom. Mean,,,,Cmax,,,,,,,,"Cmax -> Cmax,ss, N=21"
3067,Vaidyanathan 2008,https://pubmed.ncbi.nlm.nih.gov/18784280/,0.25mg po pd with aliskiren,Digoxin,360,384,h,12.74,ng*h/mL,geom. Mean,,,,AUC_tend,1.31,ng/mL,geom. Mean,,,,Cmax,,,,,,,,"Cmax -> Cmax,ss, N=19"
5201,Rane 1976,https://www.ncbi.nlm.nih.gov/pubmed/1017153,3-9d,Digoxin,0,24,h,,,,,,,,,,,,,,,1.8,mL/min/kg,arith. Mean,,,,,
5202,Rane 1976,https://www.ncbi.nlm.nih.gov/pubmed/1017153,1.3-11m,Digoxin,0,24,h,,,,,,,,,,,,,,,7.5,mL/min/kg,arith. Mean,,,,,
5203,Rane 1976,https://www.ncbi.nlm.nih.gov/pubmed/1017153,2-5y,Digoxin,0,24,h,,,,,,,,,,,,,,,11.1,mL/min/kg,arith. Mean,,,,,
5204,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID1,Digoxin,0,24,h,,,,,,,,,,,,,,,105.6,mL/min/m2,Individual,,,,,
5205,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID2,Digoxin,0,24,h,,,,,,,,,,,,,,,62.1,mL/min/m2,Individual,,,,,
5206,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID3,Digoxin,0,24,h,,,,,,,,,,,,,,,98.4,mL/min/m2,Individual,,,,,
5207,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID4,Digoxin,0,24,h,,,,,,,,,,,,,,,63.6,mL/min/m2,Individual,,,,,
5208,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID5,Digoxin,0,24,h,,,,,,,,,,,,,,,202.3,mL/min/m2,Individual,,,,,
5209,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID6,Digoxin,0,24,h,,,,,,,,,,,,,,,117.8,mL/min/m2,Individual,,,,,
5210,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID7,Digoxin,0,24,h,,,,,,,,,,,,,,,353,mL/min/m2,Individual,,,,,
5211,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID8,Digoxin,0,24,h,,,,,,,,,,,,,,,74.08,mL/min/m2,Individual,,,,,
5212,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID9,Digoxin,0,24,h,,,,,,,,,,,,,,,94.4,mL/min/m2,Individual,,,,,
5213,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID10,Digoxin,0,24,h,,,,,,,,,,,,,,,107.8,mL/min/m2,Individual,,,,,
5214,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID11,Digoxin,0,24,h,,,,,,,,,,,,,,,63.7,mL/min/m2,Individual,,,,,
5215,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID12,Digoxin,0,24,h,,,,,,,,,,,,,,,56.1,mL/min/m2,Individual,,,,,
5216,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID13,Digoxin,0,24,h,,,,,,,,,,,,,,,100,mL/min/m2,Individual,,,,,
5217,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID14,Digoxin,0,24,h,,,,,,,,,,,,,,,65.1,mL/min/m2,Individual,,,,,
5218,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID15,Digoxin,0,24,h,,,,,,,,,,,,,,,132.8,mL/min/m2,Individual,,,,,
5219,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID16,Digoxin,0,24,h,,,,,,,,,,,,,,,62.5,mL/min/m2,Individual,,,,,
5220,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID17,Digoxin,0,24,h,,,,,,,,,,,,,,,172.3,mL/min/m2,Individual,,,,,
5221,Ratnapalan 2003,https://www.ncbi.nlm.nih.gov/pubmed/12756393,ID18,Digoxin,0,24,h,,,,,,,,,,,,,,,98.7,mL/min/m2,Individual,,,,,
5222,Nyberg 1980,https://www.ncbi.nlm.nih.gov/pubmed/7398751,neonates,Digoxin,0,24,h,,,,,,,,,,,,,,,3,mL/min/1.73m2,arith. Mean,,,,,Taken from Nyber 1978 reported doses and serum concentrations
5223,Nyberg 1980,https://www.ncbi.nlm.nih.gov/pubmed/7398751,infants (moderate cl),Digoxin,0,24,h,,,,,,,,,,,,,,,4.5,mL/min/1.73m2,arith. Mean,,,,,Taken from Nyber 1978 reported doses and serum concentrations
5326,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID1,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5462,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID2,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5463,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID3,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5464,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID4,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5465,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID5,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5466,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID6,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5467,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID7,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5468,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID8,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5469,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID9,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5470,Struys 2007,https://www.ncbi.nlm.nih.gov/pubmed/17721240,ID10,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5327,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 203,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5453,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 213,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5454,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 215,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5457,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 201,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5328,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 207,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5455,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 208,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5456,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 209,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5329,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 204,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5330,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 202,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5458,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 206,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5459,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 210,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5460,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 211,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5461,Gepts 1987,https://www.ncbi.nlm.nih.gov/pubmed/3500657 ,ID 217,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5331,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID5a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5471,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID5b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5472,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID6a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5473,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID6b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5332,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID11a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5474,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID11b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5475,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID12a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5476,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID12b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5333,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID13a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5496,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID13b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5497,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID14a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5498,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID14b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5499,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID15a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5500,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID15b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5501,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID16a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5502,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID16b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5334,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID19a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5489,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID19b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5490,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID20a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5491,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID20b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5492,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID21a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5493,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID21b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5494,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID22a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5495,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID22b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5335,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID2a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5477,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID2b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5478,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID3a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5479,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID3b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5480,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID4a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5481,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID4b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5336,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID7a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5482,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID7b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5483,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID8a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5484,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID8b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5485,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID9a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5486,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID9b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5487,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID10a,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5488,Schnider 1998,https://www.ncbi.nlm.nih.gov/pubmed/9605675,ID10b,Propofol,,,,,,,,,,,,,,,,,,,,,,,,,
5337,Allegaert 2007,https://www.ncbi.nlm.nih.gov/pubmed/17897267,17d,Propofol,0,24,h,120.67,µg*min/mL,individual,,,,AUC_inf,,,,,,,,25.46,mL/min/kg,Individual,,,,,
5338,Allegaert 2007,https://www.ncbi.nlm.nih.gov/pubmed/17897267,8d,Propofol,0,24,h,225.18,µg*min/mL,individual,,,,AUC_inf,,,,,,,,13.58,mL/min/kg,Individual,,,,,
5339,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID10,Propofol,0,152,min,0.295,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5340,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID11,Propofol,0,2.5,h,0.292,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5341,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID12,Propofol,0,150,min,0.191,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5342,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID13,Propofol,0,150,min,0.276,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5343,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID14,Propofol,0,90,min,0.309,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5344,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID15,Propofol,0,60,min,0.289,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5345,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID16,Propofol,0,180,min,0.294,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5346,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID20,Propofol,0,101,min,0.195,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5348,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID21,Propofol,0,150,min,0.25,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5349,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID22,Propofol,0,158,min,0.225,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5350,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID23,Propofol,0,150,min,0.25,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5351,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID24,Propofol,0,60,min,0.222,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5352,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID25,Propofol,0,150,min,0.453,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5353,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID26,Propofol,0,119,min,0.206,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5354,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID30,Propofol,0,180,min,0.271,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5355,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID31,Propofol,0,150,min,0.25,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5356,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID32,Propofol,0,120,min,0.225,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5357,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID34,Propofol,0,240,min,0.323,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5358,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID35,Propofol,0,129,min,0.275,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5359,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID36,Propofol,0,120,min,0.275,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5360,Kataria 1994,https://www.ncbi.nlm.nih.gov/pubmed/8291699,ID37,Propofol,0,180,min,0.333,mmol*min/L,individual,,,,AUC_tend,,,,,,,,,,,,,,,
5362,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind1,Propofol,0,24,h,0.096525097,mg*min/mL,individual,,,,AUC_inf,,,,,,,,25.9,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5363,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind2,Propofol,0,24,h,0.070621469,mg*min/mL,individual,,,,AUC_inf,,,,,,,,35.4,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5364,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind3,Propofol,0,24,h,0.088967972,mg*min/mL,individual,,,,AUC_inf,,,,,,,,28.1,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5365,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind4,Propofol,0,24,h,0.09057971,mg*min/mL,individual,,,,AUC_inf,,,,,,,,27.6,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5366,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind5,Propofol,0,24,h,0.112107623,mg*min/mL,individual,,,,AUC_inf,,,,,,,,22.3,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5367,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind6,Propofol,0,24,h,0.11627907,mg*min/mL,individual,,,,AUC_inf,,,,,,,,21.5,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5368,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind7,Propofol,0,24,h,0.056306306,mg*min/mL,individual,,,,AUC_inf,,,,,,,,44.4,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5369,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind8,Propofol,0,4,h,0.088028169,mg*min/mL,individual,,,,AUC_inf,,,,,,,,28.4,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5370,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind9,Propofol,0,4,h,0.065963061,mg*min/mL,individual,,,,AUC_inf,,,,,,,,37.9,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
5434,Saint-Maurice 1989,https://www.ncbi.nlm.nih.gov/pubmed/2611067,ind10,Propofol,0,4,h,0.06377551,mg*min/mL,individual,,,,AUC_inf,,,,,,,,39.2,mL/min/kg,Individual,,,,CLiv,AUCinf calculated based on Dose/CL
852,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.J. (single dose),Carbamazepine,0,inf,h,160.7,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,,,,,,,,"AUC (n=4): 137,3 +/- 57,4"
853,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.A. (single dose),Carbamazepine,0,inf,h,188.5,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,,,,,,,,"AUC (n=4): 137,3 +/- 57,4"
854,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.R. (single dose),Carbamazepine,0,inf,h,55.6,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,,,,,,,,"AUC (n=4): 137,3 +/- 57,4"
855,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.S. (single dose),Carbamazepine,0,inf,h,144.2,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,,,,,,,,"AUC (n=4): 137,3 +/- 57,4"
856,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.J. (multiple dose),Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
857,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.A. (multiple dose),Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
858,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.R. (multiple dose),Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
859,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.S. (multiple dose),Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
860,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.J. (single dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
861,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.A. (single dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
862,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.R. (single dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
863,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.S. (single dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
864,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.J. (multiple dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
865,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.A. (multiple dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
866,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient E.R. (multiple dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
867,Eichelbaum 1975,https://pubmed.ncbi.nlm.nih.gov/1233232/,Patient R.S. (multiple dose),Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
868,Shahzadi 2011,https://pubmed.ncbi.nlm.nih.gov/21190921/,CBZ alone,Carbamazepine,0,inf,h,357.2,µg*h/mL,Arith. Mean,12.707,µg*h/mL,SE,AUC_inf,9.153,µg/mL,Arith. Mean,0.235,µg/mL,SE,Cmax,0.00635,L/h/kg,Arith. Mean,0.005065,L/h/kg,SE,CL/F,"CL = CL_B = Total body clearance. AUC Var, Cmax Var and CL Var: Significantly different (P<0,05) different from the respective value."
869,Rawlins 1975,https://pubmed.ncbi.nlm.nih.gov/1233212/,Volunteer D,Carbamazepine,0,inf,h,199,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,19,mL/min,Individual,,,,CL/F,CL = plasma clearance = (Dose x F) / AUC
870,Rawlins 1975,https://pubmed.ncbi.nlm.nih.gov/1233212/,Volunteer C,Carbamazepine,0,inf,h,142.8,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,30,mL/min,Individual,,,,CL/F,CL = plasma clearance = (Dose x F) / AUC
871,Rawlins 1975,https://pubmed.ncbi.nlm.nih.gov/1233212/,Volunteer E,Carbamazepine,0,inf,h,106.7,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,29,mL/min,Individual,,,,CL/F,CL = plasma clearance = (Dose x F) / AUC
872,Rawlins 1975,https://pubmed.ncbi.nlm.nih.gov/1233212/,"Volunteer G, 50 mg solution",Carbamazepine,0,inf,h,31.5,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,26.4,mL/min,Individual,,,,CL/F,CL = plasma clearance = (Dose x F) / AUC
873,Rawlins 1975,https://pubmed.ncbi.nlm.nih.gov/1233212/,"Volunteer G, 100 mg solution",Carbamazepine,0,inf,h,51.3,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,32.4,mL/min,Individual,,,,CL/F,CL = plasma clearance = (Dose x F) / AUC
874,Rawlins 1975,https://pubmed.ncbi.nlm.nih.gov/1233212/,"Volunteer G, 200 mg solution",Carbamazepine,0,inf,h,144.1,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,23,mL/min,Individual,,,,CL/F,CL = plasma clearance = (Dose x F) / AUC
875,Rawlins 1975,https://pubmed.ncbi.nlm.nih.gov/1233212/,"Volunteer G, 200 mg tablet",Carbamazepine,0,inf,h,123.7,µg*h/mL,Individual,,,,AUC_inf,,,,,,,,26.9,mL/min,Individual,,,,CL/F,CL = plasma clearance = (Dose x F) / AUC
876,Pynnönen 1977,https://pubmed.ncbi.nlm.nih.gov/579557/,Single 400 mg oral dose,Carbamazepine,0,inf,h,1382,µmol*h/L,Arith. Mean,244,µmol*h/L,Arith. SD,AUC_inf,21.1,µmol/L,Arith. Mean,2.8,µmol/L,Arith. SD,Cmax,17.6,mL/min,Arith. Mean,3.8,mL/min,Arith. SD,CL/F,CL = CL Total
877,Pynnönen 1977,https://pubmed.ncbi.nlm.nih.gov/579557/,Single 400 mg oral dose,Carbamazepine,0,inf,h,427,µmol*h/L,Arith. Mean,101,µmol*h/L,Arith. SD,AUC_inf,6.2,µmol/L,Arith. Mean,0.6,µmol/L,Arith. SD,Cmax,69.6,mL/min,Arith. Mean,14.5,mL/min,Arith. SD,CL/F,CL = CL Total
878,Bedada 2015,https://pubmed.ncbi.nlm.nih.gov/25624269/,Control phase,Carbamazepine,0,inf,h,195.56,µg*h/mL,Arith. Mean,39.42,µg*h/mL,Arith. SD,AUC_inf,3.43,µg/mL,Arith. Mean,0.43,µg/mL,Arith. SD,Cmax,1.06,L/h,Arith. Mean,0.23,L/h,Arith. SD,CL/F,"AUC_last: 168,09 +/- 34,35"
879,Bedada 2015,https://pubmed.ncbi.nlm.nih.gov/25624269/,Control phase,Carbamazepine-10-11-epoxide,0,inf,h,15.02,µg*h/mL,Arith. Mean,2.95,µg*h/mL,Arith. SD,AUC_inf,0.2,µg/mL,Arith. Mean,0.05,µg/mL,Arith. SD,Cmax,13.86,L/h,Arith. Mean,3.12,L/h,Arith. SD,CL/F,"AUC_last: 11,28 +/- 2,33"
880,Bedada 2016,https://pubmed.ncbi.nlm.nih.gov/27776366/,Control phase,Carbamazepine,0,96,h,157.6,µg*h/mL,Arith. Mean,29.79,µg*h/mL,Arith. SD,AUC_tend,3.26,µg/mL,Arith. Mean,0.44,µg/mL,Arith. SD,Cmax,1.13,L/h,Arith. Mean,0.23,L/h,Arith. SD,CL/F,
881,Bedada 2016,https://pubmed.ncbi.nlm.nih.gov/27776366/,Control phase,Carbamazepine-10-11-epoxide,0,96,h,12.82,µg*h/mL,Arith. Mean,2.56,µg*h/mL,Arith. SD,AUC_tend,0.22,µg/mL,Arith. Mean,0.03,µg/mL,Arith. SD,Cmax,,,,,,,,
882,Kovacević 2009,https://pubmed.ncbi.nlm.nih.gov/19248231/,CBZ CR tablet (test),Carbamazepine,0,inf,h,241.94,µg*h/mL,Arith. Mean,58.31,µg*h/mL,Arith. SD,AUC_inf,3.88,mg/L,Arith. Mean,0.9,mg/L,Arith. SD,Cmax,,,,,,,,"AUC_(0-t): 211,54 +/- 47,67"
883,Kovacević 2009,https://pubmed.ncbi.nlm.nih.gov/19248231/,CBZ CR tablet (reference),Carbamazepine,0,inf,h,236.8,µg*h/mL,Arith. Mean,87.23,µg*h/mL,Arith. SD,AUC_inf,3.65,mg/L,Arith. Mean,1.42,mg/L,Arith. SD,Cmax,,,,,,,,"AUC_(0-t): 202,77 +/- 79,95"
884,Kovacević 2009,https://pubmed.ncbi.nlm.nih.gov/19248231/,CBZ IR tablet (test),Carbamazepine,0,inf,h,259.03,µg*h/mL,Arith. Mean,69.02,µg*h/mL,Arith. SD,AUC_inf,4.74,mg/L,Arith. Mean,1.27,mg/L,Arith. SD,Cmax,,,,,,,,"AUC_(0-t): 220,42 +/- 55,94"
885,Kovacević 2009,https://pubmed.ncbi.nlm.nih.gov/19248231/,CBZ IR tablet (reference),Carbamazepine,0,inf,h,259.15,µg*h/mL,Arith. Mean,63.97,µg*h/mL,Arith. SD,AUC_inf,4.34,mg/L,Arith. Mean,1.24,mg/L,Arith. SD,Cmax,,,,,,,,"AUC_(0-t): 211,37 +/- 52,97"
886,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject TV, 50 mg CBZ-E",Carbamazepine-10-11-epoxide,0,inf,h,49.6,µmol*h/L,Individual,,,,AUC_inf,5,µmol/L,Individual,,,,Cmax,63.5,mL/h/kg,Individual,,,,CL/F,
887,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject TT, 50 mg CBZ-E",Carbamazepine-10-11-epoxide,0,inf,h,43.8,µmol*h/L,Individual,,,,AUC_inf,4.2,µmol/L,Individual,,,,Cmax,69.7,mL/h/kg,Individual,,,,CL/F,
888,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject TT, 100 mg CBZ-E",Carbamazepine-10-11-epoxide,0,inf,h,66.2,µmol*h/L,Individual,,,,AUC_inf,5.8,µmol/L,Individual,,,,Cmax,92.2,mL/h/kg,Individual,,,,CL/F,
889,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject CT, 100 mg CBZ-E",Carbamazepine-10-11-epoxide,0,inf,h,74.9,µmol*h/L,Individual,,,,AUC_inf,7.5,µmol/L,Individual,,,,Cmax,76.8,mL/h/kg,Individual,,,,CL/F,
890,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject CT, 200 mg CBZ-E",Carbamazepine-10-11-epoxide,0,inf,h,162.8,µmol*h/L,Individual,,,,AUC_inf,14.3,µmol/L,Individual,,,,Cmax,70.6,mL/h/kg,Individual,,,,CL/F,
891,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject GB, 100 mg CBZ-E",Carbamazepine-10-11-epoxide,0,inf,h,55.1,µmol*h/L,Individual,,,,AUC_inf,6.9,µmol/L,Individual,,,,Cmax,135.8,mL/h/kg,Individual,,,,CL/F,
892,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject GB, 200 mg CBZ-E",Carbamazepine-10-11-epoxide,0,inf,h,155.7,µmol*h/L,Individual,,,,AUC_inf,16.5,µmol/L,Individual,,,,Cmax,96.2,mL/h/kg,Individual,,,,CL/F,
893,Tomson 1983,https://pubmed.ncbi.nlm.nih.gov/6848300/,"Subject GB, 200 mg CBZ",Carbamazepine,0,inf,h,596,µmol*h/L,Individual,,,,AUC_inf,,,,,,,,26.8,mL/h/kg,Individual,,,,CL/F,
894,Burstein 2000,https://pubmed.ncbi.nlm.nih.gov/11180020/,Before St John’s Wort,Carbamazepine,480,504,h,142.4,mg*h/L,Arith. Mean,12.9,mg*h/L,Arith. SD,AUC_tend,7.2,mg/L,Arith. Mean,1,mg/L,Arith. SD,Cmax,2.8,L/h,Arith. Mean,0.3,L/h,Arith. SD,CL/F,
895,Burstein 2000,https://pubmed.ncbi.nlm.nih.gov/11180020/,After St John’s Wort,Carbamazepine,816,840,h,143.8,mg*h/L,Arith. Mean,27.2,mg*h/L,Arith. SD,AUC_tend,7.6,mg/L,Arith. Mean,1.3,mg/L,Arith. SD,Cmax,2.9,L/h,Arith. Mean,0.6,L/h,Arith. SD,CL/F,
896,Burstein 2000,https://pubmed.ncbi.nlm.nih.gov/11180020/,Before St John’s Wort,Carbamazepine-10-11-epoxide,480,504,h,37.5,mg*h/L,Arith. Mean,7.4,mg*h/L,Arith. SD,AUC_tend,2,mg/L,Arith. Mean,0.5,mg/L,Arith. SD,Cmax,,,,,,,,
897,Burstein 2000,https://pubmed.ncbi.nlm.nih.gov/11180020/,After St John’s Wort,Carbamazepine-10-11-epoxide,816,840,h,41.9,mg*h/L,Arith. Mean,10.3,mg*h/L,Arith. SD,AUC_tend,2.1,mg/L,Arith. Mean,0.4,mg/L,Arith. SD,Cmax,,,,,,,,
898,Dalton 1985a,https://pubmed.ncbi.nlm.nih.gov/3987645/,Placebo (without cimetidine),Carbamazepine,0,inf,h,314,µg*h/mL,Arith. Mean,79,µg*h/mL,Arith. SD,AUC_inf,,,,,,,,,,,,,,,"The total area under the plasma concentration-time curve (AUC_0-inf) was determined by adding the AUC from 0 to 154 h (trapezoid rule) to the area after 154 h (CP_p154/K), where C_p154 is the fit concentration at 154h and K is the elimination rate constant."
899,Dalton 1985a,https://pubmed.ncbi.nlm.nih.gov/3987645/,Placebo (without cimetidine),Carbamazepine-10-11-epoxide,0,inf,h,28.4,µg*h/mL,Arith. Mean,10.7,µg*h/mL,Arith. SD,AUC_inf,,,,,,,,,,,,,,,"The total area under the plasma concentration-time curve (AUC_0-inf) was determined by adding the AUC from 0 to 154 h (trapezoid rule) to the area after 154 h (CP_p154/K), where C_p154 is the fit concentration at 154h and K is the elimination rate constant."
900,Dalton 1985a,https://pubmed.ncbi.nlm.nih.gov/3987645/,Treatment with cimetidine,Carbamazepine,47,201,h,394,µg*h/mL,Arith. Mean,76,µg*h/mL,Arith. SD,AUC_tend,,,,,,,,,,,,,,,
901,Dalton 1985a,https://pubmed.ncbi.nlm.nih.gov/3987645/,Treatment with cimetidine,Carbamazepine-10-11-epoxide,47,201,h,36,µg*h/mL,Arith. Mean,9.5,µg*h/mL,Arith. SD,AUC_tend,,,,,,,,,,,,,,,
902,Dalton 1985b,https://pubmed.ncbi.nlm.nih.gov/4085354/,Placebo (without ranitidine),Carbamazepine,0,inf,h,324.2,µg*h/mL,Arith. Mean,71.1,µg*h/mL,Arith. SD,AUC_inf,,,,,,,,,,,,,,,"The total area under the plasma concentration-time curve (AUC_0-inf) was determined by adding the AUC from 0 to 154 h (trapezoid rule) to the area after 154 h (CP_154/K), where C_154 is the fit concentration at 154h and K is the elimination rate constant."
903,Dalton 1985b,https://pubmed.ncbi.nlm.nih.gov/4085354/,Placebo (without ranitidine),Carbamazepine-10-11-epoxide,0,inf,h,24,µg*h/mL,Arith. Mean,4.2,µg*h/mL,Arith. SD,AUC_inf,,,,,,,,,,,,,,,"The total area under the plasma concentration-time curve (AUC_0-inf) was determined by adding the AUC from 0 to 154 h (trapezoid rule) to the area after 154 h (CP_154/K), where C_154 is the fit concentration at 154h and K is the elimination rate constant."
904,Bianchetti 1987,https://pubmed.ncbi.nlm.nih.gov/3098557/,CBZ before progabide administration,Carbamazepine,0,inf,h,227,µg*h/mL,Arith. Mean,25,µg*h/mL,SEM,AUC_inf,5.3,µg/mL,Arith. Mean,0.3,µg/mL,SEM,Cmax,0.025,L/h/kg,Arith. Mean,0.002,L/h/kg,SEM,CL/F,
905,Bianchetti 1987,https://pubmed.ncbi.nlm.nih.gov/3098557/,CBZ-O before progabide administration,Carbamazepine-10-11-epoxide,0,inf,h,10.531,µg*h/mL,Arith. Mean,1.007,µg*h/mL,SEM,AUC_inf,233,ng/mL,Arith. Mean,18,ng/mL,SEM,Cmax,,,,,,,,
463,Barzaghi 1987,https://pubmed.ncbi.nlm.nih.gov/3440106/,Without erythromycin,Carbamazepine,0,inf,h,362.9,µg*h/mL,Arith. Mean,101.3,µg*h/mL,Arith. SD,AUC_inf,5.2,µg/mL,Arith. Mean,0.5,µg/mL,Arith. SD,Cmax,14.9,mL/h/kg,Arith. Mean,3.8,mL/h/kg,Arith. SD,,
464,Barzaghi 1987,https://pubmed.ncbi.nlm.nih.gov/3440106/,Without erythromycin,Carbamazepine-10-11-epoxide,0,inf,h,12.5,µg*h/mL,Arith. Mean,2.7,µg*h/mL,Arith. SD,AUC_inf,183.9,ng/mL,Arith. Mean,41.1,ng/mL,Arith. SD,Cmax,,,,,,,,
465,Barzaghi 1987,https://pubmed.ncbi.nlm.nih.gov/3440106/,With erythromycin,Carbamazepine,144,240,h,478.9,µg*h/mL,Arith. Mean,151.4,µg*h/mL,Arith. SD,AUC_tend,5,µg/mL,Arith. Mean,0.6,µg/mL,Arith. SD,Cmax,11.3,mL/h/kg,Arith. Mean,2.7,mL/h/kg,Arith. SD,,
466,Barzaghi 1987,https://pubmed.ncbi.nlm.nih.gov/3440106/,With erythromycin,Carbamazepine-10-11-epoxide,144,240,h,7.8,µg*h/mL,Arith. Mean,1.1,µg*h/mL,Arith. SD,AUC_tend,107.4,ng/mL,Arith. Mean,19.1,ng/mL,Arith. SD,Cmax,,,,,,,,
467,Cotter 1977,https://pubmed.ncbi.nlm.nih.gov/598420/,Single oral 800 mg dose,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
906,Saint-Salvi 1987,https://pubmed.ncbi.nlm.nih.gov/3429380/,Carbamazepine alone,Carbamazepine,0,120,h,144.5,mg*h/L,Arith. Mean,9.1,mg*h/L,SEM,AUC_tend,2.77,mg/L,Arith. Mean,0.16,mg/L,SEM,Cmax,,,,,,,,"Westlake's confidence intervals for kinetic parameters of total and free CBZ: (Total CBZ): AUC: 144; CI: 18%; Cmax: 2,77; CI: 20%; (Free CBZ): AUC: 31,6; CI: 26%; Cmax: 0,56; CI: 29%"
907,McLean 2001,https://pubmed.ncbi.nlm.nih.gov/11210399/,"CBZ, intact capsule, fed state",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
908,McLean 2001,https://pubmed.ncbi.nlm.nih.gov/11210399/,"CBZ, intact capsule, fasting state",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
909,McLean 2001,https://pubmed.ncbi.nlm.nih.gov/11210399/,"CBZ, fasting state except for administration with applesauce",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
910,McLean 2001,https://pubmed.ncbi.nlm.nih.gov/11210399/,"CBZ-E, intact capsule, fed state",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
911,McLean 2001,https://pubmed.ncbi.nlm.nih.gov/11210399/,"CBZ-E, intact capsule, fasting state",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
912,McLean 2001,https://pubmed.ncbi.nlm.nih.gov/11210399/,"CBZ-E, fasting state except for administration with applesauce",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
913,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 1,Carbamazepine,0,inf,h,,,,,,,,3.2,µg/mL,Individual,,,,Cmax,,,,,,,,
914,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 2,Carbamazepine,0,inf,h,,,,,,,,3.2,µg/mL,Individual,,,,Cmax,,,,,,,,
915,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 3,Carbamazepine,0,inf,h,,,,,,,,3,µg/mL,Individual,,,,Cmax,,,,,,,,
916,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 4,Carbamazepine,0,inf,h,,,,,,,,2.5,µg/mL,Individual,,,,Cmax,,,,,,,,
917,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 5,Carbamazepine,0,inf,h,,,,,,,,3.9,µg/mL,Individual,,,,Cmax,,,,,,,,
918,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 6,Carbamazepine,0,inf,h,,,,,,,,2.7,µg/mL,Individual,,,,Cmax,,,,,,,,
919,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 7,Carbamazepine,0,inf,h,,,,,,,,3.1,µg/mL,Individual,,,,Cmax,,,,,,,,
920,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 8,Carbamazepine,0,inf,h,,,,,,,,4.5,µg/mL,Individual,,,,Cmax,,,,,,,,
921,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 9,Carbamazepine,0,inf,h,,,,,,,,5.3,µg/mL,Individual,,,,Cmax,,,,,,,,
922,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 10,Carbamazepine,0,inf,h,,,,,,,,5.1,µg/mL,Individual,,,,Cmax,,,,,,,,
923,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 11,Carbamazepine,0,inf,h,,,,,,,,3.7,µg/mL,Individual,,,,Cmax,,,,,,,,
924,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject no. 12,Carbamazepine,0,inf,h,,,,,,,,3.5,µg/mL,Individual,,,,Cmax,,,,,,,,
1454,Strandjord 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Mean concentrations,Carbamazepine,0,inf,h,,,,,,,,3.5,µg/mL,Arith. Mean,0.8,µg/mL,Arith. SD,Cmax,,,,,,,,
925,Morselli 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Healthy volunteers,Carbamazepine,0,inf,h,322,µg*h/mL,Arith. Mean,129,µg*h/mL,Arith. SD,AUC_inf,"4,2-6,4",µg/mL,,,,,Cmax,0.017,L/h/kg,Arith. Mean,0.003,L/h/kg,Arith. SD,CL/F,Peak plasma levels (4.2-6.4 µg/ml) were attained between the 6th and the 18th hr
932,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject A,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
933,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject A,Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
934,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject B,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
935,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject B,Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
936,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject A,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
937,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject A,Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
938,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject A,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
940,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject B,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
941,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject B,Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
942,Faigle 1975,https://link.springer.com/chapter/10.1007/978-3-642-85921-2_17,Subject B,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
944,Stevens 1998,https://pubmed.ncbi.nlm.nih.gov/10189261/,Carbatrol,Carbamazepine,96,108,h,144.3,µg*h/mL,Geom. Mean,16.7,µg*h/mL,Geom. SD,AUC_tau,14.6,µg/mL,Geom. Mean,3.4,µg/mL,Geom. SD,Cmax,,,,,,,,
945,Stevens 1998,https://pubmed.ncbi.nlm.nih.gov/10189261/,Tegretol-XR,Carbamazepine,96,108,h,148.5,µg*h/mL,Geom. Mean,30,µg*h/mL,Geom. SD,AUC_tau,13.8,µg/mL,Geom. Mean,3.4,µg/mL,Geom. SD,Cmax,,,,,,,,
946,Stevens 1998,https://pubmed.ncbi.nlm.nih.gov/10189261/,Carbatrol,Carbamazepine-10-11-epoxide,96,108,h,19.3,µg*h/mL,Geom. Mean,3.8,µg*h/mL,Geom. SD,AUC_tau,1.9,µg/mL,Geom. Mean,0.4,µg/mL,Geom. SD,Cmax,,,,,,,,
947,Stevens 1998,https://pubmed.ncbi.nlm.nih.gov/10189261/,Tegretol-XR,Carbamazepine-10-11-epoxide,96,108,h,19.1,µg*h/mL,Geom. Mean,4.9,µg*h/mL,Geom. SD,AUC_tau,2,µg/mL,Geom. Mean,0.5,µg/mL,Geom. SD,Cmax,,,,,,,,
948,Meyer 1992,https://pubmed.ncbi.nlm.nih.gov/1488405/,Product 1 (Tegretol),Carbamazepine,0,inf,h,143.5,µg*h/mL,Arith. Mean,15,µg*h/mL,CV%,AUC_inf,1.89,µg/mL,Arith. Mean,20,µg/mL,CV%,Cmax,,,,,,,,"N=24. AUC(0-169): 134,8 (15)"
949,Meyer 1992,https://pubmed.ncbi.nlm.nih.gov/1488405/,Product 2,Carbamazepine,0,inf,h,86.5,µg*h/mL,Arith. Mean,47,µg*h/mL,CV%,AUC_inf,1.15,µg/mL,Arith. Mean,62,µg/mL,CV%,Cmax,,,,,,,,"N=24. AUC(0-169): 80,9 (48)"
950,Meyer 1992,https://pubmed.ncbi.nlm.nih.gov/1488405/,Product 3,Carbamazepine,0,inf,h,162.2,µg*h/mL,Arith. Mean,20,µg*h/mL,CV%,AUC_inf,2.69,µg/mL,Arith. Mean,18,µg/mL,CV%,Cmax,,,,,,,,"N=23. AUC(0-169): 154,2 (18)"
951,Meyer 1992,https://pubmed.ncbi.nlm.nih.gov/1488405/,Product 4,Carbamazepine,0,inf,h,111.7,µg*h/mL,Arith. Mean,29,µg*h/mL,CV%,AUC_inf,1.4,µg/mL,Arith. Mean,39,µg/mL,CV%,Cmax,,,,,,,,"N=23. AUC(0-169): 104,5 (30)"
952,Meyer 1998,https://pubmed.ncbi.nlm.nih.gov/9834004/,Product 1 (Tegretol),Carbamazepine,0,inf,h,157.4,µg*h/mL,Arith. Mean,18,µg*h/mL,CV%,AUC_inf,1.95,µg/mL,Arith. Mean,16,µg/mL,CV%,Cmax,,,,,,,,"AUC(0-169): 147,1 (17)"
953,Meyer 1998,https://pubmed.ncbi.nlm.nih.gov/9834004/,Product 2,Carbamazepine,0,inf,h,163.3,µg*h/mL,Arith. Mean,19,µg*h/mL,CV%,AUC_inf,2.32,µg/mL,Arith. Mean,15,µg/mL,CV%,Cmax,,,,,,,,"AUC(0-169): 153,0 (18)"
954,Meyer 1998,https://pubmed.ncbi.nlm.nih.gov/9834004/,Product 3,Carbamazepine,0,inf,h,159.2,µg*h/mL,Arith. Mean,19,µg*h/mL,CV%,AUC_inf,2.3,µg/mL,Arith. Mean,21,µg/mL,CV%,Cmax,,,,,,,,"AUC(0-169): 148,9 (18)"
955,Meyer 1998,https://pubmed.ncbi.nlm.nih.gov/9834004/,Product 4,Carbamazepine,0,inf,h,162.9,µg*h/mL,Arith. Mean,17,µg*h/mL,CV%,AUC_inf,2.34,µg/mL,Arith. Mean,15,µg/mL,CV%,Cmax,,,,,,,,"AUC(0-169): 152,8 (16)"
956,Kim 2005,https://pubmed.ncbi.nlm.nih.gov/15915352/,Placebo (without probenecid),Carbamazepine,0,inf,h,1253.9,µmol*h/L,Arith. Mean,"1099,1; 1408,8",µmol*h/L,95% CI,AUC_inf,15.6,µmol/L,Arith. Mean,"12,9; 18,3",µmol/L,95% CI,Cmax,1.21,L/h,Arith. Mean,"1,03; 1,38",L/h,95% CI,CL/F,"AUC(0-120): 1084,8 (938,8; 1230,8); CL(renal): 8,35 (6,30; 10,40) ml/h; CL(formation): 1,59 (0,95; 2,23) ml/h"
957,Kim 2005,https://pubmed.ncbi.nlm.nih.gov/15915352/,Placebo (without probenecid),Carbamazepine-10-11-epoxide,0,inf,h,137.6,µmol*h/L,Arith. Mean,"93,2; 182,0",µmol*h/L,95% CI,AUC_inf,1.4,µmol/L,Arith. Mean,"1,0; 2,0",µmol/L,95% CI,Cmax,,,,,,,,"AUC(0-120): 120,7 (78,2; 163,2); CL(renal): 135,49 (80,13; 190,85) ml/h; CL(formation): 7,45 (1,40; 13,50) ml/h"
958,Ji 2008,https://pubmed.ncbi.nlm.nih.gov/18519918/,"Efavirenz, control (Arm 1)",Efavirenz,312,336,h,71.5,µg*h/mL,adjusted geom. Mean,31,µg*h/mL,%CV,AUC_tau,5.65,µg/mL,adjusted geom. Mean,23,µg/mL,%CV,Cmax,8.56,L/h,Arith. Mean,2.25,L/h,Arith. SD,CL/F,"The pharmacokinetic parameters from subject 113 (female caucasian) in arm 1 were excluded from statistical analysis because this subject had a very high AUCτ value (279 μg×h/mL, day 35) and appeared to be an outlier. It is of note that including this subject in the statistical analysis did not affect the overall conclusions of the study."
959,Ji 2008,https://pubmed.ncbi.nlm.nih.gov/18519918/,"Efavirenz + Carbamazepine, treatment (Arm 1)",Efavirenz,816,840,h,45.6,µg*h/mL,adjusted geom. Mean,40,µg*h/mL,%CV,AUC_tau,4.48,µg/mL,adjusted geom. Mean,23,µg/mL,%CV,Cmax,13.9,L/h,Arith. Mean,4.67,L/h,Arith. SD,CL/F,"The pharmacokinetic parameters from subject 113 (female caucasian) in arm 1 were excluded from statistical analysis because this subject had a very high AUCτ value (279 μg×h/mL, day 35) and appeared to be an outlier. It is of note that including this subject in the statistical analysis did not affect the overall conclusions of the study."
960,Ji 2008,https://pubmed.ncbi.nlm.nih.gov/18519918/,"Carbamazepine, control (Arm 2)",Carbamazepine,480,504,h,139,µg*h/mL,adjusted geom. Mean,19,µg*h/mL,%CV,AUC_tau,7.89,µg/mL,adjusted geom. Mean,16,µg/mL,%CV,Cmax,4.05,L/h,Arith. Mean,1.06,L/h,Arith. SD,CL/F,
961,Ji 2008,https://pubmed.ncbi.nlm.nih.gov/18519918/,"Carbamazepine + Efavirenz, treatment (Arm 2)",Carbamazepine,816,840,h,101,µg*h/mL,adjusted geom. Mean,21,µg*h/mL,%CV,AUC_tau,6.34,µg/mL,adjusted geom. Mean,14,µg/mL,%CV,Cmax,2.93,L/h,Arith. Mean,5.66,L/h,Arith. SD,CL/F,
962,Ji 2008,https://pubmed.ncbi.nlm.nih.gov/18519918/,"Carbamazepine, control (Arm 2)",Carbamazepine-10-11-epoxide,480,504,h,19.4,µg*h/mL,adjusted geom. Mean,24,µg*h/mL,%CV,AUC_tau,1,µg/mL,adjusted geom. Mean,24,µg/mL,%CV,Cmax,,,,,,,,
963,Ji 2008,https://pubmed.ncbi.nlm.nih.gov/18519918/,"Carbamazepine + Efavirenz, treatment (Arm 2)",Carbamazepine-10-11-epoxide,816,840,h,19.1,µg*h/mL,adjusted geom. Mean,28,µg*h/mL,%CV,AUC_tau,1.05,µg/mL,adjusted geom. Mean,25,µg/mL,%CV,Cmax,,,,,,,,
964,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,single oral dose of 100 mg,Carbamazepine,0,inf,h,71,µg*h/mL,Arith. Mean,26,µg*h/mL,Arith. SD,AUC_inf,1.01,µg/mL,Arith. Mean,0.15,µg/mL,Arith. SD,Cmax,,,,,,,,
965,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,single oral dose of 200 mg,Carbamazepine,0,inf,h,118,µg*h/mL,Arith. Mean,36,µg*h/mL,Arith. SD,AUC_inf,1.72,µg/mL,Arith. Mean,0.1,µg/mL,Arith. SD,Cmax,,,,,,,,
966,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,single oral dose of 600 mg,Carbamazepine,0,inf,h,292,µg*h/mL,Arith. Mean,65,µg*h/mL,Arith. SD,AUC_inf,4.55,µg/mL,Arith. Mean,0.62,µg/mL,Arith. SD,Cmax,,,,,,,,
967,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,"Repeated dose 200 mg, Subject 1",Carbamazepine,0,inf,h,142,µg*h/mL,Individual,,,,AUC_inf,1.83,µg/mL,Individual,,,,Cmax,,,,,,,,"AUC Avg values taken from ""First dose"". Last dose: AUC_(408-432): 77; Cmax: 3,99"
968,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,"Repeated dose 200 mg, Subject 2",Carbamazepine,0,inf,h,116,µg*h/mL,Individual,,,,AUC_inf,2.09,µg/mL,Individual,,,,Cmax,,,,,,,,"AUC Avg values taken from ""First dose"". Last dose: AUC_(408-432): 91; Cmax: 4,29"
969,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,"Repeated dose 200 mg, Subject 3",Carbamazepine,0,inf,h,129,µg*h/mL,Individual,,,,AUC_inf,1.87,µg/mL,Individual,,,,Cmax,,,,,,,,"AUC Avg values taken from ""First dose"". Last dose: AUC_(408-432): 85; Cmax: 4,15"
970,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,"Repeated dose 200 mg, Subject 4",Carbamazepine,0,inf,h,101,µg*h/mL,Individual,,,,AUC_inf,1.83,µg/mL,Individual,,,,Cmax,,,,,,,,"AUC Avg values taken from ""First dose"". Last dose: AUC_(408-432): 63; Cmax: 3,09"
971,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,"Repeated dose 200 mg, Subject 5",Carbamazepine,0,inf,h,127,µg*h/mL,Individual,,,,AUC_inf,1.83,µg/mL,Individual,,,,Cmax,,,,,,,,"AUC Avg values taken from ""First dose"". Last dose: AUC_(408-432): 69; Cmax: 3,17"
972,Gérardin 1990,https://pubmed.ncbi.nlm.nih.gov/2344850/,"Subject 1, 2 h IV infusion",Carbamazepine,0,inf,h,30.9,µmol*h/L,Individual,,,,AUC_inf,,,,,,,,,,,,,,,
973,Gérardin 1990,https://pubmed.ncbi.nlm.nih.gov/2344850/,"Subject 1, 100 mg 15N-CBZ as 2% oral suspension",Carbamazepine,0,inf,h,315,µmol*h/L,Individual,,,,AUC_inf,,,,,,,,23,mL/min,Individual,,,,CL/F,
974,Gérardin 1990,https://pubmed.ncbi.nlm.nih.gov/2344850/,"Subject 2, 2 h IV infusion",Carbamazepine,0,inf,h,37,µmol*h/L,Individual,,,,AUC_inf,,,,,,,,,,,,,,,
975,Gérardin 1990,https://pubmed.ncbi.nlm.nih.gov/2344850/,"Subject 2, 100 mg 15N-CBZ as 2% oral suspension",Carbamazepine,0,inf,h,368.9,µmol*h/L,Individual,,,,AUC_inf,,,,,,,,19.5,mL/min,Individual,,,,CL/F,
976,Elqidra 2009,https://www.sciencedirect.com/science/article/pii/S1773224704500278,Tegretol,Carbamazepine,0,inf,h,72.083,µg*h/mL,Arith. Mean,21.648,µg*h/mL,Arith. SD,AUC_inf,1.235,µg/mL,Arith. Mean,0.342,µg/mL,Arith. SD,Cmax,,,,,,,,"Confidence limits for AUC_(0->inf): 94,81 +/- 49,35; Cmax: 1,59 +/- 0,87"
977,Elqidra 2009,https://www.sciencedirect.com/science/article/pii/S1773224704500278,Bulk CBZ,Carbamazepine,0,inf,h,78.672,µg*h/mL,Arith. Mean,28.688,µg*h/mL,Arith. SD,AUC_inf,1.479,µg/mL,Arith. Mean,0.445,µg/mL,Arith. SD,Cmax,,,,,,,,"Confidence limits for AUC_(0->inf): 108,78 +/- 48,55; Cmax: 1,94 +/- 1,01"
978,Elqidra 2009,https://www.sciencedirect.com/science/article/pii/S1773224704500278,Beta form CBZ,Carbamazepine,0,inf,h,71.175,µg*h/mL,Arith. Mean,24.235,µg*h/mL,Arith. SD,AUC_inf,1.178,µg/mL,Arith. Mean,0.344,µg/mL,Arith. SD,Cmax,,,,,,,,"Confidence limits for AUC_(0->inf): 96,61 +/- 45,73; Cmax: 1,55 +/- 0,82"
979,Bernus 1994,https://pubmed.ncbi.nlm.nih.gov/7875188/,CBZ conc,Carbamazepine,120,inf,h,1.65,mmol*h/L,Arith. Mean,0.27,mmol*h/L,Arith. SD,AUC_inf,,,,,,,,1.74,L/h,Arith. Mean,0.29,L/h,Arith. SD,CL/F,"AUC and CL values = SECOND DOSE values. FIRST DOSE values: AUC: 1,73 +/- 0,18; CL: 1,48 +/- 0,17"
980,Bernus 1994,https://pubmed.ncbi.nlm.nih.gov/7875188/,epoxide conc,Carbamazepine-10-11-epoxide,120,inf,h,,,,,,,,,,,,,,,,,,,,,,
985,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,CBZ solution (200 mg),Carbamazepine,0,inf,h,,,,,,,,,,,,,,,15.43,mL/h/kg,Arith. Mean,3.15,mL/h/kg,Arith. SD,CL/F,"CL= FD/AUC, with the F values of CBZ and EPO assumed to be 1.0 and 0.81, respectively"
986,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,EPO solution (150 mg),Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,112.56,mL/h/kg,Arith. Mean,36.59,mL/h/kg,Arith. SD,CL/F,"Subject 1: AUC (µg*h/ml): 22,66, Cmax (µg/ml): 2,38; Subject 2: AUC: 20,38; Cmax: 2,17; CL= FD/AUC, with the F values of CBZ and EPO assumed to be 1.0 and 0.81, respectively."
987,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Solution, CBZ",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
988,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Solution, EPO",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
989,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Tablet A, CBZ",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
990,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Tablet A, EPO",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
991,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Tablet B, CBZ",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
992,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Tablet B, EPO",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
993,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Tablet C, CBZ",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
994,Sumi 1987,https://pubmed.ncbi.nlm.nih.gov/3446773/,"Tablet C, EPO",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
995,Wada 1978,https://pubmed.ncbi.nlm.nih.gov/679894/,Tablet,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
996,Wada 1978,https://pubmed.ncbi.nlm.nih.gov/679894/,Syrup,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
997,Wada 1978,https://pubmed.ncbi.nlm.nih.gov/679894/,Tablet,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
998,Wada 1978,https://pubmed.ncbi.nlm.nih.gov/679894/,Syrup,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
999,Pisani 1990,https://pubmed.ncbi.nlm.nih.gov/2111769/,Control session (without valproate),Carbamazepine-10-11-epoxide,0,inf,h,17.5,µg*h/mL,Arith. Mean,2.9,µg*h/mL,Arith. SD,AUC_inf,1.17,µg/mL,Arith. Mean,0.34,µg/mL,Arith. SD,Cmax,90.6,mL/h/kg,Arith. Mean,18.8,mL/h/kg,Arith. SD,CL/F,
1000,Pisani 1992,https://pubmed.ncbi.nlm.nih.gov/1352988/,Control session (without valnoctamide),Carbamazepine-10-11-epoxide,0,inf,h,63.8,µmol*h/mL,Arith. Mean,22.5,µmol*h/mL,Arith. SD,AUC_inf,5.2,µmol/L,Arith. Mean,2.4,µmol/L,Arith. SD,Cmax,110,mL/h/kg,Arith. Mean,31,mL/h/kg,Arith. SD,CL/F,
1003,Levy 1975,https://pubmed.ncbi.nlm.nih.gov/1139857/,propylene glycol solution,Carbamazepine,0,inf,h,,,,,,,,6.46,mg/L,Arith. Mean,0.88,mg/L,Arith. SD,Cmax,,,,,,,,Cmax for 5 subjects! Cmax = Cbmax = maximum serum concentration reached at time Tmax
1100,Levy 1975,https://pubmed.ncbi.nlm.nih.gov/1139857/,commercial tablet,Carbamazepine,0,inf,h,,,,,,,,4.52,mg/L,Arith. Mean,0.8,mg/L,Arith. SD,Cmax,,,,,,,,Cmax = Cbmax = maximum serum concentration reached at time Tmax
1101,Gérardin 1976,https://pubmed.ncbi.nlm.nih.gov/1011076/,"Repeated dose 200 mg, Geomean",Carbamazepine,0,inf,h,,,,,,,,4.52,mg/L,Arith. Mean,0.8,mg/L,Arith. SD,Cmax,,,,,,,,Cmax = Cbmax = maximum serum concentration reached at time Tmax
1144,Eichelbaum 1985,https://pubmed.ncbi.nlm.nih.gov/3971637/,Cumulative urinary excretion,Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,8.78,mg/L,Arith. Mean,1.89,mg/L,Arith. SD,Cmax,,,,,,,,Cmax = Cbmax = maximum serum concentration reached at time Tmax
1153,Wong 1983,https://pubmed.ncbi.nlm.nih.gov/6831824/,Treatment B (without erythromycin),Carbamazepine,0,inf,h,,,,,,,,,,,,,,,15,mL/h/kg,Arith. Mean,3,mL/h/kg,Arith. SD,CL/F,"CL values = Oral Clearance (Model dependent); Model independent: 16,1 +/- 3,4"
1154,Wong 1983,https://pubmed.ncbi.nlm.nih.gov/6831824/,Treatment A (with erythromycin),Carbamazepine,120,192,h,,,,,,,,,,,,,,,12.1,mL/h/kg,Arith. Mean,3.1,mL/h/kg,Arith. SD,CL/F,"CL values = Oral Clearance (Model dependent); Model independent: 13,4 +/- 2,6"
1161,Kayali 1994,https://pubmed.ncbi.nlm.nih.gov/7737233/,Temporol,Carbamazepine,0,inf,h,161.488,,Arith. Mean,43.216,,Arith. SD,AUC_inf,2.49,µg/mL,Arith. Mean,,,,Cmax,0.018,L/h/kg,Arith. Mean,,,,CL/F,CL = CL(h) = CL(hypothetical); Clearance was computed by the formula: CL (hypothetical) = ke * V
1162,Kayali 1994,https://pubmed.ncbi.nlm.nih.gov/7737233/,Tegretol,Carbamazepine,0,inf,h,144.977,,Arith. Mean,34.905,,Arith. SD,AUC_inf,2.111,µg/mL,Arith. Mean,,,,Cmax,0.018,L/h/kg,Arith. Mean,,,,CL/F,CL = CL(h) = CL(hypothetical); Clearance was computed by the formula: CL (hypothetical) = ke * V
1163,Kayali 1994,https://pubmed.ncbi.nlm.nih.gov/7737233/,Karazepin,Carbamazepine,0,inf,h,126.516,,Arith. Mean,33.028,,Arith. SD,AUC_inf,1.714,µg/mL,Arith. Mean,,,,Cmax,0.02,L/h/kg,Arith. Mean,,,,CL/F,CL = CL(h) = CL(hypothetical); Clearance was computed by the formula: CL (hypothetical) = ke * V
1164,Dixit 2001,https://pubmed.ncbi.nlm.nih.gov/11413862/,CBZ alone (before omeprazole treatment),Carbamazepine,0,inf,h,318.53,µg*h/mL,Arith. Mean,21.75,µg*h/mL,SEM,AUC_inf,6.83,µg/mL,Arith. Mean,0.38,µg/mL,SEM,Cmax,,,,,,,,
1194,Pattanaik 2009,https://pubmed.ncbi.nlm.nih.gov/19283724/,CBZ alone (without piperine),Carbamazepine,12,24,h,66.12,µg*h/mL,Arith. Mean,5.23,µg*h/mL,Arith. SD,AUC_tend,6.69,µg/mL,Arith. Mean,0.56,µg/mL,Arith. SD,Cmax,,,,,,,,"Discrepancy: table footer states that values are mean +/- SD, but ""Statistical analysis"" chaper states that data were expressed as mean +/- SEM."
1400,Pattanaik 2009,https://pubmed.ncbi.nlm.nih.gov/19283724/,CBZ alone (without piperine),Carbamazepine,12,24,h,81.37,µg*h/mL,Arith. Mean,4.9,µg*h/mL,Arith. SD,AUC_tend,7.9,µg/mL,Arith. Mean,0.5,µg/mL,Arith. SD,Cmax,,,,,,,,"Discrepancy: table footer states that values are mean +/- SD, but ""Statistical analysis"" chaper states that data were expressed as mean +/- SEM."
1401,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,CMZ CR 400 mg tablet,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1402,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,"Tegretol CR 400 mg tablet, lot A",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1403,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,"Tegretol CR 400 mg tablet, lot B",Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1404,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,CMZ CR 400 mg tablet,Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1405,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,"Tegretol CR 400 mg tablet, lot A",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1406,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,"Tegretol CR 400 mg tablet, lot B",Carbamazepine-10-11-epoxide,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1407,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,CMZ CR 400 mg tablets,Carbamazepine,168,192,h,,,,,,,,,,,,,,,,,,,,,,
1408,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,Tegretol CR 400 mg tablets,Carbamazepine,168,192,h,,,,,,,,,,,,,,,,,,,,,,
1409,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,CMZ CR 600 mg tablet,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1410,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,Tegretol CR 600 mg tablet,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1411,European Patent Application 2000,https://patentimages.storage.googleapis.com/0c/45/b7/d2be4fa9d24371/EP1044681A2.pdf,Tegretol CR 600 mg encapsulated granulate,Carbamazepine,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1412,US Patent Application - US 2014 0302138 A1,https://patentimages.storage.googleapis.com/57/d9/18/0d8cbfa046681d/US20140302138A1.pdf,Carbamazepine XR (Test),Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
1413,US Patent Application - US 2014 0302138 A1,https://patentimages.storage.googleapis.com/57/d9/18/0d8cbfa046681d/US20140302138A1.pdf,Tegretol XR (Reference),Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
1414,US Patent Application - US 2009 0169619 A1,https://patentimages.storage.googleapis.com/66/d4/30/f3588f44ab2b6f/US20090169619A1.pdf,Test,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
1415,US Patent Application - US 2009 0169619 A1,https://patentimages.storage.googleapis.com/66/d4/30/f3588f44ab2b6f/US20090169619A1.pdf,Reference,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
1416,US Patent Application - US 2009 0169619 A1,https://patentimages.storage.googleapis.com/66/d4/30/f3588f44ab2b6f/US20090169619A1.pdf,Test,Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
1417,US Patent Application - US 2009 0169619 A1,https://patentimages.storage.googleapis.com/66/d4/30/f3588f44ab2b6f/US20090169619A1.pdf,Reference,Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
1418,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,CBZ before ERY,Carbamazepine,312,336,h,387.7,mg*h/L,Arith. Mean,151.1,mg*h/L,Arith. SD,AUC_tau,7.5,mg/L,Arith. Mean,1.43,mg/L,Arith. SD,Cmax,17.1,mL/min,Arith. Mean,5.7,mL/min,Arith. SD,CL/F,
1419,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,CBZE before ERY,Carbamazepine-10-11-epoxide,312,336,h,26.2,mg*h/L,Arith. Mean,4.1,mg*h/L,Arith. SD,AUC_tau,1.21,mg/L,Arith. Mean,0.17,mg/L,Arith. SD,Cmax,,,,,,,,
1420,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,CBZ during ERY,Carbamazepine,384,408,h,516.7,mg*h/L,Arith. Mean,151.3,mg*h/L,Arith. SD,AUC_tend,7.47,mg/L,Arith. Mean,1.47,mg/L,Arith. SD,Cmax,13.1,mL/min,Arith. Mean,4.9,mL/min,Arith. SD,CL/F,
1421,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,CBZE during ERY,Carbamazepine-10-11-epoxide,384,408,h,20.2,mg*h/L,Arith. Mean,4.4,mg*h/L,Arith. SD,AUC_tend,0.89,mg/L,Arith. Mean,0.2,mg/L,Arith. SD,Cmax,,,,,,,,
1422,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 1 (before erythromycin),Carbamazepine,312,336,h,296,mg*h/L,Individual,,,,AUC_tau,6.13,mg/L,Individual,,,,Cmax,22.5,mL/min,Individual,,,,CL/F,
1423,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 2 (before erythromycin),Carbamazepine,312,336,h,347.2,mg*h/L,Individual,,,,AUC_tau,7.71,mg/L,Individual,,,,Cmax,19.2,mL/min,Individual,,,,CL/F,
1424,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 3 (before erythromycin),Carbamazepine,312,336,h,443.7,mg*h/L,Individual,,,,AUC_tau,7.85,mg/L,Individual,,,,Cmax,15,mL/min,Individual,,,,CL/F,
1425,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 4 (before erythromycin),Carbamazepine,312,336,h,694.9,mg*h/L,Individual,,,,AUC_tau,10.06,mg/L,Individual,,,,Cmax,7.2,mL/min,Individual,,,,CL/F,
1426,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 5 (before erythromycin),Carbamazepine,312,336,h,393.4,mg*h/L,Individual,,,,AUC_tau,7.45,mg/L,Individual,,,,Cmax,12.7,mL/min,Individual,,,,CL/F,
1427,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 6 (before erythromycin),Carbamazepine,312,336,h,296.4,mg*h/L,Individual,,,,AUC_tau,7.71,mg/L,Individual,,,,Cmax,22.5,mL/min,Individual,,,,CL/F,
1428,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 7 (before erythromycin),Carbamazepine,312,336,h,242.3,mg*h/L,Individual,,,,AUC_tau,5.59,mg/L,Individual,,,,Cmax,20.6,mL/min,Individual,,,,CL/F,
1429,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 1 (during erythromycin),Carbamazepine,384,408,h,492.1,mg*h/L,Individual,,,,AUC_tend,5.92,mg/L,Individual,,,,Cmax,13.6,mL/min,Individual,,,,CL/F,
1430,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 2 (during erythromycin),Carbamazepine,384,408,h,456.5,mg*h/L,Individual,,,,AUC_tend,7.83,mg/L,Individual,,,,Cmax,14.6,mL/min,Individual,,,,CL/F,
1431,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 3 (during erythromycin),Carbamazepine,384,408,h,754.8,mg*h/L,Individual,,,,AUC_tend,8.16,mg/L,Individual,,,,Cmax,8.8,mL/min,Individual,,,,CL/F,
1432,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 4 (during erythromycin),Carbamazepine,384,408,h,562.8,mg*h/L,Individual,,,,AUC_tend,10.01,mg/L,Individual,,,,Cmax,8.9,mL/min,Individual,,,,CL/F,
1433,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 5 (during erythromycin),Carbamazepine,384,408,h,650.4,mg*h/L,Individual,,,,AUC_tend,7.31,mg/L,Individual,,,,Cmax,7.7,mL/min,Individual,,,,CL/F,
1434,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 6 (during erythromycin),Carbamazepine,384,408,h,327.1,mg*h/L,Individual,,,,AUC_tend,7.5,mg/L,Individual,,,,Cmax,20.4,mL/min,Individual,,,,CL/F,
1435,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 7 (during erythromycin),Carbamazepine,384,408,h,373.3,mg*h/L,Individual,,,,AUC_tend,5.59,mg/L,Individual,,,,Cmax,17,mL/min,Individual,,,,CL/F,
1436,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 1 (before erythromycin),Carbamazepine-10-11-epoxide,312,336,h,22,mg*h/L,Individual,,,,AUC_tau,1.03,mg/L,Individual,,,,Cmax,,,,,,,,
1437,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 2 (before erythromycin),Carbamazepine-10-11-epoxide,312,336,h,30.7,mg*h/L,Individual,,,,AUC_tau,1.39,mg/L,Individual,,,,Cmax,,,,,,,,
1438,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 3 (before erythromycin),Carbamazepine-10-11-epoxide,312,336,h,29.8,mg*h/L,Individual,,,,AUC_tau,1.33,mg/L,Individual,,,,Cmax,,,,,,,,
1439,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 4 (before erythromycin),Carbamazepine-10-11-epoxide,312,336,h,29.2,mg*h/L,Individual,,,,AUC_tau,1.28,mg/L,Individual,,,,Cmax,,,,,,,,
1440,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 5 (before erythromycin),Carbamazepine-10-11-epoxide,312,336,h,23.7,mg*h/L,Individual,,,,AUC_tau,1.05,mg/L,Individual,,,,Cmax,,,,,,,,
1441,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 6 (before erythromycin),Carbamazepine-10-11-epoxide,312,336,h,27.6,mg*h/L,Individual,,,,AUC_tau,1.38,mg/L,Individual,,,,Cmax,,,,,,,,
1442,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 7 (before erythromycin),Carbamazepine-10-11-epoxide,312,336,h,20.5,mg*h/L,Individual,,,,AUC_tau,1.02,mg/L,Individual,,,,Cmax,,,,,,,,
1443,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 1 (during erythromycin),Carbamazepine-10-11-epoxide,384,408,h,18.5,mg*h/L,Individual,,,,AUC_tend,0.82,mg/L,Individual,,,,Cmax,,,,,,,,
1444,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 2 (during erythromycin),Carbamazepine-10-11-epoxide,384,408,h,24.4,mg*h/L,Individual,,,,AUC_tend,1.09,mg/L,Individual,,,,Cmax,,,,,,,,
1445,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 3 (during erythromycin),Carbamazepine-10-11-epoxide,384,408,h,24.7,mg*h/L,Individual,,,,AUC_tend,1.1,mg/L,Individual,,,,Cmax,,,,,,,,
1446,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 4 (during erythromycin),Carbamazepine-10-11-epoxide,384,408,h,23.1,mg*h/L,Individual,,,,AUC_tend,1.02,mg/L,Individual,,,,Cmax,,,,,,,,
1447,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 5 (during erythromycin),Carbamazepine-10-11-epoxide,384,408,h,19.2,mg*h/L,Individual,,,,AUC_tend,0.84,mg/L,Individual,,,,Cmax,,,,,,,,
1448,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 6 (during erythromycin),Carbamazepine-10-11-epoxide,384,408,h,18.7,mg*h/L,Individual,,,,AUC_tend,0.84,mg/L,Individual,,,,Cmax,,,,,,,,
1449,Miles 1989,https://pubmed.ncbi.nlm.nih.gov/2911854/,Subject 7 (during erythromycin),Carbamazepine-10-11-epoxide,384,408,h,12.1,mg*h/L,Individual,,,,AUC_tend,0.54,mg/L,Individual,,,,Cmax,,,,,,,,
1450,Møller 2001,https://pubmed.ncbi.nlm.nih.gov/11593075/,CBZ alone,Carbamazepine,480,504,h,136,µg*h/mL,Arith. Mean,18,µg*h/mL,Arith. SD,AUC_tau,8,µg/mL,Arith. Mean,1.7,µg/mL,Arith. SD,Cmax,3,L/h,Arith. Mean,0.4,L/h,Arith. SD,CL/F,
1451,Møller 2001,https://pubmed.ncbi.nlm.nih.gov/11593075/,CBZ alone,Carbamazepine-10-11-epoxide,480,504,h,15,µg*h/mL,Arith. Mean,2,µg*h/mL,Arith. SD,AUC_tau,0.9,µg/mL,Arith. Mean,0.2,µg/mL,Arith. SD,Cmax,,,,,,,,CL values acc. to table 2 were not applicable.
1452,Eichelbaum 1985,https://pubmed.ncbi.nlm.nih.gov/3971637/,Healthy subject EH,Carbamazepine,,,,,,,,,,,,,,,,,,,,,,,,,
1453,Eichelbaum 1985,https://pubmed.ncbi.nlm.nih.gov/3971637/,Healthy subject EH,Carbamazepine-10-11-epoxide,,,,,,,,,,,,,,,,,,,,,,,,,
1455,Pisani 1988,https://pubmed.ncbi.nlm.nih.gov/3136790/,control (without valpromide),Carbamazepine-10-11-epoxide,0,inf,h,25.4,µg*h/mL,Arith. Mean,8.9,µg*h/mL,Arith. SD,AUC_inf,1.36,µg/mL,Arith. Mean,0.4,µg/mL,Arith. SD,Cmax,73.5,mL/h/kg,Arith. Mean,20.1,mL/h/kg,Arith. SD,CL/F,
1456,Furukori 1998,https://pubmed.ncbi.nlm.nih.gov/9536449/,treatment with placebo,Alprazolam,0,inf,h,,,,,,,,11.7,ng/mL,Arith. Mean,1.5,ng/mL,Arith. SD,Cmax,0.9,mL/min/kg,Arith. Mean,0.21,mL/min/kg,Arith. SD,CL/F,CL: Cloral = apparent oral clearance
1457,Furukori 1998,https://pubmed.ncbi.nlm.nih.gov/9536449/,treatment with carbamazepine,Alprazolam,170,218,h,,,,,,,,13,ng/mL,Arith. Mean,3.5,ng/mL,Arith. SD,Cmax,2.13,mL/min/kg,Arith. Mean,0.54,mL/min/kg,Arith. SD,CL/F,CL: Cloral = apparent oral clearance
1458,Caraco 1995,https://pubmed.ncbi.nlm.nih.gov/8547729/,Lean subjects,Carbamazepine,0,inf,h,,,,,,,,2.36,µg/mL,Arith. Mean,0.15,µg/mL,Arith. SD,Cmax,23,mL/min,Arith. Mean,4.6,mL/min,Arith. SD,CL/F,"CL = Oral Clearance; Mean extrapolated AUC: 8,0% +/- 3,4% of total AUC"
1459,Caraco 1995,https://pubmed.ncbi.nlm.nih.gov/8547729/,Obese subjects,Carbamazepine,0,inf,h,,,,,,,,1.91,µg/mL,Arith. Mean,0.31,µg/mL,Arith. SD,Cmax,19.8,mL/min,Arith. Mean,5.2,mL/min,Arith. SD,CL/F,"CL = Oral Clearance; Mean extrapolated AUC: 27,5% +/- 6,2% of total AUC"
16080,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 4,R-Verapamil,0,12,h,,,,,,,,,,,,,,,661,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16081,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 4,R-Verapamil,0,12,h,,,,,,,,,,,,,,,827,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16082,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 4,R-Verapamil,0,12,h,,,,,,,,,,,,,,,835,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16083,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 4,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1211,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16084,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 4,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1449,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16085,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 4,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1443,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16086,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 1,R-Verapamil,0,12,h,,,,,,,,,,,,,,,859,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16087,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 1,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1140,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16088,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 1,Verapamil,0,12,h,,,,,,,,,,,,,,,1030,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16089,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 2,R-Verapamil,0,12,h,,,,,,,,,,,,,,,713,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16090,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 2,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1321,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16091,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 2,Verapamil,0,12,h,,,,,,,,,,,,,,,745,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16092,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 3,R-Verapamil,0,12,h,,,,,,,,,,,,,,,796,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16093,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 3,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1650,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16094,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 3,Verapamil,0,12,h,,,,,,,,,,,,,,,1196,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16095,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 5,R-Verapamil,0,12,h,,,,,,,,,,,,,,,726,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16096,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 5,R-Verapamil,0,12,h,,,,,,,,,,,,,,,840,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16097,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 5,R-Verapamil,0,12,h,,,,,,,,,,,,,,,919,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16098,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 5,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1527,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16099,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 5,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1537,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16100,Eichelbaum 1984,https://pubmed.ncbi.nlm.nih.gov/6721991/,Subject 5,S-Verapamil,0,12,h,,,,,,,,,,,,,,,1418,mL/min,Individual,,,,CLiv,Cl normalized to bodyweight is also available
16101,Mooy et al. 1985,https://pubmed.ncbi.nlm.nih.gov/4029246/,"Normal volunteers, 3mg IV",Verapamil,0,inf,h,5.1,µg*min/mL,Arith. Mean,1.24,µg*min/mL,SEM,AUC_inf,,,,,,,,685,mL/min,Arith. Mean,136,mL/min,SEM,CLiv,Cl normalized to bodyweight is also available
16104,Mooy et al. 1985,https://pubmed.ncbi.nlm.nih.gov/4029246/,"Normal volunteers, 80mg PO",Verapamil,0,inf,h,10.5,µg*min/mL,Arith. Mean,1.09,µg*min/mL,SEM,AUC_inf,,,,,,,,8080,mL/min,Arith. Mean,970,mL/min,SEM,,Cl normalized to bodyweight is also available
16108,Streit 2005,https://pubmed.ncbi.nlm.nih.gov/15692829/,intravenous verapamil during normoxia (5 mg),Norverapamil,0,14,h,13,ng*h/mL,Arith. Mean,2.46,ng*h/mL,SD,AUC_tend,1.79,ng/mL,Arith. Mean,0.34,ng/mL,Arith. SD,Cmax,,,,,,,,
16201,Moj 2019,https://pubmed.ncbi.nlm.nih.gov/31104266/,"5 mg IV, 30 min infusion, Boehringer BI Trial No. 1160.5",Dabigatran,0,inf,h,2.89,ng*h/mL,arith. mean,3.4,ng*h/mL,arith. SD,AUC_inf,241,ng/mL,mean,,ng/mL,arith. SD,Cmax,,,,,,,,
16243,Prueksaritanont 2017,https://pubmed.ncbi.nlm.nih.gov/27943276/,Dabigatran in microdosecocktail alone,Dabigatran,0,inf,h,1440,pg*h/mL,geo. mean,,,,,173,pg/mL,geo. Mean,,,,,,,,,,,,
16244,Prueksaritanont 2017,https://pubmed.ncbi.nlm.nih.gov/27943276/,Dabigatran in microdosecocktail + Rifampicin,Dabigatran,0,inf,h,3340,pg*h/mL,geo. mean,,,,,309,pg/mL,geo. Mean,,,,,,,,,,,,
16245,Prueksaritanont 2017,https://pubmed.ncbi.nlm.nih.gov/27943276/,Dabigatran in microdosecocktail + Itraconazole,Dabigatran,0,inf,h,9970,pg*h/mL,geo. mean,,,,,1110,pg/mL,geo. Mean,,,,,,,,,,,,
16246,Prueksaritanont 2017,https://pubmed.ncbi.nlm.nih.gov/27943276/,Dabigatran in microdosecocktail + Clarithromycin,Dabigatran,0,inf,h,5790,pg*h/mL,geo. mean,,,,,793,pg/mL,geo. Mean,,,,,,,,,,,,
6162,Gurley 2008b,https://pubmed.ncbi.nlm.nih.gov/18214850/,Control to Perpetrator Echinacea,Digoxin,0,inf,h,7.3,ng*h/mL,Arith. Mean,1.6,ng*h/mL,Arith. SD,AUC_inf,1.3,ng/mL,Arith. Mean,0.3,ng/mL,Arith. SD,Cmax,,,,,,,,"AUC(0-3): 2,2 +/- 0,5"
6163,Gurley 2008b,https://pubmed.ncbi.nlm.nih.gov/18214850/,with Perpetrator (Echinacea),Digoxin,312,inf,h,7.5,ng*h/mL,Arith. Mean,1.8,ng*h/mL,Arith. SD,AUC_inf,1.2,ng/mL,Arith. Mean,0.3,ng/mL,Arith. SD,Cmax,,,,,,,,"AUC(0-3): 2,1 +/- 0,6"
16514,Gurley 2008b,https://pubmed.ncbi.nlm.nih.gov/18214850/,Digoxin without Hyperforin,Digoxin,0,inf,h,7.8,ng*h/mL,Arith. Mean,1.6,ng*h/mL,Arith. SD,AUC_inf,1.4,ng/mL,Arith. Mean,0.3,ng/mL,Arith. SD,Cmax,,,,,,,,"AUC(0-3): 2,5 +/- 0,6"
16515,Gurley 2008b,https://pubmed.ncbi.nlm.nih.gov/18214850/,Digoxin with Hyperforin,Digoxin,312,inf,h,6,ng*h/mL,Arith. Mean,1.3,ng*h/mL,Arith. SD,AUC_inf,0.9,ng/mL,Arith. Mean,0.2,ng/mL,Arith. SD,Cmax,,,,,,,,"AUC(0-3): 1,8 +/- 0,5"
17179,Kunze et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29663259/,Coproporphyrin I + rifampicin 600mg SD,Coproporphyrin I,0,16,h,38.55,nmol*h/L,Arith. Mean,6.59,nmol*h/L,SD,AUC_tend,3.6,nmol/L,Arith. Mean,0.5,nmol/L,Arith. SD,Cmax,,,,,,,,
17180,Kunze et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29663259/,Coproporphyrin I + rifampicin 600mg MD,Coproporphyrin I,0,16,h,18.41,nmol*h/L,Arith. Mean,3.32,nmol*h/L,SD,AUC_tend,2.15,nmol/L,Arith. Mean,0.4,nmol/L,Arith. SD,Cmax,,,,,,,,
17181,Lai et al 2016,https://pubmed.ncbi.nlm.nih.gov/27317801/,Coproporphyrin I,Coproporphyrin I,0,24,h,20.9,nmol*h/L,Arith. Mean,4.95,nmol*h/L,SD,AUC_tend,0.86,nmol/L,Arith. Mean,0.18,nmol/L,Arith. SD,Cmax,,,,,,,,
17182,Lai et al 2016,https://pubmed.ncbi.nlm.nih.gov/27317801/,Coproporphyrin I + rifampicin,Coproporphyrin I,0,24,h,84.2,nmol*h/L,Arith. Mean,18.7,nmol*h/L,SD,AUC_tend,5.54,nmol/L,Arith. Mean,0.8,nmol/L,Arith. SD,Cmax,,,,,,,,
17183,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Coproporphyrin I,Coproporphyrin I,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17184,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Coproporphyrin I + rifampicin 150 mg,Coproporphyrin I,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17185,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Coproporphyrin I + rifampicin 300 mg,Coproporphyrin I,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17186,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Coproporphyrin I + rifampicin 600 mg,Coproporphyrin I,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17187,Shen et al 2018,https://pubmed.ncbi.nlm.nih.gov/29777022/,Coproporphyrin I + rifampicin,Coproporphyrin I,0,24,h,56.01,nmol*h/L,Arith. Mean,15.11,nmol*h/L,SD,AUC_tend,3.91,nmol/L,Arith. Mean,0.94,nmol/L,Arith. SD,Cmax,,,,,,,,
17188,Zhang et al. 2020,https://pubmed.ncbi.nlm.nih.gov/32723847/,Coproporphyrin I,Coproporphyrin I,0,24,h,27.9,nmol*h/L,Arith. Mean,11.5,nmol*h/L,SD,AUC_tend,1.34,nmol/L,Arith. Mean,0.58,nmol/L,Arith. SD,Cmax,,,,,,,,
17189,Zhang et al. 2020,https://pubmed.ncbi.nlm.nih.gov/32723847/,Coproporphyrin I + probenecid,Coproporphyrin I,0,24,h,41.1,nmol*h/L,Arith. Mean,16.4,nmol*h/L,SD,AUC_tend,1.98,nmol/L,Arith. Mean,0.74,nmol/L,Arith. SD,Cmax,,,,,,,,
17190,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Coproporphyrin I,Coproporphyrin I,0,24,h,16.1,nmol*h/L,Arith. Mean,1.6,nmol*h/L,SEM,AUC_tend,,,,,,,,,,,,,,,
17191,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Coproporphyrin I + rifampicin 300 mg,Coproporphyrin I,0,24,h,46.9,nmol*h/L,Arith. Mean,3,nmol*h/L,SEM,AUC_tend,,,,,,,,,,,,,,,
17192,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Coproporphyrin I + rifampicin 600 mg,Coproporphyrin I,0,24,h,71.7,nmol*h/L,Arith. Mean,4,nmol*h/L,SEM,AUC_tend,6.39,nmol/L,Arith. Mean,1,nmol/L,SEM,Cmax,,,,,,,,
17193,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Pitavastatin 0.2mg,Pitavastatin,0,24,h,23.2,nmol*h/L,Arith. Mean,3.7,nmol*h/L,SEM,AUC_tend,20.4,nmol/L,Arith. Mean,2.1,nmol/L,SEM,Cmax,,,,,,,,
17194,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Pitavastatin + rifampicin 300 mg,Pitavastatin,0,24,h,49.3,nmol*h/L,Arith. Mean,4.4,nmol*h/L,SEM,AUC_tend,19.3,nmol/L,Arith. Mean,1.9,nmol/L,SEM,Cmax,,,,,,,,
17195,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Pitavastatin + rifampicin 600 mg,Pitavastatin,0,24,h,58.9,nmol*h/L,Arith. Mean,4.2,nmol*h/L,SEM,AUC_tend,,,,,,,,,,,,,,,
17196,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Pitavastatin 0.2mg,Pitavastatin,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17197,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Pitavastatin + rifampicin 150 mg,Pitavastatin,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17198,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Pitavastatin + rifampicin 300 mg,Pitavastatin,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17199,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Pitavastatin + rifampicin 600 mg,Pitavastatin,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17200,Chen et al. 2013,https://pubmed.ncbi.nlm.nih.gov/23831870/,Pitavastatin 4mg,Pitavastatin,0,48,h,357,ng*h/mL,Arith. Mean,231.4;482.7,ng*h/mL,90% CI,AUC_tend,116.7,ng/mL,Arith. Mean,81.8;151.6,ng/mL,90% CI,Cmax,,,,,,,,
17201,Chen et al. 2013,https://pubmed.ncbi.nlm.nih.gov/23831870/,Pitavastatin + rifampicin 600 mg,Pitavastatin,0,48,h,1979.3,ng*h/mL,Arith. Mean,1518.8;2439.8,ng*h/mL,90% CI,AUC_tend,892.8,ng/mL,Arith. Mean,643.5;1142,ng/mL,90% CI,Cmax,,,,,,,,
17202,Prueksaritanont et al. 2014,https://pubmed.ncbi.nlm.nih.gov/24617605/,Pitavastatin 1mg,Pitavastatin,0.5,4.5,h,29,ng*h/mL,Arith. Mean,20.6,ng*h/mL,SD,AUC_inf,16.5,ng/mL,Arith. Mean,9.32,ng/mL,Arith. SD,Cmax,,,,,,,,
17203,Prueksaritanont et al. 2014,https://pubmed.ncbi.nlm.nih.gov/24617605/,Pitavastatin + rifampicin 600 mg oral,Pitavastatin,0.5,24.5,h,157,ng*h/mL,Arith. Mean,62.2,ng*h/mL,SD,AUC_inf,78.8,ng/mL,Arith. Mean,45.3,ng/mL,Arith. SD,Cmax,,,,,,,,
17204,Prueksaritanont et al. 2014,https://pubmed.ncbi.nlm.nih.gov/24617605/,Pitavastatin + rifampicin 600 mg iv,Pitavastatin,0.5,24.5,h,193,ng*h/mL,Arith. Mean,62.3,ng*h/mL,SD,AUC_inf,91.3,ng/mL,Arith. Mean,26.6,ng/mL,Arith. SD,Cmax,,,,,,,,
17205,Lou et al. 2015,https://pubmed.ncbi.nlm.nih.gov/26082816/,Pitavastatin 1mg,Pitavastatin,0,36,h,190.04,ng*h/mL,Arith. Mean,38.97,ng*h/mL,SD,AUC_tend,66.8,ng/mL,Arith. Mean,16.32,ng/mL,Arith. SD,Cmax,,,,,,,,
17206,Lou et al. 2015,https://pubmed.ncbi.nlm.nih.gov/26082816/,Pitavastatin 2mg,Pitavastatin,0,36,h,307.87,ng*h/mL,Arith. Mean,57.94,ng*h/mL,SD,AUC_tend,106.09,ng/mL,Arith. Mean,31.59,ng/mL,Arith. SD,Cmax,,,,,,,,
17207,Lou et al. 2015,https://pubmed.ncbi.nlm.nih.gov/26082816/,Pitavastatin 4mg,Pitavastatin,0,36,h,785.1,ng*h/mL,Arith. Mean,166.08,ng*h/mL,SD,AUC_tend,232.91,ng/mL,Arith. Mean,66.42,ng/mL,Arith. SD,Cmax,,,,,,,,
17208,Ieiri et al. 2007,https://pubmed.ncbi.nlm.nih.gov/17460607/,Pitavastatin 2mg in SLCO1B1*1b*1b subjects,Pitavastatin,0,24,h,81.1,ng*h/mL,Arith. Mean,18.1,ng*h/mL,SD,AUC_tend,31.2,ng/mL,Arith. Mean,11.4,ng/mL,Arith. SD,Cmax,,,,,,,,
17209,Ieiri et al. 2007,https://pubmed.ncbi.nlm.nih.gov/17460607/,Pitavastatin 2mg in SLCO1B1*1b*15 subjects,Pitavastatin,0,24,h,144,ng*h/mL,Arith. Mean,32,ng*h/mL,SD,AUC_tend,70.7,ng/mL,Arith. Mean,18.1,ng/mL,Arith. SD,Cmax,,,,,,,,
17210,Ieiri et al. 2007,https://pubmed.ncbi.nlm.nih.gov/17460607/,Pitavastatin 2mg in SLCO1B1*15*15 subjects,Pitavastatin,0,24,h,250,ng*h/mL,Arith. Mean,57,ng*h/mL,SD,AUC_tend,129,ng/mL,Arith. Mean,24,ng/mL,Arith. SD,Cmax,,,,,,,,
17211,Prueksaritanont et al. 2014,https://pubmed.ncbi.nlm.nih.gov/24617605/,Rosuvastatin 5mg,Rosuvastatin,0.5,24.5,h,19.2,ng*h/mL,Arith. Mean,7.7,ng*h/mL,SD,AUC_tend,2.79,ng/mL,Arith. Mean,"1,06",ng/mL,Arith. SD,Cmax,,,,,,,,
17212,Prueksaritanont et al. 2014,https://pubmed.ncbi.nlm.nih.gov/24617605/,Rosuvastatin + rifampicin 600 mg iv,Rosuvastatin,0.5,24.5,h,68.5,ng*h/mL,Arith. Mean,26.4,ng*h/mL,SD,AUC_tend,15.2,ng/mL,Arith. Mean,5.41,ng/mL,Arith. SD,Cmax,,,,,,,,
17213,Prueksaritanont et al. 2014,https://pubmed.ncbi.nlm.nih.gov/24617605/,Rosuvastatin + rifampicin 600 mg oral,Rosuvastatin,0.5,24.5,h,88.5,ng*h/mL,Arith. Mean,16.7,ng*h/mL,SD,AUC_tend,26.2,ng/mL,Arith. Mean,7.69,ng/mL,Arith. SD,Cmax,,,,,,,,
17214,Prueksaritanont et al. 2017,https://pubmed.ncbi.nlm.nih.gov/27943276/,Rosuvastatin 50µg,Rosuvastatin,0,24,h,229,pg*h/mL,Geom. Mean,180;292,pg*h/mL,90% CI,AUC_tend,27.2,pg/mL,Geom. Mean,21.5;34.4,pg/mL,90% CI,Cmax,,,,,,,,
17215,Prueksaritanont et al. 2017,https://pubmed.ncbi.nlm.nih.gov/27943276/,Rosuvastatin + rifampicin 600 mg ,Rosuvastatin,0,24,h,1230,pg*h/mL,Geom. Mean,881;1720,pg*h/mL,90% CI,AUC_tend,313,pg/mL,Geom. Mean,198;496,pg/mL,90% CI,Cmax,,,,,,,,
17216,Wu et al. 2017,https://pubmed.ncbi.nlm.nih.gov/28385543/,Rosuvastatin 20mg,Rosuvastatin,0.5,48.5,h,77.2,ng*h/mL,Arith. Mean,31.5,ng*h/mL,SD,AUC_tend,7.6,ng/mL,Arith. Mean,3,ng/mL,Arith. SD,Cmax,,,,,,,,
17217,Wu et al. 2017,https://pubmed.ncbi.nlm.nih.gov/28385543/,Rosuvastatin + rifampicin 600 mg IV ,Rosuvastatin,0.5,48.5,h,278.2,ng*h/mL,Arith. Mean,73.2,ng*h/mL,SD,AUC_tend,65,ng/mL,Arith. Mean,32.2,ng/mL,Arith. SD,Cmax,,,,,,,,
17218,Wiebe et al 2020,https://pubmed.ncbi.nlm.nih.gov/32504272/,Rosuvastatin 10mg,Rosuvastatin,0,24,h,87.29,nmol*h/L,adjusted geom. Mean,,,,AUC_tend,6.84,nmol/L,adjusted geom. Mean,,,,Cmax,,,,,,,,
17219,Wiebe et al 2020,https://pubmed.ncbi.nlm.nih.gov/32504272/,Rosuvastatin 10mg,Rosuvastatin,13,37,h,106.69,nmol*h/L,adjusted geom. Mean,,,,AUC_tend,10.11,nmol/L,adjusted geom. Mean,,,,Cmax,,,,,,,,
17220,Wiebe et al 2020,https://pubmed.ncbi.nlm.nih.gov/32504272/,Rosuvastatin + rifampicin 600 mg ,Rosuvastatin,0,24,h,303.81,nmol*h/L,adjusted geom. Mean,,,,AUC_tend,77,nmol/L,adjusted geom. Mean,,,,Cmax,,,,,,,,
17221,Wiebe et al 2020,https://pubmed.ncbi.nlm.nih.gov/32504272/,Rosuvastatin + probenecid 1000 mg ,Rosuvastatin,13,37,h,238.16,nmol*h/L,adjusted geom. Mean,,,,AUC_tend,43.29,nmol/L,adjusted geom. Mean,,,,,,,,,,,,
17222,Kimoto et al 2022,https://pubmed.ncbi.nlm.nih.gov/34605015/,Pitavastatin 2 mg iv infusion,Pitavastatin,0,24,h,78.63,ng*h/mL,Arith. Mean,21.11,ng*h/mL,SD,AUC_tend,60.85,ng/mL,Arith. Mean,11.34,ng/mL,Arith. SD,Cmax,4095,mL/min,Arith. Mean,118.7,mL/min,Arith. SD,CL/F,"geomean and GSD for all parametrs available in original reference (NDA), AUC_inf also available"
17223,Kimoto et al 2022,https://pubmed.ncbi.nlm.nih.gov/34605015/,Pitavastatin 2mg,Pitavastatin,0,24,h,37.72,ng*h/mL,Arith. Mean,20.18,ng*h/mL,SD,AUC_tend,21.43,ng/mL,Arith. Mean,13.02,ng/mL,Arith. SD,Cmax,837.7,mL/min,Arith. Mean,367,mL/min,Arith. SD,CL/F,"geomean and GSD for all parametrs available in original reference (NDA), AUC_inf also available"
17224,Kimoto et al 2022,https://pubmed.ncbi.nlm.nih.gov/34605015/,Pitavastatin 4mg,Pitavastatin,0,24,h,,,,,,,,,,,,,,,,,,,,,,
17225,Backman et al. 2005,https://pubmed.ncbi.nlm.nih.gov/16084850/,Atorvastatin 40 mg,Atorvastatin,113,161,h,62.5,ng*h/mL,Arith. Mean,20.7,ng*h/mL,SD,AUC_tend,15.8,ng/mL,Arith. Mean,5.4,ng/mL,Arith. SD,Cmax,,,,,,,,"AUC_inf also available, Table 1"
17226,Backman et al. 2005,https://pubmed.ncbi.nlm.nih.gov/16084850/,Atorvastatin + rifampicin 600 mg,Atorvastatin,113,161,h,12.6,ng*h/mL,Arith. Mean,3.2,ng*h/mL,SD,AUC_tend,9.5,ng/mL,Arith. Mean,3.7,ng/mL,Arith. SD,Cmax,,,,,,,,"AUC_inf also available, Table 1"
17227,Lau et al. 2007,https://pubmed.ncbi.nlm.nih.gov/17192770/,Atorvastatin 40 mg,Atorvastatin,0.5,24.5,h,89,ng*h/mL,Arith. Mean,31.3,ng*h/mL,SD,AUC_tend,17.4,ng/mL,Arith. Mean,8.7,ng/mL,Arith. SD,Cmax,6.78,L/h/kg,Arith. Mean,2.7,L/h/kg,Arith. SD,CL/F,"AUC_inf also available, Table 1"
17228,Lau et al. 2007,https://pubmed.ncbi.nlm.nih.gov/17192770/,Atorvastatin + rifampicin 600 mg IV,Atorvastatin,0.5,24.5,h,716,ng*h/mL,Arith. Mean,219,ng*h/mL,SD,AUC_tend,182,ng/mL,Arith. Mean,75,ng/mL,Arith. SD,Cmax,0.88,L/h/kg,Arith. Mean,0.23,L/h/kg,Arith. SD,CL/F,"AUC_inf also available, Table 1"
17229,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Atorvastatin 1 mg,Atorvastatin,0,24,h,8.432,nmol*h/L,Geom. Mean,,,,AUC_tend,1.28,nmol/L,Geom. Mean,,,,Cmax,,,,,,,,Table S2
17230,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Atorvastatin + rifampicin 150 mg,Atorvastatin,0,24,h,28.191,nmol*h/L,Geom. Mean,,,,AUC_tend,9.93,nmol/L,Geom. Mean,,,,Cmax,,,,,,,,Table S2
17231,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Atorvastatin + rifampicin 300 mg,Atorvastatin,0,24,h,41.182,nmol*h/L,Geom. Mean,,,,AUC_tend,15,nmol/L,Geom. Mean,,,,Cmax,,,,,,,,Table S2
17232,Mori et al 2020,https://pubmed.ncbi.nlm.nih.gov/31628668/,Atorvastatin + rifampicin 600 mg,Atorvastatin,0,24,h,61.436,nmol*h/L,Geom. Mean,,,,AUC_tend,17.1,nmol/L,Geom. Mean,,,,Cmax,,,,,,,,Table S2
17233,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Atorvastatin 1 mg,Atorvastatin,0,24,h,1.81,nmol*h/L,Arith. Mean,0.21,nmol*h/L,SEM,AUC_tend,0.206,nmol/L,Arith. Mean,0.022,nmol/L,SEM,Cmax,1138,L/h,Arith. Mean,192,L/h,SEM,CL/F,Table 1
17234,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Atorvastatin + rifampicin 300 mg,Atorvastatin,0,24,h,6.51,nmol*h/L,Arith. Mean,0.73,nmol*h/L,SEM,AUC_tend,1.72,nmol/L,Arith. Mean,0.32,nmol/L,SEM,Cmax,301,L/h,Arith. Mean,35,L/h,SEM,CL/F,Table 1
17235,Takehara et al. 2018,https://pubmed.ncbi.nlm.nih.gov/29748935/,Atorvastatin + rifampicin 600 mg,Atorvastatin,0,24,h,9.18,nmol*h/L,Arith. Mean,1.01,nmol*h/L,SEM,AUC_tend,2.74,nmol/L,Arith. Mean,0.45,nmol/L,SEM,Cmax,213,L/h,Arith. Mean,24,L/h,SEM,CL/F,Table 1
17236,Bergan 1985,10.3109/00365528509088853,Metronidazole 1500 mg IV,Metronidazole,0,72,h,535.56,mg*h/L,Arith. Mean,,,,AUC_tend,40.1,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17237,Männistö 1984,10.1007/BF01640899,Metronidazole 500 mg IV,Metronidazole,0,24,h,126.24,mg*h/L,Arith. Mean,,,,AUC_tend,21.58,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17238,Männistö 1984,10.1007/BF01640899,Metronidazole 400 mg TID PO,Metronidazole,72,78,h,74.92,mg*h/L,Arith. Mean,,,,AUC_tend,16.45,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17239,Salas-Herrera 1991,10.1093/jac/28.2.283,Metronidazole 400 mg BID PO,Metronidazole,0,12,h,70.62,mg*h/L,Arith. Mean,,,,AUC_tend,8.27,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17240,Salas-Herrera 1991,10.1093/jac/28.2.283,Metronidazole 400 mg BID PO,Metronidazole,108,132,h,184.4,mg*h/L,Arith. Mean,,,,AUC_tau,13.9,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17241,Salas-Herrera 1991,10.1093/jac/28.2.283,Metronidazole 400 mg BID PO,Metronidazole,0,12,h,45.16,mg*h/L,Arith. Mean,,,,AUC_tend,5.21,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Cervicovaginal fluid; calculated from extracted data
17242,Salas-Herrera 1991,10.1093/jac/28.2.283,Metronidazole 400 mg BID PO,Metronidazole,108,132,h,135.29,mg*h/L,Arith. Mean,,,,AUC_tau,10.44,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Cervicovaginal fluid; calculated from extracted data
17243,Salas-Herrera 1991,10.1111/j.1365-2125.1991.tb03962.x,Metronidazole 500 mg BID Vaginal,Metronidazole,0,12,h,6.58,mg*h/L,Arith. Mean,,,,AUC_tend,0.8,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17244,Salas-Herrera 1991,10.1111/j.1365-2125.1991.tb03962.x,Metronidazole 500 mg BID Vaginal,Metronidazole,96,120,h,23.56,mg*h/L,Arith. Mean,,,,AUC_tau,1.39,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17245,Cunningham 1994,10.1002/j.1552-4604.1994.tb01981.x,Metronidazole 500 mg PO,Metronidazole,0,48,h,138.62,mg*h/L,Arith. Mean,,,,AUC_tend,11.51,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17246,Cunningham 1994,10.1002/j.1552-4604.1994.tb01981.x,Metronidazole 37.5 mg Vaginal,Metronidazole,0,48,h,5.23,mg*h/L,Arith. Mean,,,,AUC_tend,0.23,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17247,Matilla 1983,10.1128/AAC.23.5.721,Metronidazole 500 mg IV,Metronidazole,0,24,h,90.68,mg*h/L,Arith. Mean,,,,AUC_tend,9,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17248,Matilla 1983,10.1128/AAC.23.5.721,Metronidazole 500 mg PO,Metronidazole,0,48,h,119.46,mg*h/L,Arith. Mean,,,,AUC_tend,8.36,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17249,Matilla 1983,10.1128/AAC.23.5.721,Metronidazole 500 mg Vaginal,Metronidazole,0,48,h,33.66,mg*h/L,Arith. Mean,,,,AUC_tend,1.68,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17250,Fredericsson 1987,10.1159/000298803,Metronidazole 500 mg IV,Metronidazole,0,24,h,106.99,mg*h/L,Arith. Mean,,,,AUC_tend,30.21,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17251,Fredericsson 1987,10.1159/000298803,Metronidazole 400 mg PO,Metronidazole,0,24,h,90.4,mg*h/L,Arith. Mean,,,,AUC_tend,8.8,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17252,Fredericsson 1987,10.1159/000298803,Metronidazole 500 mg Vaginal,Metronidazole,0,48,h,21.52,mg*h/L,Arith. Mean,,,,AUC_tend,0.91,mg/L,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17253,Korth-Bradley 2012,10.1177/2160763X11432508,Moxidectin 10 mg PO solution,Moxidectin,0,180,day(s),4981.72,ng*h/mL,Arith. Mean,,,,AUC_tend,78.7,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17254,Korth-Bradley 2012,10.1177/2160763X11432508,Moxidectin 10 mg PO tablet,Moxidectin,0,180,day(s),3823.89,ng*h/mL,Arith. Mean,,,,AUC_tend,52.5,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17255,Korth-Bradley 2012,10.4269/ajtmh.2012.11-0415,Moxidectin 8 mg PO fasted,Moxidectin,0,90,day(s),3119.61,ng*h/mL,Arith. Mean,,,,AUC_tend,55.43,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17256,Korth-Bradley 2012,10.4269/ajtmh.2012.11-0415,Moxidectin 8 mg PO fed,Moxidectin,0,90,day(s),4593.77,ng*h/mL,Arith. Mean,,,,AUC_tend,66.96,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17257,Cotreau 2003,10.1177/0091270003257456,Moxidectin 18 mg PO fasted,Moxidectin,0,80,day(s),5046.15,ng*h/mL,Arith. Mean,,,,AUC_tend,105.13,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17258,Cotreau 2003,10.1177/0091270003257456,Moxidectin 36 mg PO fasted,Moxidectin,0,80,day(s),9057.32,ng*h/mL,Arith. Mean,,,,AUC_tend,298.1,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17259,Cotreau 2003,10.1177/0091270003257456,Moxidectin 36 mg PO fed,Moxidectin,0,80,day(s),3346.93,ng*h/mL,Arith. Mean,,,,AUC_tend,51.91,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17260,Cotreau 2003,10.1177/0091270003257456,Moxidectin 3 mg PO fasted,Moxidectin,0,80,day(s),1168.22,ng*h/mL,Arith. Mean,,,,AUC_tend,21.66,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17261,Cotreau 2003,10.1177/0091270003257456,Moxidectin 9 mg PO fasted,Moxidectin,0,80,day(s),2301.19,ng*h/mL,Arith. Mean,,,,AUC_tend,58.4,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17262,Cotreau 2003,10.1177/0091270003257456,Moxidectin 9 mg PO fed,Moxidectin,0,80,day(s),3346.93,ng*h/mL,Arith. Mean,,,,AUC_tend,51.91,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17263,Kinrade 2018,10.1111/cts.12583,Moxidectin 16 mg PO,Moxidectin,0,72,day(s),2024.29,ng*h/mL,Arith. Mean,,,,AUC_tend,133.44,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17264,Kinrade 2018,10.1111/cts.12583,Moxidectin 24 mg PO,Moxidectin,0,72,day(s),2725.6,ng*h/mL,Arith. Mean,,,,AUC_tend,161.54,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17265,Kinrade 2018,10.1111/cts.12583,Moxidectin 36 mg PO,Moxidectin,0,72,day(s),3675.56,ng*h/mL,Arith. Mean,,,,AUC_tend,232.37,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17266,Kinrade 2018,10.1111/cts.12583,Moxidectin 4 mg PO,Moxidectin,0,72,day(s),411.21,ng*h/mL,Arith. Mean,,,,AUC_tend,25.99,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
17267,Kinrade 2018,10.1111/cts.12583,Moxidectin 8 mg PO,Moxidectin,0,72,day(s),928.59,ng*h/mL,Arith. Mean,,,,AUC_tend,55.29,ng/mL,Arith. Mean,,,,Cmax,,,,,,,,Plasma; calculated from extracted data
